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i Abstract 
The picornavirus family includes significant human and animal viruses such as poliovirus 
(PV), human rhinovirus (HRV) and foot-and-mouth-disease virus (FMDV). Current disease 
treatment and control strategies are limited by an incomplete understanding of the 
interactions between the non-structural, replicative picornavirus proteins and host cell 
components. To investigate these interactions, Theiler's murine encephalomyelitis virus 
(TMEV) 2B, 2C, 2BC and 3A proteins were transiently expressed in BHK-21 cells and 
detected by indirect imrnunostaining and laser-scanning or epifluorescence microscopy. The 
signal of the 2B protein overlapped with that of the ER marker protein, ERp60, as well as 
that of the peripheral Golgi marker protein, ~-COP. The 2C protein overlapped with ERp60 
in a faint reticular stain, and localised to large punctate structures that partially overlapped 
with ~-COP at higher levels of expression. The 2BC protein located to large perinuclear 
structures that overlapped exclusively with ~-COP. The TMEV 3A protein signal 
overlapped with both ERp60 and ~-COP stains, in addition in cells expressing the 3A 
protein the ER appeared swollen and bulbous while the Golgi was dispersed in some cells. 
2C and 2BC proteins with C-terminal deletions localised in the same manner as the wild 
type proteins indicating that the localisation signals that determine subcellular localisation 
of the proteins are within the N-terminal60 amino acids of the 2C protein. 
The significance of the high degree of conservation of the N-terminal domain of the 2C 
protein throughout the Picornaviridae was investigated through the introduction of amino 
acid substitution mutations at highly conserved residues in the N-terminal domain of 2C 
into the viral cDNA. Upon transfection ofthe viral RNA into BHK-21 cells, it was observed 
that substitution of amino acid residues 8, 18 and 29 abolished the ability of TMEV to 
induce cytopathic effect (CPE), while substitution ofresidues 4, 14 and 23 only attenuated 
the ability ofTMEV to induce CPE. 
To determine whether amino acid substitution mutations would affect the localisation of the 
2C protein, 2C proteins with substitution mutations at amino acids 4, 8, 14, 18, 23 and 29 
were transiently expressed in BHK-21 cells and detected by indirect imrnunostaining and 
examination by laser-scanning confocal and epifluorescence microscopy. The 2C mutant 4, 
8 and 29 proteins showed slightly altered localisation patterns compared to the wild type 
protein with a significant portion of the proteins localising in a perinuclear stain suggesting 
possible localisation to the nuclear envelop. The 2C mutant 14 and 18 proteins localised to a 
diffuse pattern in BHK -21 cells while the 2C mutant 23 protein located to small punctate 
structures that partially overlapped with the ERp60 stain but were completely separate from 
the [3-COP stain. 
Finally, a hydrophilic, antigenic region of the 2C protein was expressed in frame with an N-
tenninal GST tag and was successfully purified on a pilot-scale and detected by Western 
analysis. This 2C 178 peptide will be used to generate antibodies against the 2C and 2BC 
proteins for use in future studies. This study has furthered our knowledge of the localisation 
of the picornavirus 2B, 2C, 2BC and 3A proteins in host cells and identified a possible link 
between this localisation and an ability ofTMEV to replicate in BHK-21 cells. 
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1 Review of Literature 
1.1 PICORNAVIRUSES: A GLOBAL BATTLE 
The picornavirus family includes a significant number of highly virulent human and 
animal pathogens, notable examples being Poliovirus (PV), Human rhinoviruses 
(HRV) and Foot-and-mouth disease virus (FMDV). The diseases caused by these 
viruses have significant economical impact worldwide and consequently the 
picornavirus family is the most intensely studied of all the positive sense single-
stranded RNA viruses. A brief description of some of the socio-economic 
consequences caused by picornavirus infections is given below. 
As a prominent human pathogen and the cause of severe poliomyelitis worldwide, PV 
is the most studied virus picornavirus and is the prototypic member of the 
Picornaviridae. The severely disabling effects of poliomyelitis brought financial 
burden to developing countries during the 20h century leading to an aggressive 
vaccination program. By 2002 the occurrence of poliovirus infections had 
significantly decreased on a global scale (World Health Organisation, 2002). Recently 
however, reservoirs ofPV infection have re-emerged in North West Africa. 
Another significant human disease: the "common cold", is estimated to cause the loss 
of more working hours worldwide each year than any other single cause (US 
Department of Health, 2006). In the United States alone an estimated I billion cases 
of the common cold occur in the population each year (U.S. Department Of Health, 
2006). Although symptoms of the common cold are known to be caused by more than 
200 viruses, it is estimated that 30-35% of adult individuals diagnosed as suffering 
from the common cold have contracted an HRV infection (U.S. Department Of 
Health, 2006). To date no effective vaccine or cure has been developed against HR V 
infection. Although this can be largely attributed to the rapid antigenic drift observed 
with HRV (Savolainen el ai, 2002), the lack of understanding of the picornavirus 
replication cycle on a molecular level must also be taken into account. 
FMDV is a highly virulent and infectious pathogen that infects ruminant animals 
including domestic sheep and cattle. Despite international efforts to control the 
movement of cattle and sale of beef, outbreaks of this disease are still prominent in 
1 
sub-Saharan Africa and other parts of the world. If not rapidly brought under control 
such outbreaks can have disastrous effects. An outbreak of foot-and-mouth disease in 
Britain in 2001 severely damaged the British beef industry and created significant 
financial risks for the European agricultural community as a whole. A range of 
vaccines against FMDV are currently available but these are continuously challenged 
by the emergence of novel strains of FMDV and persistent infections in vaccinated 
and infected animals (Alexandersen et ai, 2002). 
In view of the substantial economic threat posed by various picornavirus infections, 
made more tangible by the rapid increase in global travel and trade in animal 
products, it is essential that more effective disease treatment and control strategies be 
developed. To this end, we propose that a more detailed understanding of the 
interactions formed between host cell components and picornavirus proteins will 
ultimately lead to the identification of possible drug targets for the treatment of 
picornavirus infections. 
2 
1.2 PICORNAVIRUS GENOME ORGANISATION AND REPLICATION 
STRATEGY 
The Picornaviridae are highly diverse, comprising seven genera with over two 
hundred known serotypes that infect a wide range of mammalian hosts, including 
humans and livestock (Table 1.2.1). 
Table 1.2.1. The genera of the Picornaviridae (adapted from Bedard and Semler, 
2004) 
Genus Example of member species Clinical disease 
Aphthovirus Foot-and-mouth disease virus Foot-and-mouth disease in 
ruminants 
Cardiovirus Theiler's murine Mouse encephalomyelitis 
encephalomyelitis virus 
Enteroviruses Poliovirus Poliomyelitis 
Hepatoviruses Hepatitis A virus Liver disease 
Parechoviruses Human parechovirus Chronic meningoencephalitis, 
neonatal carditis 
Rhinoviruses Human rhinoviruses Common cold 
Teschovirus Porcine teschovirus Teschen-Talfan neurological 
disease 
Picornaviruses possess a positive-sense single-stranded RNA (ssRNA) genome of7.2 
kb - 8.5 kb that encodes the viral proteins in a single open reading frame (ORF). 
Picornavirus genomes are characterised by a 5' VPg and a 3' poly-A tail (Reviewed in 
Bedard and Semler, 2004, Figure 1.2.1). The 5' VPg is necessary for the initiation of 
viral RNA replication and it is thought that the 3' poly-A tail lends stability to the 
viral RNA (Bedard and Semler, 2004). 
Following the uncoating of the virus particle in the cytoplasm of an infected cell the 
VPg is cleaved from the viral genome by a cellular enzyme and the single open 
reading frame is translated as a polyprotein of 2100-2400 amino acids (reviewed in 
Bedard and Semler, 2004). The full -length polyprotein is not observed in infected 
cells as it undergoes co- and post-translational cleavage by virus-encoded proteinases, 
3 
2Apro, 3Cpro and 3CDpro, to give a range of mature protein products and precursor 
polyproteins (Figure 1.2.1) which exist independently in infected cells (Harris et ai, 
1990; Wimmer et ai, 1993; Ypma-Wong et ai, 1998). Although the precise cleavage 
patterns do vary between picornaviruses the genome can be broadly divided into three 
regions: PI, P2 and P3 (Figure 1.2.1). PI encodes the viral coat proteins while P2 and 
P3 encode the non-structural proteins involved in facilitating virus replication 
(Wimmer et ai, 1993) through the modification of the intracellular environment, the 
assembly of the virus replication complex and the replication of viral RNA. 
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Figure 1.2.1. Schematic representation of PV genome organisation and protein expression. The single ORF is 
flanked by a 5' UTR comprising a cloverleaf structure and IRES, which mediate the initiation of CAP-
independent translation, a 3' UTR and poly-A tail. The ORF is translated as a polyprotein that is co- and post-
translationally cleaved to yielding four structural proteins (VPI-4) from the PI domain, which are incorporated 
into nascent viral capsids, and numerous non-structural replicative proteins derived from the P2 and P3 domains 
(adapted from Bedard and Semler, 2004). 
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In addition to VPg, the 5' terminus of the picornavirus genome is further characterised 
by an untranslated region (5' UTR) that contains a cloverleaf structure required for 
positive-sense viral RNA replication (Andino et ai, 1990) and an internal ribosome 
entry site (IRES) (Figure 1.2.1) that facilitates catabolite activator protein (CAP)-
independent translation (Pelletier and Sonenberg, 1988). CAP-independent translation 
facilitates the translation of the viral genome while host translation is shut down 
during infection (Bedard and Semler, 2004). The 5' cloverleaf structure forms a 
ribonucleoprotein complex with the viral protein 3CDpro and a 36 kDa ribosome-
associated cellular protein (Harris et ai, 1994; Andino el ai, 1993). The 3' UTR is also 
known to associate with 3CDpro as well as 3AB in the absence of other viral proteins 
and possesses a stem-loop structure that is required during RNA replication (Harris et 
ai, 1994). However the precise role it plays during viral RNA replication is unknown 
(reviewed in Bedard and Semler, 2004). It is thought that 3AB may be the immediate 
precursor ofVPg at the site of viral RNA replication (Giachetti and Semler, 1991). 
Subsequent to ViruS protein translation and multiple cleavage events the virus 
replication complex is assembled and is the site of viral RNA replication. The 
positive-sense viral RNA of the infecting virion is used as a template for negative-
sense RNA replication, mediated by the viral RNA-dependent RNA polymerase 3Dpol 
(Flanegan and Baltimore, 1977; Tuschall et ai, 1982; Van Dyke and Flanegan, 1980; 
Van Dyke et ai, 1982). The negative-sense viral RNA possesses a 3' cloverleaf 
structure that is possibly anchored to the replication complex through binding of the 
vesicle-bound 2C protein (Banerjee et ai, 1997; Banerjee and Dasgupta, 2001). 
The negative-sense viral RNA is in turn used as a template for the production of 
nascent positive-sense RNA molecules that are translated to yield additional nascent 
viral proteins and are later incorporated into progeny virions (Barton and Flanegan, 
1997). Nascent viral RNA synthesis occurs asymmetrically with far more positive 
strands being made than negative strands as the negative strands only serve as 
templates for positive strands, which are later incorporated into nascent virions 
(Barton and Flanegan, 1997). 
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Picornavirus capsids consist of 60 protomers, which each comprise one of each of the 
four polypeptides (VP 1-4, Figure 1.2.1) encoded by the P I region. The protomers are 
tightly packed in an icosahedral arrangement to fonn particles of 27-30nrn in size 
(Internet I). The genomic RNA is densely packed into the capsid together with 
sodium or potassium ions, which serve to stabilise the particle by counteracting the 
negative charge conferred by the phosphate groups on the genomic RNA (Internet 1). 
Despite extensive investigation, the mechanisms of picornavirus RNA translation 
initiation and RNA replication and the cellular proteins involved in these events are 
not fully understood. This is a serious hindrance in the development of novel drug 
therapy strategies for the treatment of diseases caused by picornaviruses. 
1.3 PICORNAVIRUS INFECTION: EFFECT ON HOST MEMBRANES 
1.3.1 Effects on host cell ultrastructure by positive sense ssRNA virus 
infection 
To date all investigated positive-sense ssRNA viruses are known to induce the 
modification of specific host cell membranes and the proliferation of membranous 
vesicles that support the virus replication complex, the site of viral RNA replication 
(Doedens and Kirkegaard, 1995; Aldabe and Carasco, 1995; Bienz et ai, 1987; Bienz 
et aI, 1990; Bienz et ai, 1992; Cho et ai, 1994; Schlegel et aI, 1996; Mackenzie et ai, 
1999; Miller and Ahlquist, 2002). A variety of organelles are targeted by different 
viruses, with some viruses modifying the membranes of more than one organelle 
during the replication cycle (Schlegal et aI, 1996; Rust et ai, 2001). It is interesting to 
note that, unlike many enveloped viruses that also utilise host membranes, positive-
sense ssRNA viruses lack a membranous envelope. 
Some positive-sense ssRNA viruses target membranes of the secretory pathway, i.e. 
the Golgi apparatus (Doedens and Kirkegaard, 1995), intermediate compartment (IC) 
(Mackenzie et ai, 1999), endoplasmic reticulum (ER) (Aldabe and Carasco, 1995; 
Bienz et ai, 1987; Bienz et ai, 1990; Bienz et ai, 1992; Cho et ai, 1994; Schlegel et ai, 
1996; Mackenzie et ai, 1999), lysosomes and endosomes (Magliano et ai, 1998), 
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while others have been shown to target the mitochondrial membrane (Miller and 
Ahlquist, 2002). Although extensive studies have been conducted on various viral 
proteins that localise to specific membranes, no conserved virus protein organelle-
targeting sequences have been identified to date. However, a number of different 
mechanisms through which viral proteins interact with host cell membranes have been 
identified (Schmidt-Mende et ai, 2001, Magliano et ai, 1998, Mackenzie et ai, 1999, 
Miller and Ahlquist, 2002). 
1.3.2 Picornavirus infection: modification of host membranes 
(i) Picornavirus infection: targeting the secretory pathway 
During picornavirus infection non-structural proteins of the P2 and P3 genomic 
domains (Figure 1.2.1) target and modify membranes of the secretory pathway 
(Schlegel et ai, 1996). However, the observed modifications to these membranes and 
the specific involvement of the different non-structural proteins vary between 
different viruses (Doedens et ai, 1997; Neznanov et ai, 2001; Moffat et ai, 2005). This 
is not unexpected as non-structural proteins of different picornavirus proteins vary in 
size and sequence, indicating that while certain features of viral replication may be 
ubiquitous throughout the Picornaviridae, the interactions formed between the 
different viral proteins and host cell components may vary (Moffat et ai, 2005). 
Characteristic of infection by some picornaviruses, such as PV and FMDV, is the 
inhibition of anterograde protein trafficking in infected cells (Moffat et ai, 2005 ; 
Doedens et ai, 1997; Neznanov et ai, 2001). Although it is possible that this 
phenomenon is of no consequence to viral replication and pathogenesis it has been 
suggested that in addition to providing membranes for the proliferation of virus-
induced vesicles (Sandoval and Carasco, 1997), the modification of secretory pathway 
membranes may promote an evasion of the host immune response (Doedens and 
Kirkegaard, 1995; Dodd et ai, 2001; Neznanov et ai, 2001; Deitz et ai, 2000). The 
host immune response to viral infections is in part reliant on the presentation of viral 
antigens on the surface of the infected cell by major histocompatibility complexes 
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(MHCs). Thus the inhibition of protein trafficking would block the transport of MHC 
class 1 to the cell surface (Doedens and Kirkegaard, 1995). Inhibition of protein 
secretion is not vital for viral replication as mutant polioviruses that do not inhibit ER-
to-Golgi trafficking do not show inhibited replication ability in tissue culture (Dodd et 
ai, 200 I; Doedens et ai, 1997). 
Modified host membranes derived from the secretory pathway are incorporated into 
virus-induced vesicles prior to the assembly of the virus replication complex and the 
initiation of viral RNA replication (Sandoval and Carasco, 1997). The secretory 
pathway is a suitable target as it provides a rich supply of transport vesicle 
membranes to support viral replication (Sandoval and Carasco, 1997). 
(iiJ Picornavirus infections: effects on membranes of the secretory pathway 
As the prototypic member of the Picornaviridae, PV is the most extensively 
investigated picornavirus with respect to virus-host membrane interactions. The origin 
of PV -induced membranous vesicles remains uncertain. Rust et al (200 I) 
demonstrated that PV -induced vesicles are initially derived from COPII coated 
vesicles budding from the ER but later in infection they colocalise with Golgi marker 
proteins. An alternative study conducted by Schlegel et al (! 996) showed that PV-
induced vesicles contain ER, Golgi and lysosomal marker proteins thus demonstrating 
that the vesicles are in fact derived from membranous compartments throughout the 
secretory pathway. Schlegel el al (! 996) suggested that the apparent ER origin and the 
double-membraned morphology of PV -induced vesicles indicated that they were of an 
autophagic origin. However, PV infection has been shown to induce increased lipid 
synthesis, thus signifying that a proportion of virus-induced vesicle membranes may 
be synthesised de novo (Guinea and Carrasco, 1990). 
PV RNA replication is intricately linked to the vesiculation of host membranes as 
demonstrated by the localisation of viral RNA replication to the cytoplasmic surface 
of virus-induced double-membraned vesicles arranged in rosette-like configurations 
(Schlegel et ai, 1996; Suhy et ai, 2000; Bienz et ai, 1992; Egger et ai, 1996). 
Evidence supporting the dependency of PV replication on the virus-induced 
vesiculation of host cells includes the immunolocalisation of PV RNA replication to 
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the surface of the ER (Pfister et ai, 1992; Troxler et ai, 1992), the capacity of the PV 
2C protein to bind viral RNA and membranes (Bienz et ai, 1992, Bienz et ai, 1994), 
the copurification of PV non-structural proteins 2B, 2C, 3A and 3AB with the vesicle 
rosettes (Bienz et ai, 1994), the presence of ER and Golgi marker proteins in PV-
induced vesicles (Schlegel et ai, 1996) and the observation that the secretory pathway 
is disrupted in PV infected cells (Barco and Carasco, 1998; Deitz et ai, 2000; Dodd et 
ai, 2001; Doedens et ai, 1997; Doedens and Kirkegaard, 1995; Neznanov et ai, 2001; 
Sanz-Parra et ai, 1998; van Kuppeveld et ai, 1997). 
Brefeldin A (BFA) acts as an inhibitor of ER-to-Golgi transport by blocking the 
formation of copn coated vesicles (Fujiwara et ai, 1988). The inhibition of PV 
replication by BFA further demonstrates the dependency of PV replication on the 
functioning membranes of the secretory pathway (Irurzun et ai, 1992; Maynell et ai, 
1992). Additional evidence for the link between the secretory pathway and PV 
replication is provided by the inhibition of the characteristic disassembly of the Golgi 
complex during PV infection by Ro, a flavonoid compound that inhibits retrograde 
but not anterograde protein transport from the Golgi apparatus (Sandoval and 
Carasco, 1997). 
In addition to the disassembly of the Golgi complex and the proliferation of 
membranous vesicles, cells infected with PV display an enlarged perinuclear space 
and swelling of the ER cisternae (Sandoval and Carasco, 1997; Bienz et ai, 1987; 
Troxler et ai, 1992). As PV infection progresses the coating normally situated at the 
sites of vesicle budding on ER cisternae becomes broadly distributed over the surface 
of the cisternae and the vesicles induced by PV infection are often associated with an 
electrodense membrane material (Bienz et ai, 1987; Troxler et ai, 1992). Both these 
features are indicative of an inhibition of protein transport (Sandoval and Carasco, 
1997). 
An accumulation of electrodense material is also observed in the lumen of the stacked 
Golgi cisternae (SGC) and adjacent vesicles prior to the disruption of the CGN and 
the dispersion of these elements throughout the cytosol as evidenced by the 
distribution of ~-COP (Sandoval and Carrasco, 1997), a component of COP1 coats 
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and marker protein of the peripheral Oolgi (Duden et ai, 1991). Later the SOC are 
dispersed in thread-like structures and the SOC marker protein OMPc_1 locates to a 
reticulum-like pattern with some punctate structures (Sandoval and Caras co, 1997). 
The microtubules and intennediate filaments of PV infected cells are radically 
modified, however it has been shown that the disassembly of the Oolgi complex is a 
direct result of PV infection and not a secondary effect of the remodelling of the 
cytoskeleton (Sandoval and Carasco, 1997). The disassembled Oolgi elements could 
possibly be assimilated into the ER, contributing to the extensive swelling observed in 
ER cisternae (Sandoval and Carasco, 1997). 
FMDV infection affects the host cell in a slightly different manner to PV (Monaghan 
et ai, 2004). Firstly, the disassembled Oolgi apparatus and rough ER accumulate to 
one side of the nucleus with the newly fonned membranous vesicles. This is distinctly 
different to the seemingly random dispersal of the Oolgi apparatus in PV infected 
cells (Sandoval and Carasco, 1997; Monaghan et ai, 2004). The FMDV-induced 
vesicles are fewer in number than those induced by PV infection and do not aggregate 
into rosette-like clusters. Finally, a large proportion of the FMDV-induced vesicles do 
not possess a double membrane (Monaghan et ai, 2004). These differences suggest 
that while there may be many common features of picornavirus infection the 
mechanisms through which host cell membranes are modified and virus-induced 
vesicles generated may vary between individual viruses. 
In addition, FMDV and not PV, is able to establish persistent infection in vaccinated 
and infected animals, unlike many other picornaviruses, suggesting that FMDV 
possesses an ability to evade innate and acquired host immune responses. It is 
possible that this ability is linked to the effect of FMDV infection on host protein 
secretion (Alexandersen et ai, 2002) . 
To gain a broader understanding of the effects of different picornavirus infections on 
host cell membranes the roles played by the various non-structural picornavirus 
proteins in the modification of the host cell environment and the replication of viral 
RNA require further investigation. 
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1.3.3 The picornavirus 2B protein 
The sequence of the 2B protein is not highly conserved throughout the PicornGlliridae 
(Moffat et aI, 2005) and it is therefore not surprising that the interactions formed 
between 2B and host cell membranes differ between different picornaviruses. 
Transient expression of PV 2B in Vero cells causes the complete disassembly of the 
Golgi complex (Doedens and Kirkegaard, 1995) suggesting that this protein may be 
solely responsible for the phenomena observed by Sandoval and Caras co (1997), 
described above in Section 1.3.2. This hypothesis is supported by the observation that 
cells transiently expressing the PV 2C, 2BC and 3A proteins do not show disruption 
of the Golgi apparatus except after extensive expression times where any damage to 
the Golgi could be attributed to nonspecific cell damage as a result of the extreme 
vacuolation observed in the cells at this stage (Doedens and Kirkegaard, 1995). It is 
interesting to note that modifications to host cell membranes caused by individually 
expressed viral proteins are often more profound than those induced by viral infection 
(Suhy et aI, 2000). 
In addition to its effects on the integrity of the Golgi apparatus, expression of PV 2B 
has been shown to block protein secretion (Doedens and Kirkegaard, 1995). This 
characteristic can be linked with the disassembly of the Golgi complex by 2B as this 
protein has been shown to inhibit protein secretion 'causing the retention of Ap 1 PI 
molecules with marmose oligosaccharide chains in the Golgi cisternae (Doedens and 
Kirkegaard, 1995). 
The essential role played by picornavirus protein 2B in viral replication was verified 
when mutations in the 2B region of the PV genome were found to cause 
noncomplementable defects in viral RNA replication (Bernstein et ai, 1986; Johnson 
and Sarnow, 1991). This could reflect a necessity for the presence of 2B or 2BC at the 
site of RNA replication or a disruption of the structure of the viral RNA causing 
defective RNA synthesis (Bernstein et ai, 1986; Johnson and Sarnow, 1991). 
Alternatively these mutations may have affected the proliferation of virus-induced 
vesicles by altering the ability of 2B to modify Golgi membranes. 
II 
Membrane fractionation and immunolocalisation studies of transiently expressed 
FMDV 2B protein in Vero cells revealed that 2B is membrane associated and that it 
localises to a reticular stain closely aligned with that of the ER marker protein ERpS7, 
suggesting that unlike PV 2B, FMDV 2B associates with ER membranes (Moffat et 
ai, 200S). Later stages of 2B expression revealed modification of ER membranes into 
honeycomb structures adjacent to the nucleus (Moffat et ai, 200S). 
Aside from its role in the disassembly of the Golgi complex, the 2B protein has been 
shown to alter membrane permeability (van Kuppeveld et ai, 1997; Aldabe et ai, 
1996; Doedens and Kirkegaard, 1995). This suggests that it may playa role in the 
anchorage of the replication complex to the virus-induced vesicles. Using a yeast two-
hybrid approach Cuconati et al (1998) demonstrated that homomultimers form 
between PV proteins 2B and 2BC and heteromultimers are formed between proteins 
2B: 2BC and 2C: 2BC in vivo. de Jong et al (2002) revealed similar results for 
Coxsakie B3 virus (CBV3) P2 proteins using a mammalian two-hybrid system. The 
multimerisation reactions were found to be mediated by the hydrophobic regions of 
the amphipathic a-helix and the second hydrophobic domain located on the 2B 
protein (de Jong et ai, 2002) and these same domains have been shown to be 
responsible for the permeabilisation of the modified host membranes (Barco and 
Carrasco, 1998; Doedens and Kirkegaard, 1995; van Kuppeveld et ai, 1997). 
However, the actual mechanism through which membrane permeability is increased is 
unknown. It has been hypothesised that aqueous pores may form in the targeted 
membranes through the formation of integral homo- or heteromultimers of the 2B and 
2BC proteins, arranged with the hydrophilic regions of their amphipathic a-helices 
facing each other (de Jong et ai, 2002). 
In summary, the picornavirus 2B protein is implicated in the modification of host 
membranes (Doedens and Kirkegaard, 1995) prior to the assembly of the replication 
complex. Evidence also suggests that this protein plays a role in viral RNA replication 
(Bernstein et ai, 1986; Johnson and Samow, 1991) and the alteration of host 
membrane permeability (van Kuppeveld et ai, 1997; Aldabe et ai, 1996; Doedens and 
Kirkegaard, 1995). 
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1.3.4 The picornavirus 2C protein 
The 2C protein is very highly conserved throughout the Picornaviridae, indicating 
that it plays a vital role in the replication cycle of picornaviruses. Although the tertiary 
structure for any picornavirus 2C protein is yet to be solved, the occurrence of 
conserved a-helices and p-sheets in the secondary structure of the 2C protein have 
been identified. In addition, the existence of several functional domains has been 
established. Figure 1.3.1 is a schematic representation of the secondary structure and 
the functional domains identified in several picornavirus 2C proteins (Banerjee et ai, 
2004). 
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Figure 1.3.1. Schematic representation of the putative domain structure identified to date of the PV 2C 
protein (adapted from Banerjee e/ ai, 2004). The structural features of the picornavirus 2C protein 
include: two RNA binding domains dLl ), a membrane binding domain " ), three NTP-binding domains 
.), three regions with serpin homology ~ ) and a cysteine-rich zinc finger ~ ). 
(i) Membrane association characteristics of 2C 
The 2C protein is membrane associated and is implicated in the proliferation of virus-
induced membranous vesicles in infected cells. The PV 2C protein localises to the 
RER during PV infection where it stimulates the formation of smooth membranous 
vesicles that bud off the ER membranes and later support the virus replication 
complex (Aldabe and Carasco, 1995; Bienz et ai, 1987; Bienz et ai, 1990; Bienz et ai, 
1992; Cho et ai, 1994; Schlegel et ai, 1996). In addition to induction of vesiculation, 
the PV 2C protein has also been shown to cause extensive tubulation of ER 
membranes resulting in "myelin-like swirls of ER derived membrane" (Aldabe et ai, 
1996; Cho et ai, 1994; Teterina et ai, 1997). 
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Transiently expressed FMDV 2C is also membrane associated but its subcellular 
localisation is different to PV 2C. Like PV 2C, FMDV 2C localises to the RER and 
co localises with the ER marker protein ERp57 (Moffat el ai, 2005). In addition to the 
reticular localisation, FMDV 2C also locates to punctate structures adjacent to the 
nucleus that show the same distribution as, but do not colocalise with, the Golgi 
marker protein I3-COP. This suggests that the FMDV protein associates with Golgi 
membranes but excludes some cellular proteins, including I3-COP, from these 
membranes (Moffat el ai, 2005). 
Knox el al (2005) observed that at early stages of FMDV infection 2C locates to a 
diffuse punctate pattern to one side of the nucleus and is concentrated into larger 
structures adjacent to the nucleus at later stages. In addition a-mannosidase II (Man 
II), an enzyme located in the medial Golgi cisternae, was dispersed in the region of, 
but did not colocalise with, the 2C-containing structures at later stages of infection 
suggesting that the medial Golgi membranes are targeted by FMDV 2C but that the 
2C protein excludes the Man II protein from these membranes (Knox el ai, 2005). 
Further investigations by Knox el al (2005) using immunolocalisation techniques and 
marker proteins from the various membrane compartments showed that the FMDV 2C 
protein does not colocalise with marker proteins of the ER, intermediate compartment, 
trans-Golgi network or lysosomal membranes. The most likely explanation for the 
lack of host organelle marker proteins in the membranes supporting the FMDV 
replication complex is that the host proteins are efficiently excluded from the 
membranes during the virus-induced vesicle proliferation process (Knox el ai, 2005). 
However it is possible that a proportion of virus induced vesicles are synthesised de 
novo (Guinea and Carrasco, 1990) or that other membranes such as the nuclear 
envelope are exploited. 
The precise mechanism by which the 2C protein interacts with host membranes is 
unclear. However, the putative class A amphipathic helix located towards the N-
terminus of the protein (Figure 1.3.1) has been implicated in mediating the membrane 
binding and rearranging abilities of 2C (Paul el ai, 1994; Echeverri and Dasgupta, 
1995; Echeverri el ai, 1998) and the N-terminal 72 amino acids of the PV 2C protein 
have been shown to mediate membrane targeting to the ER membranes (Echeverri el 
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ai, 1998). Class A amphipathic helices comprise a hydrophobic face separated from a 
basic hydrophilic face by acidic amino acid residues and are a common feature of 
membrane-associated viral proteins (Saier and McCaldon, 1988). They are thought to 
insert the hydrophobic face halfway into the phospholipid monolayer while the 
hydrophilic face aligns along the aqueous interface (Segrest et ai, 1994). An 
alternative mechanism whereby 2C binds a cellular membrane protein has also been 
suggested (Echeverri et ai, 1998) but no such interaction has yet been described. A 
second amphipathic a-helix on the C-terminal of the 2C protein has also been 
implicated in membrane binding (Teterina et ai, 1997). 
(ii) 2C binds viral RNA: involvement in RNA replication 
In addition to the membrane-binding activities of 2C, the protein is able to interact 
with viral RNA (Banerjee and Dasgupta, 2001; Banerjee et ai, 1997; Rodriguez and 
Carasco, 1995; Rodriguez and Carasco, 1993). PV 2C has two RNA-binding motifs: 
an N-termina1 region (located at amino acids 21-54) and a C-termina1 region (located 
at amino acids 312-319) (Rodriguez and Carasco, 1995). 
The PV, Hepatitis A virus (HAV) and HRV 2C proteins specifically bind the 3' 
cloverleaf structure of negative sense viral RNA but do not bind the corresponding 5' 
cloverleaf structure of the positive sense viral RNA (Banerjee et ai, 1997; Banerjee 
and Dasgupta, 200 I). This ability appears to be unique to the 2C protein as it has been 
shown that the picornavirus proteins 2A, 2B, 3CD and 3C do not bind negative sense 
PV RNA (Banerjee et ai, 1997). 
In view of the membrane and RNA-binding capabilities of 2C it has been suggested 
that the 2C protein plays a role in anchoring the negative-sense viral RNA to the 
surface of virus-induced vesicles at the site of the replication complex. This could 
allow viral proteins, such as 3CD or 3AB, or host proteins such as the eukaryotic 
translation initiation factor, p36, to transfer from the 5' cloverleaf structure of the 
positive RNA strand to the 3' end of the negative strand, thus facilitating the initiation 
of nascent positive-sense viral RNA synthesis (Andino et ai, 1993; Xiang et ai, 1995; 
Harris et ai, 1994). In addition, 2C is thought to possess RNA he Ii case activity which 
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would, along with 3DPOi , enable the protein to facilitate the unwinding of double-
stranded RNA structures occurring during the elongation of nascent positive-sense 
viral RNA (Haenni and Kadare, 1997). The helicase activity is however, yet to be 
demonstrated and is thought to require other viral or cellular proteins (Haenni and 
Kadare, 1997). Thus, 2C plays two important roles in viral RNA replication: a cis-
acting function during the initiation of RNA replication and a trans-acting function 
during RNA elongation (Aldabe and Carasco, 1995; Li and Baltimore, 1988; 
Mirzayan and Wimmer, 1992). 
The PV 2Cprotein possesses ATPase and GTPase activity (Rodriguez and Carasco, 
1992, Mirzayan and Wimmer, 1994, Teterina et ai, 1992). PV replication and 
specifically the initiation of negative sense RNA replication are inhibited by 
millimolar concentrations of guanidine hydrochloride (Pfister and Wimmer, 1999; 
Barton and Flanegan 1997). The 2C protein has three nucleoside triphosphatase 
(NTP) binding domains (Figure 1.3.1), all of which are necessary for the ATPase 
activity of the protein (Pfister and Wimmer, 1999). The function of 2C NTPase 
activity in virus replication is poorly understood. It has been suggested that it may 
play a part in the stabilisation or organisation of the replication complex on the 
surface of virus-induced vesicles, the modification of host membranes during the 
virus-induced vesicle proliferation stage or even the uncoating or assembly of 
picornavirus virions (Pfister and Wimmer, 1999). 2C has previously been implicated 
in both the uncoating (Li and Baltimore, 1990) and encapsidation (II ance et ai, 1997) 
of picornaviruses. However it is more likely that the NTPase activity is linked to viral 
RNA replication as lethal mutations to the NTP-binding domains of PV 2C inhibited 
RNA replication in vivo, while no translational defects were detected (Teterina et ai, 
1992). 
(iii) 2C has protease inhibition activity 
In addition to its involvement with viral RNA replication and the proliferation of 
membranous vesicles in infected cells 2C has also been implicated in the control of 
viral protease activities (Banerjee et ai, 2004). Multiple alignment of 2C sequences 
with protease inhibitors revealed that 2C possesses three putative serine protease 
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inhibitor motifs (Figure 1.3.1), suggesting that 2C plays a regulatory role in viral or 
host protease activity (Banerjee et ai, 2004). It was also discovered that the PV 2C 
protein coimmunoprecipitates with the viral protease 3Cpro and is able to inhibit the 
protease activity of 3CPro both in vitro and in vivo through a physical interaction that 
occurs either in the cytoplasm or at the membrane-bound replication complex 
(Banerjee et ai, 2004). It is yet to be shown whether this regulatory activity of 2C 
extends to 3CDPro (Banerjee et ai, 2004). The biological significance of the serine 
protease inhibitory activity of 2C is not fully understood although it has been 
suggested that the inhibition of viral proteases would increase the proportion of viral 
polyproteins in infected cells (Banerjee et ai, 2004). The 2C protein may also playa 
role in the inhibition of cellular serine proteases, thus inhibiting apoptosis in infected 
cells (Banerjee et ai, 2004). 
In summary, the 2C protein is a highly conserved picornavirus protein that has been 
implicated to perform an extensive range of functions at several stages of the 
picornavirus replication cycle. However, the mechanisms through which 2C is 
involved in the assembly of the viral replication complex, RNA replication and viral 
encapsidation are poorly understood. 
1.3.5 The picornavirus 2BC protein 
The picornavirus 2BC polyprotein is a membrane associated precursor of the 2B and 
2C proteins that exists separately to its cleavage products (Cho et ai, 1994; Moffat et 
ai, 2005). Like many of the non-structural picornavirus proteins, PV 2BC is located 
within the viral replication complex on the surface of virus-induced vesicles (Cho et 
ai, 1994). Transiently expressed PV 2BC protein is capable of inducing the 
proliferation of membranous vesicles in transformed yeast cells (Barco and Carasco, 
1995) and in transfected HeLa cells (Cho et ai, 1994). ATPase activity has also been 
detected with the PV 2BC protein (Pfister and Wimmer, 1999) but as with the 2C 
protein, the biological significance of this activity remains obscure. 
The distribution of FMDV 2BC in transiently expressing Vero cells does not resemble 
that of either the 2B or 2C proteins (Moffat et ai, 2005). 2BC was located in large 
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elements adjacent to the nucleus as well as being distributed throughout the cytoplasm 
in small punctate structures. Expression of FMDV 2BC resulted in the redistribution 
of the ER marker protein ERp57 to areas in close proximity to but not fully 
colocalising with 2BC (Moffat et ai, 2005). Through imrnunolocalisation studies, 
Rust et al (2001) found that the PV 2BC protein in cells infected with PV or 
transiently expressing the protein also associated with ER membranes. The PV 2BC 
protein localised to small punctate structures in the cytoplasm that colocalised with 
ER-derived membranes containing the marker protein copn (Rust et ai, 2001). PV 
2BC was also observed to localise to the sites of vesicle budding on the ER 
membranes and to vesicles containing the sec 13 protein, a component of the COPlI 
complex that is involved in vesicle budding during ER-to-Golgi protein transport 
(Barlowe et ai, 1994). 
PV 2BC showed some ability to inhibit ER-to-Golgi transport (Doedens and 
Kirkegaard, 1995). As the PV 2C protein does not affect anterograde protein transport 
when expressed in isolation from other viral proteins it is thought that the 2B segment 
of the 2BC protein, which is known to arrest protein traffic in the Golgi, is responsible 
for this inhibitory activity transport (Doedens and Kirkegaard, 1995). In the same 
study, the FMDV 2BC protein and not the 2B, 2C or 3A proteins inhibited protein 
transport to the plasma membrane (Moffat et ai, 2005). 2BC modified the ER 
cisternae into distinct punctate structures that retained protein normally transported to 
the plasma membrane in the absence of2BC (Moffat et ai, 2005). 
In summary, the picornavirus 2BC protein appears to play an integral role in the 
modification of host cell membranes and the proliferation of membranous vesicles 
prior to the assembly of the viral replication complex (Cho et ai, 1994) and possibly 
affects anterograde protein trafficking in host cells (Doedens and Kirkegaard, 1995). 
No evidence has been presented to date to suggest that this protein plays any role in 
viral RNA replication or encapsidation. 
18 
1.3.6 The picornavirus 3A protein 
The 3A protein is a membrane associated protein (Doedens el aI, 1997; Neznanov el 
aI, 2001; Moffat et ai, 2005; O'Donnell et ai, 2001; Pevear et ai, 1988; Monteyne et 
ai, 1997) and is the cleavage product of the 3AB protein, which is associated with the 
3' UTR along with 3CDpro (Harris el ai, 1994). Only the structure of the 59 N-terminal 
amino acids has been elucidated by nuclear magnetic resonance (NMR) (Strauss et aI, 
2003). The first 14 N-terminal amino acids were unstructured and it was discovered 
that 3A exists as a dimer, with monomers adjoining between helical hairpin loops 
from each monomer (Strauss el ai, 2003). The PV 3A protein is not able to induce 
vesiculation when transiently expressed in isolation from other viral proteins. 
However, co-expression of PV 3A and 2BC proteins induces the formation of 
membranous vesicles with similar morphology to those observed in PV -infected cells 
(Suhy et ai, 2000). 
Transiently expressed PV 3A has been shown to specifically inhibit ER-to-Golgi 
protein trafficking, causing the accumulation of proteins otherwise destined for 
secretion and the ensuing distortion and extreme swelling of the ER cisternae 
(Doedens el ai, 1997; Neznanov el ai, 2001). Unlike PV 2B, PV 3A inhibits protein 
secretion at an early stage in the anterograde pathway, as demonstrated by the 
retention of the secretory protein Ap 1 PI in the ER and inhibition of the processing of 
mannose oligosaccharide chains into complex carbohydrates (Doedens and 
Kirkegaard, 1995). 
FMDV 3A is partially associated with membranes while a significant proportion of 
the protein is distributed throughout the cytoplasm in transiently expressing cells 
(Moffat el ai, 2005). Membrane-bound FMDV 3A is associated with ER membranes 
containing the ER marker protein calreticulin (Moffat el aI, 2005 ; O'Donnell el ai, 
2001). However, unlike PV 3A, FMDV 3A does not affect ER-to-Golgi membrane 
trafficking (Moffat et aI, 2005). 
An extensive study by Choe et al (2005) investigated the ability of the 3A proteins of 
several picornaviruses to inhibit ER-to-Golgi protein transport. Of the viruses 
investigated only the 3A proteins from the closely related viruses: PV serotype 1, PV 
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serotype 1 and coxsakievirus B3 inhibited anterograde protein transport from the ER 
(Choe et ai, 2005). There was no evidence of inhibition of ER-to-Golgi trafficking in 
cells expressing 3A proteins of rhinovirus 14, hepatitis A virus and enterovirus 71 
(Choe et ai, 2005). In addition expression of the 3A proteins of both the virulent 
GDVII strain and the non-virulent BeAn strain of TMEV did not alter anterograde 
protein transport (O'Donnel et ai, 2001; Pevear et ai, 1988). Choe et al (2005) found 
that only one conserved N-terminus amino acid, Lys9, appeared to be linked to the 
ability of picornavirus 3A proteins to inhibit ER-to-Golgi protein transport and 
suggested that the unstructured 14 N-terminal amino acids are likely to be involved in 
3A-host protein interactions. 
As the 3A protein is not highly conserved throughout the Picornaviridae it is not 
surprising that proteins from different picornaviruses interact with host cell 
components in different ways. The consequences of these differences on the 
pathology of different picornaviruses are unknown. A lack of inhibition of 
anterograde protein transport would enable infected cells to display viral antigens with 
MHCs on the cell surface triggering, among other immune responses, an 
inflammatory response (Choe et ai, 2005). It has been suggested that a functioning 
secretory pathway may be advantageous for viruses, such as rhinovirus 14, who ' s 
spread from cell to cell is enhanced by inflammation (Choe et ai, 2005). The PV 3A 
protein is known to inhibit several characteristics of host immune responses, namely 
the presentation of viral antigens with MHC class 1 molecules (Deitz el ai, 2000), the 
inhibition of the secretion of antiviral cytokines (e.g. IL-6, IL-8) and interferon-~ 
from poliovirus-infected cells (Dodd et ai, 2001). Various mutations created in the 3A 
proteins of both FMDV and hepatitis A virus have been linked with changes in viral 
pathogenesis (Beard and Mason, 2000; Nunez et ai, 2001; Beneduce et ai, 1995), 
further linking the activity of the 3A protein with the evasion of host immune 
responses. 
In summary, evidence suggests that the picornavirus 3A protein, and its precursor 
polyprotein 3AB, are involved in several events during the picornavirus replication 
cycle including the modification of host membranes (Suhy el ai, 2000), viral RNA 
replication (Harris et ai, 1994) and possibly in the evasion of the host immune 
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responses through the inhibition of anterograde protein transport in the host cell 
(Doedens et aI, 1997; Neznanov et aI, 2001). 
1.4 TMEV: AN AVAILABLE PICORNAVIRUS REPLICATION SYSTEM 
1.4.1 A replication system for TMEV in BHK-21 cells 
From the information above, it is clear that the non-structural picornavirus proteins 
have a broad range of functions, some of which involve interactions with host cell 
components and others that involve other viral proteins. In view of this, it is important 
to study the various non-structural proteins both in isolation, through transient 
expressIOn in transfected cells, and in the presence of other viral proteins during 
infection. 
Due to the health and economic risks posed by picornaviruses such as PV, FMDV, 
HRV and HAV, disease security regulations restrict the infection of cell cultures with 
these viruses to facilities with appropriate disease protection and security measures. 
Such facilities were not available to this study necessitating the development of an 
infection system of a less hazardous picornavirus in tissue culture. 
TMEV is a picornavirus that belongs to the Genus Cardiovirus. Four strains are 
currently recorded: the virulent strains GDVII and FA and the non-virulent strains DA 
and BeAn. TMEV is a naturally occurring enteric pathogen in mice but poses no 
threat to humans or livestock, thus enabling its use in conventional tissue culture 
facilities. 
The ability of TMEV to infect the BHK-21 cell line is previously recorded (Kong et 
aI, 1994; van Pesch et ai, 2001). This same cell line was used in this study to further 
our understanding of the interactions formed between the picornavirus P2 and 3A 
proteins and host cell components. 
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1.4.2 Pathology ofTMEV infection in mice 
Briefly, TMEV infects the central nervous system of mice causing either acute lethal 
encephalomyelitis (strains GDVII and FA) or biphasic disease whereby after mild 
encephalomyelitis lasting approximately two weeks the mice show chronic 
demyelination, similar to that seen in human multiple sclerosis patients (Monteyne et 
ai, 1997). This demonstrates that despite host immune responses TMEV, like FMDV, 
is capable of developing persistent infections. The L protein (Figure 1.2.1) has been 
implicated in interfering with a /13 interferon production, thus inhibiting the host 
immune response (van Pesch el ai, 200 I). TMEV strain GDVII is frequently used as 
an animal model during multiple sclerosis research. Although the causal factors of 
multiple sclerosis are complex, viruses have been implicated in affecting the 
progression of this condition (Tolley et ai, 1999). 
1.4.3 TMEV non-structural proteins: interactions with host cell components 
As with other picomaviruses, TMEV expresses the 2B, 2C, 2BC and 3A non-
structural replicative proteins. However, relatively little is known about these proteins 
with respect to the roles they play in modifying the host cell environment and 
mediating TMEV RNA replication. The subcellular localisation and membrane 
association characteristics of these proteins as well as their involvement in virus RNA 
replication and encapsidation are yet to be investigated. Additionally the effect each 
of these proteins and TMEV infection in general on host cell ultrastructure are also 
unknown. 
22 
I.S IDENTIFICATION OF KNOWLEDGE GAP 
An extensive range of studies has been conducted regarding the structure of the 
picornavirus replication complex, the replication of picornaviral RNA and the roles 
played by the various non-structural proteins in the viral replication cycle. Despite 
this, very little is known of the precise molecular mechanisms through which 
picornavirus proteins interact with host cell components. It is assumed that some 
unknown interactions between the non-structural proteins and host proteins exist and 
the identification and description of these interactions could provide valuable 
information for the design of drug therapies for picornavirus infections. For example, 
the development of persistent FMDV infections in cattle and sheep pose a dire threat 
to the agricultural industry worldwide. The development of more effective disease 
treatment and control strategies relies on further understanding of the mechanisms 
through which picornaviruses evade host immune responses. 
As discussed above, these objectives can only be met through the study of 
picornavirus proteins in isolation through transient expression, and in the context of 
viral replication through infection. Consequently this study initially focussed on the 
subcellular localisation and membrane association of the TMEV 2B, 2C, 2BC and 3A 
proteins. This enabled a comparison of these characteristics of the TMEV proteins 
with the localisation and modification of host membranes by the corresponding 
proteins of PV and FMDV. Secondly, this study endeavoured to determine the effect 
of mutating highly conserved amino acids in the 2C protein on the subcellular 
localisation of the 2C protein as well as on TMEV replication. 
Most of what is known about picornavirus replication is based on studies using PV 
proteins and replication systems. Alternative studies using FMDV and other 
picornaviruses have provided evidence that the non-structural proteins of different 
picornaviruses vary in function and interactions with host components. However, the 
variety of picomaviruses investigated with respect to molecular interactions with host 
components is limited. Thus, this study will contribute significantly to the general 
understanding of picornavirus biology. 
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1.6 PROBLEM STATEMENT 
There is an incomplete appreciation of the interactions formed between the various 
non-structural picornavirus proteins and host cell components and the role that these 
interactions play in the virus replication cycle and the evasion of host immune 
responses. The characterisation of the membrane association and localisation of the 
2B, 2C, 2BC and 3A protein of the relatively less studied TMEV will add to the 
general understanding of picornavirus replication and provide a platform for further 
studies involving the identification of novel interactions between picornavirus and 
host proteins. 
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1.7 AIMS AND OBJECTIVES 
The overriding intension of this study was to increase the general understanding of the 
interactions formed between picornavirus non-structural proteins and host membranes 
through the investigation ofthe TMEV P2 and 3A proteins. 
1. To this end we aimed to first transiently express the 2B, 2C, 2BC and 3A 
TMEV proteins in BHK-2l cells and determine their subcellular localisation 
by immunolocalisation studies. 
2. Further investigations into the importance of the highly conserved N-terminal 
domain of the 2C protein with respect to subcellular localisation of this protein 
was then conducted. We aimed to first identify specific amino acids in the N-
terminal domain of the 2C protein that are particularly highly conserved by the 
computational multiple alignment of picornavirus 2C sequences. Point 
mutations were created at these residues and the subcellular localisation of the 
mutant proteins was determined as with the wild type 2C protein above. 
3. Additionally we aimed to determine the effect of these point mutations on the 
ability of TMEV to replicate in BHK-21 cells. This involved the transfection 
of BHK-2l cells with infectious RNA encoding wild type and mutant TME 
viruses to determine which mutations were lethal and which merely slowed the 
replication of the virus. Next, for the mutant viruses showing limited 
replication abilities, we aimed to quantify the extent to which the point 
mutations inhibited the rate of TMEV replication by constructing a viral 
replication curve of virus particles produced per unit time. 
4. Finally, in view of future studies involving the identification of novel 
interactions between the picornavirus 2C protein and host proteins we aimed 
to express and purify a hydrophobic, antigenic GST - tagged fragment of the 
2C protein for use in future protein pull-down assays and in the production of 
an antibody against the TMEV 2C and 2BC proteins. 
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2 Localisation of TMEV P2 and 3A proteins 
2.1 INTRODUCTION 
An increased understanding of the molecular interactions formed between 
picornavirus proteins and host cell components is essential for the development of 
novel disease treatment and control strategies. Prior to this study the localisation of 
the non-structural TMEV 2B, 2C, 2BC and 3A proteins to host membranes was 
unexplored. 
The localisation of these viral proteins to specific cellular organelles was investigated 
through their transient expression in BHK-2l cells followed by indirect 
immunofluorescent staining of the cells with primary antibodies against epitope-
tagged viral proteins and marker proteins of the ER and Golgi apparatus. Subsequent 
to secondary staining with fluorophore conjugated secondary antibodies, laser 
scarming confocal microscopy was employed to image the localisation of the viral 
proteins. BHK-21 cells were chosen as the cell line in which to express these proteins 
as later experiments involving the infection of mammalian cells with TMEV were 
also carried out using this cell line. 
It was necessary to express the viral proteins as fusions with the C-terminal VS-
epitope tag as antibodies against the TMEV proteins investigated in this study were 
not available. The coding regions for the TMEV 2B, 2C, 2BC and 3A proteins were 
subcloned into the pcDNA3.lNS-His© TOPO® (Invitrogen) mammalian expression 
vector (see Appendix A). This vector was selected as the small size of the VS epitope 
encoded downstream of the inserted protein coding sequence ensures that it does not 
interfere with the localisation of fusion proteins (Invitrogen, 2004). 
Future investigations of the interactions formed between the TMEV 2B, 2C, 2BC and 
3A proteins and host cell proteins as well as the ability of the individual proteins to 
induce host cell membrane rearrangement will require antibodies against these 
proteins. 
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Subsequent to localising to the RER during PV infection, the PV 2C protein promotes 
the budding of vesicles from ER membranes (Aldabe and Carasco, 1995; Bienz et ai, 
1987; Bienz et ai, 1990; Bienz et ai, 1992; Cho et ai, 1994; Schlegel et ai, 1996). In 
addition the PV 2BC protein has been shown to cause extensive vesiculation when 
transiently expressed in HeLa cells (Cho et ai, 1994). In view of these findings with 
the PV proteins, future studies characterising the interactions formed between the 
TMEV proteins and host membranes would seek to determine the ability of firstly 
TMEV infection, and secondly the transient expression of the TMEV 2C and 2BC 
proteins to cause vesiculation of the membranes of the secretory pathway of host cells 
by electron microscopy and using an antibody to detect the 2C and/or 2BC proteins. 
An antibody against the TMEV 2C protein would also be used in future studies to 
identify interaction formed between the TMEV 2C or 2BC proteins and host proteins 
by protein pull-down assays. This study sought to express and purify a hydrophilic 
and antigenic region of the 2C protein to be used in the generation of such an 
antibody. 
The cDNA coding sequence of the selected region of the TMEV 2C protein was 
inserted into a bacterial expression vector encoding a Glutathione S-transferase 
(GST)-tag on the N-terminus of the peptide. The expression of the peptide with a tag 
was necessary to facilitate purification by affinity chromatography. Although the 
GST - tag is relatively large (26kOa) compared to alternative protein tags such as a His 
tag (0.66 kOa) it was selected based on its ability to increase the solubility of the 
fusion peptide (Constans, 2002). The fusion peptide was expressed on a pilot-scale 
and purified by affinity chromatography. Future work will include the large-scale 
expression of the fusion peptide and the generation of the anti-TMEV 2C antibody in 
a mammal such as mice or rabbits. 
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2.2 AIMS AND OBJECTIVES 
Broadly, the aims of this component of the study was to explore the membrane 
association of the TMEV 2B, 2C, 2BC and 3A proteins with respect to their 
localisation to membranes of the host secretory pathway, and secondly to identify and 
express a soluble region of the 2C protein against which antibodies can be raised. 
Specifically, the objectives were as follows: 
1. To subclone the coding sequences for the TMEV 2B, 2C, 2BC and 3A 
proteins into the mammalian expression vector pcDNA3.IN5-His© TOPO®. 
2. To express the TMEV 2B, 2C, 2BC and 3A proteins transiently in BHK-21 
cells through the transfection of this cell line with recombinant DNA encoding 
the proteins. 
3. To immunolocalise the TMEV 2B, 2C, 2BC and 3A proteins in BHK-21 cells 
by the immunostaining of cells and laser scanning confocal microscopy. 
4. To identify a region of the 2C protein that possesses a high degree of 
hydrophilicity and antigenicity and to insert the cDNA coding region for the 
selected peptide sequence into the bacterial expression vector pGEX-2T. 
5. To express the peptide as a GST-fusion peptide in E. coli cells on a pilot-scale, 
purify by affinity chromatography and to confirm the successful expression 
and purification by SDS-PAGE and Western analysis. 
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2.3 METHODS AND MATERIALS 
2.3.1 Construction of recombinant vectors for the expression of TMEV 2B, 
2C, 2BC and 3A coding regions in mammalian cells 
In order to transiently express the TMEV 2B, 2C, 2BC and 3A proteins in cells the 
coding regions for these proteins were subcloned into the mammalian expression 
vector pcDNA3.1N5-His© TOPO®. 
The coding regions for the TMEV 2B, 2C, 2BC and 3A proteins were PCR amplified 
(see Appendix C for primers used) using the high fidelity DNA-dependent DNA 
polymerase Expand (Promega) and pGDVII-WT DNA (see Appendix A) as a 
template. Subsequent to electrophoresis on a 1% agarose gel (I % wt/vol agarose in 
TAE buffer: 0.114 % Glacial acetic acid, I mM EDTA pH 8, 40 rnM Tris-HCI), PCR 
products were excised and purified using the Wizard SV Gel and PCR Clean-up 
System (Promega) according to manufacturers instructions. 
The purified 2B PCR product was subcloned directly into pcDNA3.IN5-His© 
TOPO® (Invitrogen) using the pcDNA3.IN5-His© TOPO® TA Expression Kit 
according to manufacturers instructions. Due to limited availability of the "empty" 
pcDNA3.lN5-His© TOPO® vector an alternative strategy was employed to insert 
the coding regions for the 2C, 2BC and 3A proteins into the vector. The pCKF2C 
construct, comprising the coding sequence for FMDV 2C inserted into the multiple 
cloning site (MCS) of pcDNA3.lN5-His© TOPO®, was subjected to restriction 
digestion with Bam HI (Promega) andXba 1 (Promega). 1 Ilg of each of the 2C, 2BC 
and 3A PCR products was subjected to the same restriction digestion and both the 
linearised pcDNA3.1N5-His© TOPO® vector and the PCR products were purified 
using the Wizard SV Gel and PCR Clean-up System, subsequent to electrophoresis on 
a 1 % agarose gel. The coding sequences for the 2C, 2BC and 3A proteins were 
subcloned into the linearised pcDNA3.1N5-His© TOPO® vector in frame with the 
C-terminal V5 epitope using T4 DNA ligase (Promega) at room temperature for four 
hours followed by overnight incubation at 4°C. 
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Competent E. coli JM I 09 cells (Promega) were transformed with the recombinant 
vectors and spread plated on Luria agar plates (0.5 % NaCI, 0.5 % yeast extract, 1% 
tryptone, 2% nutrient agar) containing ampicillin (100 J.!glml) (Roche). Plates were 
incubated at 37°C overnight. Bacterial colonies were inoculated into 5ml Luria Broth 
(0.5 % NaCI, 0.5 % yeast extract, 1 % tryptone) cultures containing Ampicillin (100 
J.!g/rnl) and incubated overnight at 37°C, shaking at 200 rpm. The presence of 
recombinant plasmids containing the correct insert in the bacterial cultures was 
detected by the "colony PCR" screening technique. This involved the PCR 
amplification of the insert of interest using I J.!I of confluent bacterial culture as a 
source of template DNA and the same reaction parameters and specific primers 
originally used to amplify the insert (see Appendix C). 
Recombinant plasmids were isolated using the QIAprep ® Spin Miniprep Kit 
(Qiagen) and named as shown in Table 2.3.1. The presence of correct inserts was 
confirmed by restriction analysis with Bam HI (PLMT2B) or Bam HI and Xba I 
(pLMTIC, pLMTIBC and pLMT3A), and later by chain-termination-based 
sequencing (performed by Inqaba Biotechnical Industries (Pty) Ltd) using standard T7 
and BGH primers (Invitrogen). 
Table 2.3.1. Recombinant vectors constructed by inserting cDNA coding sequences of 
the TMEV 2B, 2C, 2BC and 3A proteins into the mammalian expression 
vector pcDNA3.1N5-His© TOPO® 
Name Forward Reverse Insert Size Protein encoded insert 
primer primer (nucleotides) 
pLMT2B 2BF 2BR 380 TMEV2B 
pLMT2C 2CF 2CR 978 TMEV2C 
pLMTIBC 2BF 2CR 1 358 TMEV2BC 
pLMT3A 3AF 3AR 264 TMEV3A 
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2.3.2 Construction of recombinant vectors for the expression of truncated 
TMEV 2C and 2BC coding regions in mammalian cells 
The N-terminal 60 amino acids of the Picornavirus 2C protein are thought to include 
the residues responsible for membrane association and the RNA binding activity of 
the protein (Banerjee et aI, 2004; Echeverri and Dasgupta, 1995). If this is true for the 
TMEV 2C protein it is possible that the localisation of this protein, and possibly the 
2BC protein, in host cells during viral replication is controlled by signal sequences 
within this region. To test whether the localisation of the 2C and 2BC proteins in host 
cells was affected by the absence ofthe C-terminal regions of the 2C protein truncated 
coding regions of the 2C and 2BC proteins, containing only the first 180 nucleotides 
(and thus 60 amino acids) of the 2C coding sequence, were subcloned into the 
pcDNA3.1N5-His© TOPO® vector. 
The truncated coding regIOns for the TMEV 2C and 2BC proteins were PCR 
amplified as described above in Section 2.3.1 (see Appendix C for primers used). 
Subsequent to purification, restriction digestion and subcloning of these truncated 
coding regions into the pcDNA3.IN5-His© TOPO® vector was performed as 
described with pLMT2C above (Section 2.3.1). The truncated 2C and 2BC coding 
sequences will be referred to as 2C60 and 2BC60 from this point forward. 
Table 2.3.2. Recombinant vectors constructed by inserting cDNA coding sequences of the 
truncated TMEV 2C and 2BC proteins into the mammalian expression vector 
pcDNA3.1N5-His© TOPO® 
Name Forward Reverse Insert Size Insert 
primer primer (nucIeotides) 
Truncated TMEV 2C 
pLMT2C60 2CF 2C60R 180 (2C60) 
Truncated TMEV 2BC 
pLMT2BC60 2BF 2C60R 560 (2BC60) 
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2.3.3 Maintaining a BHK-21 cell line 
BHK-21 cells (kind gift of Dr A. Moore, University of Alabama, USA) were used in 
this study as both a host for viral infection and as a platform for the transient 
expression of viral proteins. At all times cells were maintained in Dulbecco' s 
Modified Eagle ' s Medium (DMEM) (Highveld Biological (Pty) Ltd or Cambrex) with 
5% fetal calf serum (FCS) (Highveld Biological (Pty) Ltd) and I % Penicillin! 
Streptomycin! Fungizone (PSF) (Highveld Biological (Pty) Ltd) in 25 cm3 non-vented 
flasks (Sarstedt) and were incubated in a Series II Water Jacketed CO2 Incubator 
(Thermo Forma) at 37°C and 5% CO2. At 5% CO2, using non-vented culture flasks 
with the lids untightened, the dissolved C02 in the unbuffered media is sufficient to 
maintain a pH of approximately 7.4, which is ideal for mammalian cell growth. All 
experiments pertaining to the culture or transfection of mammalian cells were carried 
out in a sterile environment in a laminar flow hood. 
(i) Subculturing cells 
Confluency can be described as the percentage of the growth surface of a culture flask 
that is covered by the cultured cells. When cells reached 100% confluency, i.e. the 
growth surface was completely covered; they were subcultured into fresh culture 
flasks. Cell-matrix and cell-cell interactions were broken through the addition of 
Trypsin (Highveld Biological (Pty) Ltd). Once cells had been vigorously resuspended 
in I ml of DMEM (5% FCS, 1% PSF) to remove any remaining cell-cell interactions, 
approximately 1.00 x 106 resuspended cells were seeded into 7 ml DMEM (5% FCS, 
1% PSF) in a fresh culture flask. Flasks were incubated as described above. Using this 
protocol it was observed that cells reached 100% confluency after approximately 72 
hours incubation and were thus subcultured at these intervals for the duration of the 
experiments described in this study. 
(ii) Cryopreservation of BHK-21 cells 
It is important to store reserve stocks of a cell line in case of contamination of existing 
cultures or incubator failure. BHK-21 cells that had reached 100% confluency in a 25 
cm3 culture flask were trypsinised as described above and resuspended in I ml 
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cryopreservation medium (50% FCS, 39% DMEM, 10% glycerol, 1% PSF). 
Resuspended cells were aliquoted into cryovials (Sarstedt) and slowly cooled to -80°C 
overnight before long-term storage in liquid nitrogen. 
2.3.4 Transfection of BHK-21 cells with cDNA encoding TMEV P2 and 3A 
proteins 
(i) Preparation of cells for transfection 
A 13 mm glass coverslip (VWR International) was placed at the bottom of each well 
in a 24-well plate (Greiner Bio-one) with I ml DMEM (5% FCS, 1% PSF). BHK-21 
cells grown to 100% confluency in a 25 cm3 culture flask were passaged as described 
above. After trypsinised cells were resuspended in Iml DMEM (5% FCS, 1% PSF), 
approximately 7.50 x 104 cells were aliquoted into each well and the 24-well plate 
was incubated at 37°C and 5% CO2 for approximately 24 hours by which time cells 
were 70 - 90% confluent. 
(ii) Transfection ofBHK-21 cells 
Recombinant plasmids were introduced into BHK-21 cells using the transfection 
reagent ExGen (Fermentas). According to manufacturer's instructions the 
recommended ratio of DNA: ExGen in a transfection reaction in a 24-well plate is I 
!!g DNA: 3.3 !!I ExGen and the recommended amount of DNA added to cells in each 
well is I!!g (Fermentas). Accordingly, transfection mixtures comprising 100 !!I ISO 
mM NaCl, I !!g DNA and 3.3 !!I ExGen, were made up in sterile eppendorftubes and 
incubated for 1 hour at room temperature (RT), vortexing at 5 -minute intervals. 
After overnight incubation at 37°C and 5% CO2, medium was aspirated from 70% 
confluent BHK cells growing on coverslips in a 24-well plate and 400 !!l DMEM (5% 
FCS, 1% PSF) was ali quoted into each well. The transfection mixtures were added 
drop wise to their respective wells and the 24-well plate was incubated at 37°C and 
5% C02. After 4 hours incubation the medium and transfection reagents were 
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aspirated off the cells in each well and 500 III of DMEM (5% FCS, 1% PSF) was 
added to each well and incubation continued for a further 15 hours to allow protein 
expresslOn. 
2.3.5 Indirect immunofluorescent staining of transfected cells 
Transfected cells were rinsed four times in 1 x PBS (8.0 g NaC!, 1.44 g Na2HP04, 0.2 
g KC1, 0.24 g KH2P04 in 1 000 ml dH20) (PH 7.4) before 400lli of 4% (wt/vol) 
paraformaldehyde (pH 7.8) was added to each well to fix the cells. The plate was 
incubated for 20 minutes at room temperature, shaking at 50 rpm. Fixed cells were 
rinsed twice in 1 x phosphate-buffered saline (PBS, pH 7.4) and permeabilised in 
permeabilisation buffer (10% wtlvol sucrose and 0.5% Triton X-IOO (Saarchem) in I 
x PBS, pH 7.4) for 20 minutes at room temperature, shaking at 50 rpm. 
Cells were stained with anti-V5 mouse monoclonal IgG antibody (1: 500) (Invitrogen) 
and either anti-I3COP (1: 250) (Kind gift of T. Wileman, University of East Anglia, 
UK) or anti-ERp60 rabbit polyclonal IgG antibody (1: 5 000) (Kind gift of T. 
Wileman, University of East Anglia, UK) primary antibodies diluted in 
permeabilisation buffer, for I hour 30 minutes at room temperature, shaking at 50 
rpm. Cells were then washed in 1 x PBS (PH 7.4) containing 1 % Tween-20 
(Saarchem). Primary antibodies were detected using Texas Red® Goat anti-mouse 
IgG (H+L) (1: 500) (Molecular probes) and Alexa Fluor® 488 Goat anti-rabbit IgG 
(H+L) (l: 500) (Molecular probes) diluted in permeabilisation buffer for 20 minutes 
at room temperature, shaking at 50 rpm. Details of the antibodies used in the indirect 
immunofluorescent staining are shown below in Table 2.3.3. Cells were washed in I x 
PBS (PH 7.4) containing 1 % Tween-20. DNA was stained with 10ng/ml DAPI 
(Roche) diluted in 1% Tween-20 in PBS for 10 minutes at room temperature, shaking 
at 50 rpm. Coverslips were mounted on microscope slides using Vectashield Hard Set 
Fluorescent Mounting Medium (Vector Laboratories). 
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Table 2.3.3. Antibodies used in the indirect immunofluorescent staining of BHK-
21 cells expressing TMEV P2 and 3A roteins 
Antibody Target protein Subcellular 
localisation 
Anti-VS mouse V 5 antigenic tag 
monoclonal IgG on C-terminus of None 
Primary recombinant viral 
antibodies proteins 
Anti-j3COP rabbit j3-COP Mostly membrane 
poly clonal IgG associated in the CGN, 
although some 
cytoplasmic 
distribution occurs 
Anti-ERp60 rabbit ERp60 Lumen of the ER 
polyclonal IgG 
Alexa Fluor® 488 Anti-j3COP and 
Secondary Goat anti-rabbit anti -ERp60 rabbit None 
antibodies IgG (H+L) polyclonal IgG 
primary antibodies 
Texas Red® Goat Anti-V5 mouse 
anti-mouse IgG monoclonal IgG None 
(H+L) primary antibody 
2.3.6 Microscopic examination of BHK-21 cells expressing TME viral 
proteins 
Immunostained BHK-21 cells transiently expressing TMEV proteins were examined 
using the Zeiss LSM 510 Meta confocal microscope at the Electron Microscopy Unit 
at the University of Kwazulu-Natal, Petermaritzburg. The number of cells expressing 
the viral protein in question was counted on each sample and expressed as a 
percentage of the approximate total number of cells present. The distribution of the 
viral proteins, as indicated by red fluorescence, was also noted. Cells were imaged 
using the Zeiss LSM 510 Meta confocal microscope and LSM 510 software (Zeiss) at 
400x magnification using the 40x oil immersion objective and laser lines at 488 run 
and 543 run. The 488 run laser line excited the Alexa Fluor® fluorophore 
(ExcitationlEmission: 495 nmI519 run) conjugated to the anti-rabbit JgG causing the 
emission of green fluorescence, while the 543 run laser line excited the Texas Red® 
fluorophore (ExcitationlEmission: 596 nmI615 run) conjugated to the anti-mouse IgG 
causing the emission of red fluorescence. 
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2.3.7 Identification of a hydrophobic, antigenic region of 2C 
In view of the ultimate objective of expressing a soluble region of the 2C protein that 
could be used to raise antibodies against that protein, the hydrophobicl hydrophilic 
and antigenic properties of the amino acid sequence of the 2C protein was analysed 
with the aim of identifying a hydrophilic region of the protein with several possible 
antigenic sites. 
The internet-based software program ProtScale (Internet 2) was used to construct a 
Kyte and Doolittle plot of the amino acid sequence of the TMEV 2C protein, 
indicating the relative hydrophilicityl phobicity of different regions of the protein. 
Likewise, the internet-based software program Emboss antigenic (Internet 3) was used 
to identify antigenic regions of the TMEV 2C protein. The region selected for 
expression will be referred to as the 2C178 peptide from this point forward. 
2.3.8 Construction of a recombinant vector for the expression of the 2C178 
region of tbe TMEV 2C protein in E. coli 
In order to express the 2C 178 peptide in E. coli cells the coding region for this peptide 
was inserted into the bacterial expression vector pGEX-2T (Arnersham Biosciences) 
in frame with the coding region for the GST antigen. The coding region for the 2C 178 
peptide was PCR amplified (see Appendix C for primers and therrnocycle reaction 
programs) using the high fidelity DNA-dependent DNA polymerase Expand 
(Promega) and pGDVII-WT DNA (see Appendix A) as a template. Subsequent to 
electrophoresis on a 1% agarose gel at 100 V, the PCR product was excised and 
purified using the Wizard SV Gel and PCR Clean-up System (Promega) according to 
manufacturer's instructions. 
Both the 2CI78 PCR product and the pGEX-2T vector were subjected to restriction 
digestion with Barn HI and Eco RI, following which the digested 2CI78 insert and 
pGEX-2T vector were purified using the Wizard SV Gel and PCR Clean-up System, 
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subsequent to electrophoresis on a 1% agarose gel. The coding sequences for the 
2CI78 peptide was subcloned into the linearised pGEX-2T vector using T4 DNA 
ligase (Promega) at room temperature for four hours followed by overnight incubation 
at 4°C. 
Competent E. coli JMI09 cells (Promega) were transformed with the ligation mix and 
transformed cells were spread plated on Luria agar plates containing ampicillin (100 
[.Iglml) (Roche). Plates were incubated at 37°C overnight. Bacterial colonies were 
inoculated into 5 ml Luria Broth cultures containing ampicillin (100[.lglrnl) and 
incubated overnight at 37°C, shaking at 200 rpm. The presence of recombinant 
plasm ids containing the correct insert in the bacterial cultures was detected by colony 
PCR as described in Section 2.3.1. 
The recombinant plasmid was termed pLMGT2CI78 and was isolated using the 
QIAprep ® Spin Miniprep Kit (Qiagen). The presence of correct inserts was 
confirmed by restriction analysis with Bam HI and Eco Rl, and later by chain-
termination-based sequencing (performed by Inqaba Biotechnical Industries (Pty) 
Ltd) using a standard 3' pGEX Sequencing Primer (Amersham Biosciences, see 
appendix C). 
2.3.9 Expression of 2C178 in E. coli BL-21 cells and pilot-scale purification by 
affinity chromatography 
(i) IPTG-induced expression of the 2el78 peptide in E. coli BL-21 cells 
No more than 48 hours prior to the expression of the GST-2CI78 peptide, 30 [.II of 
competent E. coli BL-21 cells were transformed with 1 [.Ig of either pLMGT2C 178 or 
pGEX-2T DNA and transformed cells were spread plated on Luria agar plates 
containing ampicillin (100 [.Iglml) and incubated at 37°C overnight. 
Bacterial colonies were inoculated into 5 ml Luria broth cultures containing ampicillin 
(100 [.Iglml) and incubated overnight at 37°C, shaking at 200 rpm. A 100 [.II sample 
confluent bacterial culture was inoculated into 100 ml Luria broth containing 
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ampicillin (100 Ilglml) and incubated at 37°C, shaking at 200 rpm until bacterial 
growth was mid log phase and the OD600 of the culture was 0.700. Expression of the 
GST-2CI78 fusion peptide and GST protein was induced for 3 hours at 37°C, shaking 
at 200 rpm, through the addition of isopropyl-beta-D-thiogalactopyranoside (IPTG, 
Fermentas) to the cultures at a final concentration of 5 mM. Untransformed E. coli 
BL-21 cells grown to a confluency of OD600= 0.7 were also subjected to IPTG-
induction as a negative control. 
(ii) Purification of the 2C178 peptide by affinity chromatography 
Following IPTG-induced protein expression, bacterial cells were pelleted at 9 000 
rpm at 4°C for I minute and resuspended in 0.5ml ice-cold Lysis buffer (5 mM 
phosphomethylsulfonyl fluoride (PMSF), 1% Triton x-tOO in PBS, pH 7.4). Cells 
were lysed by sonication at 40 Amps for 2 x 30-second bursts at 4°C. Cell debris was 
pelleted by centrifugation at 14000 rpm at 4° C for 5 minutes. 
Approximately 16 hours prior to the purification of the GST -2C 178 fusion peptide 
and GST protein, 0.07 g lyophilised glutathione agarose beads (Sigma) were added to 
I ml sterile dH20 and allowed to swell at 4°C. To purify the expressed GST-2CI78 
fusion peptide and GST protein, 200 III swollen glutathione agarose beads were added 
to 1 ml of each cell lysate and incubated at room temperature for I hour, rotating 
gently every 5 minutes. Impurities were removed from the beads by six wash steps of 
1 ml ice-cold Lysis buffer added to the beads and pulse-centrifugation at 6 000 rpm. 
Both the GST-2CI78 fusion peptide and GST protein were eluted from the 
glutathione agarose beads by incubation by adding IOOlll ice-cold elution buffer (50 
mM Tris-HCL, pH 8.0, 5 mM reduced glutathione [Sigma]) and incubating at room 
temperature for 10 minutes. Beads were subjected to pulse-centrifugation at 6 000 
rpm. The elution step was repeated three times before pooling all 300 III of eluent. 
(iii) SDS-PAGE electrophoresis and Western blot analysis of purified 2Cl78 peptide 
Immediately following purification the GST-2C178 fusion peptide and GST protein 
were denatured by adding 0.25 volume SDS-PAGE sample buffer and boiling for 5 
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minutes. Denatured isolates of the GST-2CI78 fusion peptide and GST protein were 
subjected to SDS-PAGE electrophoresis through a 12% SDS-PAGE gel, followed by 
either staining with Coomassie staining solution (45% methanol, 45% water, 10% 
glacial acetic acid, 0.002% wt/vol Coomassie Brilliant Blue (Saarchem) or transfer 
onto Hybond nitrocellulose membrane at 250 A for 1 hour. Remaining protein binding 
sites on the membrane were blocked by incubating the membrane in BLOTIO 
solution (10% 1M Tris pH 7.6, 3% 5M NaCI, 5% wt/vol fat-free milk powder, 0.05% 
Tween 20) overnight at room temperature. GST was detected using the anti-GST Goat 
IgG Horse radish phosphatase (HRP)-conjugated antibody (Amersham Biosciences) 
and the ECL Advance ™ Western Blotting Detection Kit (Amersham Biosciences) as 
per manufacturer' s instructions. The resulting chemiluminescence was detected by a 1 
second exposure of the nitrocellulose membrane to X-ray film. 
2.4 RESULTS AND DISCUSSION 
2.4.1 Construction of recombinant vectors for the expression of TMEV 2B, 
2C, 2BC, 3A, 2C60 and 2BC60 coding regions in mammalian cells 
(i) Restriction analysis of recombinant vectors 
The coding regions for the TMEV 2B, 2C, 2BC and 3A proteins as well as the coding 
regions for the truncated 2C60 and 2BC60 proteins were subcloned into the 
mammalian expression vector pcDNA3.1N5-His© TOPO® as described in Section 
2.3.1. Subsequent to purification from transformed E. coli JMI09 cells, recombinant 
vectors underwent restriction analysis with Bam HI (PLMT2B) or Bam HI and Xba 1 
(PLMT2C, pLMT2BC and pLMT3A) to confirm the presence of the correct insert. 
Figure 2.4.1 is a digital image of agarose gel electrophoresis of the digested 
constructs. 
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Figure 2.4.1 Diagnostic restriction digest of recombinant plasm ids encoding wild type TMEV proteins. 
Coding sequences for the TMEV 2B, 2C, 2BC, 3A, 2C60 and 2BC60 proteins were PCR amplified 
from the eDNA of the viral genome and inserted into the mUltiple cloning site of the mammalian 
expression vector pcDNA3. IN5-His© TOPO® ®. The presence of the correct coding sequence inserts 
in the recombinant vectors was con finned via restriction analysis. Digested vectors were 
electrophoresed through a 1% agarose gel (O.5g agarose, 50ml Ix TAE buffer, 8f11 Img/ml O'Gene 
Ruler I kb DNA Ladder Plus (Fermentas), Lane 2- pLMT2B digested with Bam HI, showing an insert 
of 380 base pairs (hp), Lane 3- pLMT2C digested with Bam H I and Xba I, showing an insert of 978 
bp, Lane 4- pLMT2BC digested with Bam H I and Xba I, showing an insert of 1357 bp, Lane 5-
pLMT3A digested with Bam HI andXba I, showing an insert of264 bp, Lane 6- pLMT2C60 digested 
with Bam HI and Xba I, showing an insert of 180 bp, Lane 7- pLMT2BC60 digested with Bam HI 
and Xba I, showing an insert of 560 bp. 
(ii) Chain-termination-based sequencing of recombinant vectors 
Chain-termination-based sequencmg was performed on the recombinant vectors 
shown in Figure 2.4.1 by Inqaba Biotechnical Industries (Pty) Ltd) using standard T7 
and BOH primers (Invitrogen). All inserts shown in Table 2.3.1 and 2.3.2 were 
successfully sequenced. All coding sequences for the various TMEV proteins were 
compared with the sequence of the ODVII strain of TMEV (Pubmed accession 
number: 2251141). All sequences were in frame with no mutations except a single 
Olu to Lys substitution mutation located at amino acid 69 on the 2B sequence in the 
pLMT2B, pLMT2BC and pLMT2BC60 constructs. This mutation was later 
discovered to be present on the original pODVII-WT template DNA (see Appendix B 
for summary of sequencing data) 
40 
2.4.2 Microscopic examination of BHK-21 cells expressing TME viral 
proteins 
With the aim of characterising the subcellular distribution and effect on host 
membranes of the TMEV 2B, 2C, 2BC and 3A proteins, BHK-21 cells were 
transfected with recombinant mammalian expression vectors encoding these proteins. 
Protein expression progressed for 19 hours before cells were fixed with a 
paraformaldehyde solution and immunostained with primary antibodies recognising 
the V5 fusion tag on the C-terminus of the expressed viral proteins as well as primary 
antibodies raised against specific marker proteins of the ER or Goigi apparatus. 
Secondary staining was performed with fluorophore-conjugated secondary antibodies. 
Texas Red® Goat anti-mouse IgG (H+L) and Alexa Fluor® 488 Goat anti-rabbit IgG 
(H+L) recognised the anti-V5 and anti-ERp60/ anti--p-COP primary antibodies, 
respectively. Cells were mounted on microscope slides with Vectashield Hard Set 
Fluorescent Mounting Medium and examined by laser-scanning confocal microscopy. 
Successful expression ofTMEV protein-V5 fusions in transfected and immunostained 
BHK-21 cells was indicated by the observation of red fluorescence when samples 
were excited with the 543nm laser line. Staining of organelle marker proteins was 
identified by green fluorescence when samples were excited with the 543nm laser 
line. 
(i) TMEV 2B protein transiently expressed in BHK-21 cells 
Transfection efficiency can be described as the proportion of cells in a sample that are 
transfected with the nucleic acid in question and in these experiments is indicated by 
the proportion of cells in a sample that are expressing the protein encoded by the 
transfecting construct. The TMEV 2B protein was successfully expressed in BHK-21 
cells but at repeatedly low transfection efficiencies varying between 0.5% - 2%. 
Transfection efficiencies were not improved by varying the ratio of DNA: ExGen 
transfection reagent, by varying the amount of DNA transfected into the cells or even 
using different isolates of the same plasmid samples. Transfections were also 
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performed on HeLa and Cos-7 cell lines with no improvement III transfection 
efficiency. In addition, the transfection efficiency of the recombinant vectors 
expressing the different TMEV proteins varied greatly despite the transfections with 
the different constructs being repeatedly performed in the same experiment. The 
reason for this phenomenon remains unknown. The only variable between cells 
transfected with the different constructs was the actual coding sequence of the viral 
protein expressed. This leads to the possibility that the number of cells expressing the 
viral proteins may not in fact reflect the true transfection efficiency of the experiment 
but may instead be dependent on the ability of the RNA encoding the viral proteins to 
exit the nucleus following transcription (Personal communication, Professor T. 
Wileman). As picornavirus RNA never enters the nucleus during the viral replication 
cycle it is unlikely that these RNA sequences would encode nuclear export signals. 
Thus although transfection of the BHK-2l cells with the DNA constructs encoding 
the viral proteins may have been successful, the export of transcribed viral RNA from 
the nucleus may have been inefficient to different extents for the different viral 
protein coding sequences. In future studies this problem could be avoided by cloning 
the coding sequences for the viral proteins into mammalian expression vectors that 
encode a nuclear export signal at the C-terminal of the MCS. 
All cells expressing the 2B-V5 fusion showed a similar distribution of this protein. 
Frames A, D and G in Figure 2.4.2 shows the 2B protein located to fine reticular 
structures with several larger punctate structures concentrated in the perinuclear 
region. Some of these structures overlapped with the ERp60 stain, as indicated by the 
yellow signal in frames C, F and I in Figure 2.4.2, while a significant proportion of 
the 2B-V5 fusion remained separate. This suggests that although a proportion of the 
2B protein locates to the ER, this protein may also associate with other host 
membranes. Although the concentration of 2B in the perinuclear region suggests a 
possible association with the nuclear envelope, the dispersion of this protein 
throughout the cytosol as far as the plasma membrane may suggest a possible 
association with endosomal and/or lysosomal membranes. 
42 
Figure 2.4.2 Transient expression of TMEV 2B protein in BHK-21 cells stained with antibodies 
against a marker protein for the ER. BHK-2I cells transfected with pLMT2B and expressing the 
TMEV 2B-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 
software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein, as well as f1uorophore-conjugate secondary antibodies. Red fluorescence indicates the 
position oftbe 2B-V5 fusion protein (Frames A, D, G), green fluorescence indicates the ERp60 stain 
(Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) indicates an overlap of 
red and green signals. 
All BHK-21 cells expressing the 2B-V5 fusion and counterstained with antibodies 
against the Oolgi apparatus marker protein /3-COP (Figure 2.4.3) showed the same 
distribution of the 2B protein (Frames A, D and 0) as those counterstained with anti-
ERp60. Interestingly some of the 2B accumulated in the perinuclear region appeared 
to overlap with the /3-COP stain indicating a possible association between TMEV 2B 
and membranes of the CON. 
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Figure 2.4.3 Transient expression of TMEV 2B protein in BHK-21 cells stained with antibodies 
against a marker protein for the Golgi apparatus. BHK-21 cells transfected with pLMT2B and 
expressing the TMEV 2B-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope 
and LSM 510 soltware. Cells are immunostained with primaI)' antibodies raised against the V5 tag and 
the Golgi apparatus marker protein B-COP, as well as fluorophore-conjugate secondary antibodies. 
Red fluorescence indicates the position of the 2B-V5 fusion protein (Frames A, D, G), green 
fluorescence indicates the B-COP stain (Frames B, E, H) and yellow signal in the merged images 
(Frames C, F and \) indicates an overlap of red and green signals. 
As mentioned in Section 1.3.2, the PV 2B protein localises exclusively with the Golgi 
membranes causing the complete disassembly of the Golgi cisternae, consequently 
disrupting protein secretion through the exocytic pathway (Doedens and Kirkegaard, 
1995). In contrast, the FMDV 2B protein was observed to locate to a reticular stain 
closely associated with that of the ERp57 protein, suggesting an association with 
membranes of the ER (Moffat et ai, 2005). The distribution of the TMEV 2B protein 
most closely mimics that of the corresponding FMDV protein although these results 
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suggest that some localisation to the Golgi apparatus may also occur. No gross 
disassembly of the Golgi complex was observed, although this can not be confinned 
without examining cells transiently expressing the 2B protein by transmission electron 
mIcroscopy. 
Further studies are required to conclusively detennine the subcellular localisation of 
the TMEV 2B protein in host cells and its effect on membranes of the host cell 
secretory pathway. These would include further localisation studies using marker 
proteins for lysosomal and endosomal membranes, electron microscopic examination 
of cells transiently expressing the viral protein and the coimmunoprecipitation of the 
2B protein and the various organelle marker proteins from membrane fractions 
pertaining to specific organelles. The biological significance of the possible 
association of the TMEV 2B protein with membranes derived from the ER and Golgi 
complex remains unexplored. The effect of the TMEV 2B protein on protein secretion 
through the exocytic pathway could be detennined through the implementation of 
protein transport assays as described in Doedens and Kirkegaard (1995) and Moffat et 
at (2005). 
(iiJ TMEV 2C protein transiently expressed in BHK-21 cells 
The 2C protein was successfully expressed in BHK-21 cells as a 2C-V5 fusion with 
transfection efficiencies of 1% - 5% achieved. Although higher than that observed 
with cells expressing the 2B-V5 fusion, this efficiency is also extremely low 
compared to the advertised transfection efficiency of >80% expected with the ExGen 
transfection reagent (Fennentas). 
In expressing cells, the 2C-V5 fusion protein showed several distributions that 
appeared to be linked to the amount of protein expression. At low expression levels 
2C located to a relatively faint reticular stain (Frames A, D and G of Figure 2.4.4) that 
partially overlapped with the ERp60 stain (Frames C, F and I of Figure 2.4.4). At 
higher levels of expression 2C was concentrated in the perinuclear region and was 
also located in large structures adjacent to the nucleus (Frames A, D and G of Figure 
2.4.5) that overlapped with the ~-COP stain (Frames C, F and I of Figure 2.4.5). Of 
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the cells expressing the 2C protein, an approximately equal number showed the two 
different protein distributions. These observations suggest that the TMEV 2C protein 
may localise to different regions of the host cell, possibly at different stages of protein 
expression. Further examination of this phenomenon through the examination of cells 
stably expressing the TMEV 2C protein is necessary to resolve this whether this is the 
case. Furthermore, in addition to colocalising with marker proteins of the ER and 
Golgi apparatus, the persistently evident perinuclear stain suggests that this protein 
may also be associated with either the nuclear envelope or the rough endoplasmic 
reticulum (RER) that is continuous with the nuclear envelope. 
Figure 2.4.4 Transient expression of TMEV 2C protein in BHK-2l cells stained with antibodies 
against a marker protein for the ER. BHK-2l cells transfected with pLMT2C and expressing the 
TMEV 2C-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 
software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein ERp60, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the 2C-V5 fusion protein (Frames A, D, G), green fluorescence indicates the 
ERp60 stain (Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) indicates 
an overlap of red and green signals. 
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Figure 2.4.5 Transient expression of TMEV 2C protein in BHK-21 cells stained with antibodies 
against a marker protein for the Golgi apparatus. BHK-2l cells transfected with pLMT2C and 
expressing the TM EV 2C-V5 fu sion protein imaged using Zeiss LSM 510 Meta confocal microscope 
and LSM 510 software. Cells are immunostained with primary antibodies raised against the V5 tag and 
the Golgi apparatus marker protein p-COP, as well as fluorophore-conjugate secondary antibodies. 
Red fluorescence indicates the position of the 2C-V5 fusion protein (Frames A, D, G), green 
fluorescence indicates the p-COP stain (Frames B, E, H) and yellow signal in the merged images 
(Frames C, F and I) indicates an overlap of red and green signals. 
As already mentioned in Section 1.3.3, the PV 2C protein locates to reticular-like 
structures and is known to associate with and modify RER membranes (Aldabe and 
Carasco, 1995 ; Bienz et aI, 1987; Bienz et aI, 1990; Bienz et aI, 1992; Cho et ai, 
1994; Schlegel et aI, 1996). The FMDV 2C protein also interacts with RER 
membranes but has also been shown to localise to large perinuclear structures (Moffat 
et aI, 2005) similar to those observed with the transient expression of the TMEV 2C 
protein. In addition, Knox et al (2005) observed that at early stages of FMDV 
infection 2C locates to a diffuse punctate pattern to one side of the nucleus and is 
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concentrated into larger structures adjacent to the nucleus at later stages. The evidence 
presented in Figures 2.4.4 and 2.4.5 suggests that the TMEV 2C protein may interact 
with host membranes in a similar manner to the FMDV 2C protein. 
As described above with the 2B protein, further studies are required to conclusively 
determine whether the 2C protein is membrane-associated in host cells and to explore 
the biological significance of the interactions formed between the 2C protein and host 
membranes with respect to its effects on host cell protein secretion. 
(iii) TMEV 2Be protein transiently expressed in BHK-21 cells 
Expression of the TMEV 2BC-V5 fusion protein was achieved in BHK-21 cells but 
transfection efficiencies were extremely low with fewer than thirty cells expressing 
the protein per sample, i.e. transfection efficiency varied between 0.010% - 0.015%. 
Consequently it was difficult to obtain a number of quality images of the subcellular 
distribution of the 2BC protein. 
Figure 2.4.6 Transient expression of TMEV 2BC protein in BHK-21 cells stained with antibodies 
against a marker protein for the ER. BHK-21 cells transfected with pLMTIBC and expressing the 
TMEV 2BC-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 
software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein ERp60, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the 2BC-V5 fusion protein (Frames A, D, G), green fluorescence indicates the 
ERp60 stain (Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) indicates 
an overlap of red and green signals. 
In all cells expressing the 2BC-V5 fusion protein (frame A, Figure 2.4.6) most of the 
2BC protein was located to large perinuclear structures that closely overlapped with 
the p-COP stain (Frame C, F and I, Figure 2.4.7), suggesting that this protein localises 
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to the peripheral Golgi, while the remainder of the protein was distributed to small 
punctate structures throughout the cytoplasm (Frames A, D and G, Figure 2.4.7). 
Figure 2.4.7 Transient expression of TMEV 2BC protein in BHK-21 cells stained with antibodies 
against a marker protein for the Golgi apparatus. BHK-21 cells transfected with pLMT2BC and 
expressing the TMEV 2BC-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope 
and LSM 510 software. Cells are immunostained with primary antibodies raised against the V5 tag and 
the Golgi apparatus marker protein j3-COP, as well as fluorophore-conjugate secondary antibodies. 
Red fluorescence indicates the position of the 2BC-V5 fusion protein (Frames A, D, G), green 
fluorescence indicates the j3-COP stain (Frames B, E, H) and yellow signal in the merged images 
(Frames C, F and I) indicates an overlap of red and green signals. 
These observations were reminiscent of the localisation of the FMDV 2BC protein to 
the Golgi apparatus determined by Moffat et at (2005). However, unlike with the 
FMDV 2BC protein, there was almost complete overlap of the ~-COP stain with the 
2BC-V5 stain. Interestingly, the distribution of the TMEV 2BC protein (Frames A, D 
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and G, Figure 2.4.7) in BHK-21 cells was similar to that of TMEV 2C in cells 
expressing the protein at high levels (Frames A, D and G of Figure 2.4.5) in that both 
proteins showed a strong overlap with the !3-COP stain. The small punctate structures 
extended throughout the cytosol, frequently as far as the plasma membrane, 
suggesting a possible association with endosomal and/or lysosomal membranes. 
Observation revealed that in all cells expressing the 2BC protein, the ERp60 stain was 
very faint compared to untransfected neighbouring cells and no clear overlap of red 
and green signals was observed. As ERp60 is located in the lumen of the ER 
membranes it is possible that the 2BC protein associates with ER membranes, 
effectively coating them and preventing access of the anti-ERp60 antibody to the 
marker protein during the immunostaining process. However, the transient expression 
of FMDV 2BC protein has been shown to cause the redistribution of the ER marker 
protein ERp57 (Moffat et ai, 2005). There was some overlap between the transiently 
expressed TMEV 2BC protein and the ERp60 stain (Frame C, Figure 2.4.6), however 
without examining cells transiently expressing the 2BC protein by transmission 
electron microscopy it can not be determined whether the TMEV 2BC protein has a 
redistribution effect on these membranes. 
Rust et ai (2001) demonstrated the colocalisation of the PV 2BC protein with ER-
derived membranes containing the marker protein COPI!. In addition the FMDV 2CB 
protein is responsible for the inhibition of protein transport to the plasma membrane 
(Moffat et ai, 2005) and the PV 2BC protein has also shown some ability to inhibit 
ER-to-Golgi transport (Doedens and Kirkegaard, 1995). In view of these findings with 
other picornavirus 2BC proteins it is not unlikely that the TMEV 2BC protein does 
associate with ER membranes and may affect ER-to-Golgi protein transport. These 
phenomena will be examined in future studies using protein transport assays in 
addition to electron microscopic examination of cells transiently expressing the 
TMEV 2BC protein, as mentioned above. 
However in order to further explore the interactions of the 2BC protein with host cell 
components, the membrane association of this protein must first be confirmed in 
further studies. 
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The biological significance of the possible membrane association of the TMEV 2BC 
protein is unexplored. The PV 2BC protein is capable of inducing the proliferation of 
vesicles from secretory pathway membranes. In view of this, further studies may also 
focus on the ability of TMEV 2BC to modifY membranes of the secretory pathway 
and cause the proliferation of membranous vesicles. 
(iv) TMEV 3Aprolein transiently expressed in BHK-21 cells 
Transfection of cells with the pLMT3A construct resulted in far higher transfection 
efficiencies than those experienced with constructs encoding the 2B, 2C and 2BC 
proteins. Efficiencies ranging from 5% - 10% were observed with almost all cells that 
expressed the 3A protein displaying very high levels of protein expression. However, 
despite the relative success of these transfection experiments when compared to those 
with pLMT2B, pLMT2C and pLMT2BC, these efficiencies are still low compared to 
the possible transfection efficiency of >80% with the ExGen transfection reagent 
(Fermentas). As mentioned above, these experiments were conducted repeatedly 
together with the constructs encoding the other wild type TMEV proteins. 
The difference in "transfection efficiencies" thus indicates that the actual sequence of 
the protein coding region is somehow important for viral protein expression in 
mammalian cells transfected with eDNA encoding that protein. It is possible that a 
larger proportion of cells were successfully transfected but that expression levels in 
these cells was too low to be detected by immunofluorescence microscopy. However, 
this is unlikely as there was no significant difference observed in the transfection 
efficiencies of any of the plasmids encoding the TMEV proteins in cells with a 12-
hour expression period compared to those with a 19-hour expression period. The 
transfection efficiencies experienced with the different plasmids encoding the 2B, 2C, 
2BC and 3A proteins did not vary significantly when BHK-21 cells were transfected 
with different isolates of these plasm ids, thus indicating that the variation in 
transfection efficiencies was not a product of varying DNA quality. 
The TMEV 3A protein stain overlapped with stains of both the ER marker protein 
ERp60 (Figure 2.4.8) and the peripheral Golgi marker protein ~-COP (Figure 2.4.9.). 
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The ERp60 stain was modified in cells expressmg the 3A protein compared to 
untransfected neighbouring cells with the ER appearing distorted with large bulbous 
swellings that overlapped with the location of the 3A protein. In addition, the 3A 
protein partially overlapped with the ~-COP stain in approximately 30% of the cells 
expressing the protein and in approximately 10% of expressing cells, at particularly 
high levels of 3A protein expression, the ~-COP stain appeared dispersed throughout 
the cytoplasm. 
Figure 2.4.8 Transient expression of TMEV 3A protein in BHK-21 cells stained with antibodies 
against a marker protein for the ER. BHK-21 cells transfected with pLMT3A and expressing the 
TMEV 3A-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 
software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein ERp60, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the 3A-V5 fusion protein (Frames A, D, G), green fluorescence indicates the 
ERp60 stain (Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) indicates 
an overlap of red and green signals. 
PV 3A is involved in the proliferation of virus-induced vesicles (Suhy et ai, 2000) 
and inhibits ER-to-Golgi protein trafficking (Choe et ai, 2005), causing the 
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accumulation of proteins otherwise destined for secretion and the ensuing distortion 
and extreme swelling of the ER cisternae (Doedens et ai, 1997; Neznanov et ai, 
2001). FMDV 3A is also associated with ER membranes but does not affect ER-to-
Golgi trafficking (Moffat et ai, 2005; O'Donnell et ai, 2001; Monteyne et ai, 1997). 
As mentioned in Section 1.3.6, only the 3A proteins of PV and closely related 
serotypes are known to affect anterograde protein trafficking. The 3A proteins of 
rhinovirus 14, hepatitis A virus and enterovirus 71 and both the virulent GDVII strain 
and the non-virulent BeAn strain of TMEV do not affect protein secretion (Choe el ai, 
2005; O'Donnel etal, 2001). 
Figure 2.4.9 Transient expression of TMEV 3A protein in BHK-21 cells stained with ant ibodies 
against a marker protein for the Golgi apparatus. BHK-21 cells transfected with pLMT3A and 
expressing the TMEV 3A-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope 
and LSM 510 software. Cells are immunostained with primary antibodies raised against the V5 tag and 
the Golgi apparatus marker protein J3-COP, as well as fluorophore-conjugate secondary antibodies. 
Red fluorescence indicates the position of the 3A-V5 fusion protein (Frames A, D, G), green 
fluorescence indicates the J3-COP stain (Frames B, E, H) and yellow signal in the merged images 
(Frames C, F and I) indicates an overlap of red and green signals. 
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Taken together the results obtained in this study and the studies mentioned above 
indicate that the TMEV 3A protein possibly modifies ER (and possibly Golgi 
apparatus) membranes for a purpose not involved in the blockage of protein secretion. 
Further studies may involve an investigation of the ability of this protein to bind host 
membranes and induce proliferation of vesicles in BHK-21 cells. 
(v) TMEVtruncated 2C and 2BC proteins transiently expressed in BHK-21 cells 
The transfection efficiencies obtained through the transfection of BHK-21 cells with 
the pLMT2C and pLMT2BC constructs encoding the wild type TMEV 2C and TMEV 
2BC proteins were excessively low. The N-tenninal 60 amino acids of the 
picornavirus 2C protein are thought to include the residues responsible for membrane 
association and the RNA binding activity of the protein (Banerjee et ai, 2004; 
Teterina et ai, 1997; Echeverri and Dasgupta, 1995). In view of this it was postulated 
that expressing only the first 60 amino acids of the 2C protein in the 2C and 2BC 
coding sequences might not affect the subcellular localisation of these proteins. 
The transfection of BHK-21 cells with the recombinant vectors encoding the truncated 
2C and 2BC proteins resulted in transfection efficiencies ranging from 10% - 30%. 
This result contrasted greatly with the low transfection efficiencies observed with the 
wild type 2C and 2BC proteins. The reason for this increased efficiency is unknown. 
All transfection experiments were carried out repeatedly alongside transfections with 
the recombinant vectors encoding the truncated 2C and 2BC proteins, indicating once 
again that the efficiency of viral protein expression in transfected manunalian cells is 
affected by the coding sequence of the protein. 
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Figure 2.4.10 Transient expression of TMEV 2C60 protein in BHK-21 cells stained with antibodies 
against a marker protein for the ER. BHK-21 cells transfected with pLMT2C60 and expressing the 
TMEV 2C60-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 
software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein ERp60, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the 2C60-V5 fusion protein (Frames A, D, G), green fluorescence indicates 
the ERp60 stain (Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) 
indicates an overlap of red and green signals. 
It is possible that the TMEV proteins are cytotoxic to varying extents resulting in the 
death of cells expressing these proteins and thus the apparent low transfection 
efficiencies. This is unlikely as there was no significant observable difference in the 
number of cells surviving after expression of the different wild type and truncated 
TMEV proteins. A possible, although unlikely, alternative explanation is that the 
truncation of the 2C coding sequence created a nuclear export signal on the mRNA, 
protecting the transcribed RNA from being degraded in the nucleus and increasing 
export efficiency. 
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Figure 2.4.11 Transient expression ofTMEV 2C60 protein in BHK-21 cells stained with antibodies against a 
marker protein for the Golgi apparatus. BHK-21 cells transfected with pLMT2C60 and expressing the TMEV 
2C60-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 510 software. 
Cells are immunostained with primary antibodies raised against the V5 tag and the Golgi apparatus marker 
protein ~-COp, as well as fluorophore-conjugate secondary antibodies. Red fluorescence indicates the 
position of the 2C60-V5 fusion protein (Frames A, D, G), green fluorescence indicates the ~-COP stain 
(Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) indicates an overlap of red 
and green signals. 
The distribution of the truncated 2C protein (2C60) was indistinguishable from that of 
the wild type 2C protein. At low expression levels 2C60 was located to a reticular 
stain, partially overlapping with the ERp60 stain (Frames A, D and G, Figure 2.4.10), 
and at high levels it was located to a perinuclear stain and large structures adjacent to 
the nucleus that partially overlapped with the ~-COP stain (Frames A, D and G, 
Figure 2.4.11). An approximately equal number of cells showed each of these 
distributions. 
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, Figure 2.4.12 Transient expression ofTMEV 2BC60 protein in BHK-2l cells stained with antibodies 
against a marker protein for the ER. BHK-2l cells transfected with pLMT2BC60 and expressing the 
TMEV 2BC60-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal microscope and LSM 
510 software. Cells are immunostained with primary antibodies raised against the V5 tag and the ER 
marker protein ERp60, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the 2BC60-V5 fusion protein (Frames A, D, G), green fluorescence indicates 
the ERp60 stain (Frames B, E, H) and yellow signal in the merged images (Frames C, F and I) 
indicates an overlap of red and green signals. 
Similarly, the distribution of the truncated 2BC protein (2BC60) was 
indistinguishable from that of the wild type 2BC protein. 2BC60 was located to large 
structures adjacent to the nucleus that almost completely overlapped with the ~-COP 
stain (Frames A, D and G, Figure 2.4.13). As with the wild type 2BC, smaller 
punctate structures were also located in the cytosol. These structures extended to the 
plasma membrane in a distribution not dissimilar to that of the LAMPI (a lysosomal 
marker protein) stain recorded by Knox et at, 2005. Very little or no overlap of the 
2BC60 protein and the ERp60 stain and, as with wild type 2BC, the ERp60 stain was 
very faint in most cells expressing the 2BC60 protein (Frames A and D, Figure 
2.4.12). 
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Figure 2.4. \3 Transient expression of TMEV 2BC60 protein in BHK-21 cells stained with antibodies 
against a marker protein for the Golgi apparatus. BHK-21 cells transfected with pLMT2BC60 and 
expressing the TMEV 2BC60-V5 fusion protein imaged using Zeiss LSM 510 Meta confocal 
microscope and LSM 510 software. Cells are immunostained with primary antibodies raised against the 
V5 tag and the Golgi apparatus marker protein P-COP, as well as fluorophore-conjugate secondary 
antibodies. Red fluorescence indicates the position of the 2BC60-V5 fusion protein (Frames A, D, G), 
green fluorescence indicates the p-COP stain (Frames B, E, H) and yellow signal in the merged 
images (Frames C, F and I) indicates an overlap of red and green signals. 
Taken together, these results suggest that the truncated 2C60 and 2BC60 proteins 
localise to the same regions within the host cell as the wild type 2C60 and 2BC60 
proteins, thus indicating that amino acids 61 - 326 are not important for the 
membrane targeting and membrane association of the TMEV 2C and 2BC proteins. 
This supports the findings of Banerjee et af (2004) who determined a putative 
membrane association domain in the N-terminal45 amino acids of the PV 2C protein. 
Furthermore, these results suggest that when low transfection efficiencies are 
encountered in cells expressing viral proteins the expression of truncated proteins may 
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be an alternative strategy to cloning the coding sequences of viral protein into 
mammalian expression vectors encoding nuclear export signals in order to avoid the 
degradation of RNA transcribed from transfected DNA. 
2.4.3 Identification of a hydrophobic, antigenic region of 2C 
Figure 2.4.14 depicts the Kyte and Doolittle hydrophobicity/ hydrophilicity plot 
generated using the Internet based program Protscale (Internet 2). Values above 0 on 
the y-axis indicate amino acid residues with hydrophobic character while values 
below 0 on the y-axis indicate amino acid residues with hydrophilic character. In view 
of this, the region highlighted (amino acids 31-210) in Figure 2.4.14 was chosen as 
the region of the protein that was most hydrophilic and therefore likely to be soluble 
in a bacterial expression system. 
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Figure 2.4.14 Kyte and Doolittle hydrophobicity/ hydrophilicity plot of the amino acid sequence ofthe 
326 amino acids of the TMEV strain GDVII 2C protein created by the Internet based software program 
PratScale. Values above 0 on the y-axis indicate amino acid residues with hydrophobic character while 
values below 0 on the y-axis indicate amino acid residues with hydrophilic character. The high degree 
of hydro phi Ii city of the highlighted region (red arrow) suggests its solubility in the cytoplasm of E. coli 
cells. 
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The identification of antigenic regions of the 2C protein was performed by the 
Internet based program Emboss Antigenic (Internet 3). Of the possible 13 antigenic 
regions identified within this protein, 7 were located between amino acids 31-210 
(Table 2.4.1). On the basis of the relatively high hydrophilicity and antigenicity of 
amino acids 31-210 of the 2C protein this region was selected for expression in E. coli 
cells and will be referred to as the 2CI78 peptide. This peptide has a molecular mass 
of 36871.2g and the molecular formula CI634Hz547N4470482SZ, as calculated by the 
internet-based program ProtParam (Gasteiger et ai, 2005) . 
Table 2.4.1 Antigenic regions of the 2C protein as detected by the internet based protein 
analysis program Emboss Antieenic 
Amino acid Total NQ Antigenicity Amino acid sequence 
residues of amino acid score * 
TMEV2C residues 
protein 
106-122 
220-235 
67-100 
181-188 
267-285 
296-306 
239-251 
128-141 
208-216 
23-30 
145-152 
42-58 
164-170 
* 
** 
*** 
17 1.246 DHSVTRPEPVVVVLRGA 
16 1.175 KFRPVTVAHYPAVDRR 
34 1.172 KAYCECTASFKYFDDLYNLAVTCKRIPLASLCEK 
8 1.160 FTVFCQMV 
19 1.144 SKPQLACFSADCPLLHKRG 
11 1.140 VYNLQQVVKMV 
13 1.116 DFTVTAGPHCKTP 
14 1.113 SVTSQIIAQSVSKM 
9 1.093 TSSFIVATT 
8 1.079 IQSIVNWL 
8 1.075 RQSVYSMP 
17 1.070 QSKLDKLLMEFPDHCRN 
7 1.051 QFSVIMD 
Antigenicity scores above 1 are proportionally representative of polypeptide regions that are 
likely to induce an antigenic response in mammals 
The antigenic regions detected in the 2C protein are shown in decreasing rank of antigenic 
potential 
Antigenic regions located between amino acids 31 -210 on the 2C protein are indicated in bold 
type 
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2.4.4 Construction of a recombinant vector for the expression of an antigenic, 
hydrophobic region of the TMEV 2C protein in E. coli 
(i) Restriction analysis of the pLMGT2CI78 recombinant vector 
A pilot scale study was perfonned to ensure that the 2C 178 peptide was expressed as 
a soluble protein in E. coli. To this end the coding region for the 2C 178 peptide was 
inserted into the bacterial expression vector pGEX-2T, encoding a GST-tag on the N-
terminus of the peptide, as described in Section 2.3.8. Following purification from 
transformed E. coli JMI09 cells, the recombinant pLMT2C178 vector underwent 
restriction analysis with Bam HI and Eco RI to confinn the presence of the correct 
insert. Figure 2.4.15 below is a digital image of agarose gel electrophoresis of the 
digested construct. 
Ikb DNA ladder 
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Figure 2.4.15 The coding sequence for the 2C I78 peptide inserted into the bacterial expression vector 
pGEX-2T. The coding sequence of the peptide was PCR amplified from the eDNA of the viral genome 
and inserted into the multiple cloning site of the bacterial expression vector pGEX-2T. The presence of 
the correct coding sequence insert in the recombinant vector was confmned via restriction analysis. 
Digested vector DNA was electrophoresed through a 1% agarose gel before being imaged under UV 
illumination. Lane 1- 8f11 Img/ml O'Gene Ruler I kb DNA Ladder Plus (Fermentas), Lane 2-
pLMGT2C178 digested with Bam HI and Eco RI , showing an insert of534 base pairs. 
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(ii) Chain-termination-based sequencing of the pLMGT2C 178 recombinant vector 
Chain-termination-based sequencing was performed on pLMGT2CI78 by Inqaba 
Biotechnical Industries (Pty) Ltd) using the 3' pGEX Sequencing Primer (Amersham 
Biosciences). The coding sequence for the 2CI78 peptide was in frame with the N-
terminal GST tag and no mutations were detected. 
2.4.5 Expression of 2C178 in E. coli BL-21 cells and pilot-scale purification by 
affinity chromatography 
Subsequent to the successful insertion of the coding sequence of the 2C 178 peptide 
into the MCS of the pGEX-2T bacterial expression vector, E. coli BL-21 cells were 
transformed with the recombinant pLMGT2C178 vector and expression of the GST-
2C 178 fusion peptide was induced by exposure of the cells to IPTG, an artificial 
inducer of the lac promoter on the pGEX-2T vector. The GST-2CI78 fusion peptide 
was purified by affinity chromatography, as described in Section 2.3.9, by exploiting 
the affinity of glutathione agarose beads for the N-terminal GST tag of the 2CI78 
peptide. Likewise the unfused GST protein was purified from E. coli cells 
transformed with the pGEX-2T vector as a positive control. The same purification and 
detection procedure was carried out on untransformed E. coli BL-21 cells as a 
negative control. Figure 2.4.16 shows the proteins present in the various fractions 
during the purification of the GST -2C 178 fusion peptide and the GST protein 
(positive control). The fractions were electrophoresed through a 12% acrylamide 
SOS-PAGE gel, which was subsequently stained with Coomassie staining solution. 
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Figure 2.4.\6 Purification of GST-2CI78 peptide and GST protein from E. coli BL-21 cell lysate. 
Following a four-hour IPTG-induced expression interval, cell lysates of E. coli BL-21 cells 
transformed with the pLMG2T2C 178 and pGEX-2T plasm ids were subjected to an affinity 
chromatography purification step whereby the GST-2CI78 peptide and GST protein were purified 
using glutathione agarose beads. Samples were subjected to SDS-PAGE through a 12% acrylamide gel 
before staining with Coomassie staining solution. Lane \- 1O~1 Prestained SDS-PAGE Standard Broad 
Range (BioRad), position and size of marker bands is indicated, Lane 2- l5~1 unpurified E. coli BL-21 
cell lysate containing the GST protein, Lane 3- 15~1 unpurified E. coli BL-2l cell lysate containing the 
GST-2CI78 fusion peptide, Lane 4- 1 5 ~1 purified GST protein, Lane 5- 15~1 purified GST-2CI78 
peptide. 
A variety of proteins was detected in the raw bacterial lysate prior to the purification 
step (Lanes 2-3, Figure 2.4.16) while Lanes 4-5 of Figure 2.4.16 indicate that the 
affinity chromatography-based purification procedure successfully removed all 
proteins from the samples except the 26Da GST protein (Lane 4) and the 45.8 kDa 
GST-2CI78 peptide (Lane 5). The bands in Lanes 4-5 of Figure 2.4.16 were identified 
as the GST protein and GST-2CI78 peptide, respectively through the subjection of 
these samples to SDS-PAGE and Western blot analysis followed by immunodetection 
of the GST peptide (Figure 2.4.17). 
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Figure 2.4.17 Autoradiograph of the immunodetection of the GST-2C 178 fu sion and GST peptides 
following SOS-PAGE and Western analysis of samples derived from the GST-specific affinity 
chromatography purification procedure performed on the cell lysate of pilot-scale E. coli BL-2l 
cultures. Lane 1- 1O~1 Prestained SOS-PAGE Standard Broad Range (BioRad), position and size of 
marker bands is indicated, Lane 2- 15~1 purified GST peptide, Lane 3- l5~1 purified GST-2CI78 
fusion peptide and Lane 4- Untransformed E. coli BL-2l cell lysate subjected to the same purification 
procedure. 
The GST-2CI78 fusion peptide and the positive control GST peptide were 
successfully purified from E. coli BL-21 cells transformed with the pLMGT2CI78 
and pGEX-2T vectors, respectively, as shown in Lanes 2 and 3 of Figure 2.4.17. No 
protein was recognised by the antibody raised against GST in the sample derived from 
untransformed E. coli BL-21 cell lysate (Lane 4, Figure 2.4.17) indicating positive 
identification of the proteins detected in Lanes 2 and 3 of Figure 2.4.17 as the GST 
and GST-2CI78 fusion peptides, respectively. Taken together these results indicate 
that the expression of the GST-2C178 fusion peptide was successfully induced by 
IPTG in E. coli BL-21 cells transformed with the pLMGT2CI78 recombinant vector 
and that the fusion peptide was successfully purified on a pilot-scale by affinity 
chromatography. 
Additionally, the successful purification of the GST -2C 178 fusion peptide from the 
lysate of E. coli BL-21 cells after the removal of cell debris indicates that this peptide 
is indeed soluble in the cytoplasm of these bacterial cells. This feature is essential for 
maximum yield of the peptide during the large-scale purification of the peptide that 
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must precede antibody production. Due to time constraints experienced during this 
particular study the large-scale expression and purification of the GST -2C 178 fusion 
peptide will be included in future work. 
As described in Section 2.1 the antibodies raised against the 2C 178 peptide will be 
utilised in further studies for the immunodetection of the TMEV 2C and 2BC proteins 
in BHK-21 cells transfected with plasmids encoding the proteins as well as BHK-21 
cells infected with TMEV to allow the further characterisation of the effect of these 
proteins on host membranes by electron microscopy. Antibodies against the 2C and 
2BC proteins will also be utilised during pull-down assays to detect the interaction of 
these proteins with host proteins. 
In addition to viral protein-host membrane interactions future studies will also seek to 
identify and describe interactions that form between viral and host proteins. As the 
2C 178 peptide comprises slightly over half of the amino acid sequence of the TMEV 
2C protein it is possible that it includes regions that form interactions with host 
proteins. The ability of the GST tag of the GST-2CI78 fusion peptide to bind a 
glutathione agarose matrix could be exploited to allow the use of the 2C 178 peptide as 
"bait" during protein pull-down assays. This will be discussed in more detail in 
Section 4.1 . 
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2.5 CONCLUSIONS 
The insertion of the coding sequences for the TMEV 2B, 2C, 2BC and 3A proteins 
into the mammalian expression vector pcDNA3.1NS-His© TOPO® and the 
subsequent expression of these proteins in BHK-21 cells was successfully achieved. 
The following conclusions were reached respecting the subcellular localisation of the 
TMEV 2B, 2C, 2BC and 3A proteins: 
I. The TMEV 2B protein locates to fine reticular structures with several larger 
punctate structures concentrated in the perinuclear region. Some of the 
reticular structures overlapped, and therefore possibly colocalise, with the 
ERp60 stain, while a significant proportion of the 2B-VS fusion remained 
separate. In addition some of the 2B accumulated in the perinuclear region 
appeared to overlap with the ~-COP stain indicating a possible localisation of 
TMEV 2B to the peripheral Golgi. The dispersion of this protein throughout 
the cytosol as far as the plasma membrane suggests that the localisation of 2B 
to endosomal and/or lysosomal membranes must be investigated. 
2. At low expressIOn levels the TMEV 2C protein locates to faint reticular 
structures that overlap with ERp60 staining while at higher expression levels 
this protein locates to a concentrated perinuclear stain and larger structures 
adjacent to the nucleus that overlap with the ~-COP stain. These observations 
indicate that this protein localises to both the ER and peripheral Golgi but that 
these associations may be dependent on levels of protein expression. The 
persistently evident perinuclear stain suggests that this protein may also be 
associated with either the nuclear envelope or the RER that is continuous with 
the nuclear envelope. 
3. The TMEV 2BC protein locates to large structures adjacent to the nucleus that 
appear to colo calise with the ~-COP stain. No overlap of2BC with the ERp60 
stain was observed. However, ERp60 staining in cells expressing this TMEV 
protein was very faint suggesting that 2BC may be masking the ERp60 stain. 
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4. The TMEV 3A protein signal overlapped with both ERp60 and p-COP stains. 
In cells expressing the 3A protein the ER appeared swollen and bulbous while 
the Golgi was dispersed in some cells. 
5. The localisation of the truncated 2C60 and 2BC60 proteins in BHK-21 cells 
appeared indistinguishable from that of the wild type 2C and 2BC proteins. 
This indicated that the amino acids 61 - 326 of the 2C protein are not 
important for the membrane targeting and membrane association of the TMEV 
2C and 2BC proteins. Secondly the transfection efficiencies achieved with 
these proteins were significantly greater than those achieved with the wild type 
proteins, suggesting that the expression of truncated viral proteins is a possible 
strategy for increasing poor transfection levels. 
6. Further studies are required to investigate the association of the TMEV 2B, 
2C, 2BC and 3A proteins with endosomal and lysosomal membranes. 
7. Further studies are also required to investigate the effect of the TMEV 2B, 2C 
and 2BC proteins on host cell protein secretion as it has already been 
determined that the TMEV 3A protein does not affect exocytic protein 
trafficking. 
The identification, expression and purification of a region of the TMEV 2C protein in 
E. coli BL-21 cells for the purpose of producing a soluble antigenic peptide for the 
generation of antibodies against the TMEV 2C and 2BC protein in a mammal was 
successful. Specifically the following conclusions were reached: 
8. Amino acids 31-210 of the TMEV 2C protein were identified as possessing a 
predominantly hydrophilic character as well as 7 of 13 identified antigenic 
regions of the 2C protein. The identified peptide sequence was named 2C178. 
9. The cDNA coding region for the 2CI78 peptide was successfully inserted into 
the bacterial expression vector pGEX-2T. 
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10. Pilot-scale expression of the GST-2C 178 fusion peptide was achieved through 
IPTG induction and the fusion peptide was purified by affinity 
chromatography with a matrix of glutathione agarose beads. 
11. Immunodetection of the GST-2C178 fusion peptide, subsequent to SDS-
PAGE and Western blot confirmed that the protein was successfully expressed 
and purified. The GST-2C178 fusion peptide was soluble as it was purified 
from the cell lysate of E. coli BL-2l cells. 
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3 Point mutations in 2C: effect on localisation and 
TMEV replication 
3.1 INTRODUCTION 
The 2C protein is highly conserved throughout the picornavirus family and is thought 
to be intricately involved in the assembly of the virus replication site as well as viral 
RNA replication (Aldabe and Carasco, 1995; Bienz et ai, 1987; Bienz et ai, 1990; 
Bienz et ai, 1992; Cho et ai, 1994; Schlegel et ai, 1996; Banerjee et ai, 1997; 
Banerjee and Dasgupta, 2001; Rodriguez and Carasco, 1995; Mirzayan and Wimmer, 
1994; Rodriguez and Carasco, 1993). In view of the 2C protein's importance in the 
virus replication cycle it was hypothesised that the mutation of particularly highly 
conserved residues within the 2C protein may have an effect on the localisation of 
both the 2C and 2BC proteins in host cells and would therefore affect the ability of 
TMEV to replicate. The N-terminal domain of the 2C protein, which is thought to be 
involved with both the membrane association and the RNA binding activity of the 
protein (Paul et ai, 1994; Echeverri and Dasgupta, 1995; Echeverri et ai, 1998; 
Rodriguez and Carasco, 1995), was selected as the region for mutagenesis. 
The sequences of the N-terminal domain of several picornavirus 2C proteins were 
aligned in order to identify particularly highly conserved amino acid residues. Point 
mutations were created in the cDNA of the TMEV genome and the wild type and 
mutant cDNA genomes were transcribed in vitro to produce infectious viral RNA. 
Infectious wild type and mutant TME viruses were obtained through the transfection 
of BHK-2l cells with these RNAs. Quantification of the effect of the amino acid 
substitution mutations on the ability of TMEV to induce CPE was expressed as the 
increase in viable virus particle concentration in BHK-2l cells infected with wild type 
or mutant TMEV, against time. It was thought that the ability of the various mutant 
TME viruses to induce CPE in BHK-21 cells might be indicative of their replication 
proficiency. 
A preliminary investigation on the effect of the engineered specific point mutations on 
the subcellular localisation of the TMEV 2C protein was performed through the 
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transient expression of the mutant 2C proteins in BHK-21 cells. To determine the 
localisation of the expressed viral proteins, cells were stained with primary antibodies 
against the V5 epitope expressed on the C-terminus of the 2C mutant proteins as well 
as primary antibodies against marker proteins for the ER and Golgi apparatus. 
Secondary staining was performed with fluorophore-conjugated secondary antibodies 
and cells were examined either by laser scanning confocal microscopy or by 
epifluorescence microscopy. 
3.2 AIMS AND OBJECTIVES 
The fundamental goal of this component of the study was to identify highly conserved 
specific amino acid residues in the N-terminal domain of the TMEV 2C protein and to 
assess the importance of these amino acids with respect to the replication proficiency 
of TMEV in host cells and the localisation of the TMEV 2C protein. The specific 
objectives were as follows: 
I. The identification of highly conserved amino acid residues in the N-terminal 
domain of the TMEV 2C protein by multiple alignment analysis of 
picornavirus 2C amino acid sequences. 
2. The creation of amino acid substitutions in the TMEV 2C coding sequence. 
3. An assessment of the effect of these amino acid substitution mutations on the 
replication proficiency of TMEV by the in vitro transcription of wild type and 
mutant TMEV cDNA and transfection of BHK-21 cells with infectious viral 
RNA. 
4. A quantitative analysis of the effect of the engineered amino acid substitutions 
on the replication kinetics of TMEV by measuring virus yield at different time 
points. 
5. An investigation of the host range of TMEV by the exposure of different 
mammalian cell cultures to TMEV. 
6. The insertion of the coding sequences for the mutant TMEV 2C proteins into 
the mammalian expression vector pcDNA3.1N5-His© TOPO®. 
7. The expression of the mutant TMEV 2C proteins in BHK-21 cells through the 
transfection of this cell line with recombinant DNA encoding the proteins. 
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8. The irnmunolocalisation of the mutant TMEV 2C proteins in BHK-21 cells by 
the irnmunostaining of cells and either laser scanning confocal microscopy or 
epifluorescence microscopy. 
3.3 METHODS AND MATERIALS 
3.3.1 Identification of conserved residues in picornavirus 2C proteins 
With the aim of identifying specific residues that are particularly highly conserved, 
the N-terminal 30 amino acids of a number of picornavirus 2C proteins were 
subjected to multiple alignment analysis using Blastp internet-based software (NCB!, 
2006). This software program aligns the amino acid sequences of the various proteins 
and denotes a degree of conservation to each amino acid with respect to the sequences 
represented. 
3.3.2 Creation of amino acid substitution mutations in the cDNA ofTMEV 
Amino acid substitution mutations were created in the cDNA of TMEV, encoded by 
the recombinant vector pGDVII-WT (see Appendix A, kind gift of Dr M Ryan, 
University of St Andrews, UK) where an alanine residue was substituted at amino 
acid residues 4, 8, 14, 18,23 and 29 by overlap PCR. Figure 3.3.1 is a diagrammatic 
representation of the overlap PCR procedure. Alanine was chosen as the substitute 
amino acid as its small size and neutral charge was unlikely to have a significant 
effect on the tertiary structure of the 2C and 2BC proteins. 
The pGDVII-WT recombinant vector comprises the cDNA genome of the GDVII 
strain of TMEV (Pubmed accession number: 2251141) inserted into the pBlueScript® 
II Phagemid Vector (Stratagene). Prior to this study overlap PCR was performed as 
described in Figure 3.3 .1 by Dr Caroline Knox to create recombinant vectors 
encoding the cDNA genome of TMEV with amino acid substitution mutations at 
amino acid positions 4, 8, 18, 23 and 29 in the 2C protein (detailed in Table 3.3.1) 
(See Appendix C for primers used). The same overlap PCR procedure was performed 
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by Ms Cassandra Olds in this laboratory to create an amino acid substitution mutation 
at amino acid 14 in the 2C protein (See Appendix C for primers used). 
5' dsDNA 3' 
Wild type TMEV cDNA 3' S' 
~ Point mutation r- en cod ed by primer 
- 'I' 'I ' ....... S' S' 
....... 
Point mutation ~ ~ peR round 1 -
encoded by primer 
-S' 
• 
'I ' peR product 1 
'I ' S' 
5' 'I ' peR product 2 
'I ' 
• 5' 
-
~ peR round 2 
TMEV cDNA with S' • 
'I' peR product 3 
point mutation 'I ' • S' 
t 
Point mutation 
Figure 3.3.1 Diagrammatic representation of the overlap peR procedure used to engineer specific point 
mutations into the cDNA genome ofTMEV. Two forward primers are designed: one that binds at the 5' end 
of the positive strand (red) and the other that binds over the nucleotides to be mutated on the negative strand 
(blue). Likewise, two reverse primers are designed: the first of which binds at the 3 ' end of the negative 
strand (green) and the second that binds over the nucleotides to be mutated on the positive strand (orange). 
The first round of peR reactions involves two distinct reactions involving different sets of forward and 
reverse primers, as indicated above, and results in two different peR products, each of which encode the 
engineered point mutation on one strand of the peR product. The second round of peR uses both peR 
products from the first round as template molecules and only the two primers that bind at the 5' end of the 
positive strand (red) and the 3' end of the negative strand (green), resulting in a full length peR product that 
encodes the engineered point mutation on both strands. 
Subsequent to purification with the Wizard SV Gel and PCR Clean-up System 
(Promega) according to manufacturers instructions, overlap PCR products underwent 
restriction digestion with Ace III (Fermentas) and Eco Nl (Fermentas), as did the 
pBlueScript® II Phagemid vector. Following a second purification step, overlap PCR 
products were inserted into the linearised pBlueScript® II Phagemid vector using T4 
DNA ligase (Promega). Figure 3.3.2 is a schematic representation of the insertion of 
the various overlap PCR products into the pBlueScript® II Phagemid vector. 
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Figure 3.3.2 Insertion of eDNA genomes of TMEV strain GDVlI into the pBlueScript® 1I Phagemid 
vector subsequent to the creation of single amino acid substitution mutations in the 2C coding region 
by overlap PCR. Overlap PCR products comprising the TMEV strain GDVlI eDNA genome with a 
single amino acid substitution mutation engineered into the 2C coding region, and the pBlueScript® 1I 
Phagemid vector were subjected to restriction digestion with Ace III and Eco Nl. Following a 
purification step, the overlap peR products were inserted into the linearised vector using T4 DNA 
ligase. 
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The presence of the correct mutation in the 2C coding sequence was confirmed by 
chain-termination-based sequencing (performed by Inqaba Biotechnical Industries 
(Pty) Ltd). All constructs described in Table 3.3.1 were sequenced between theAcc III 
(located at 3929 bp on TMEV sequence) and Eco NI (located at 5537 bp on TMEV 
sequence) restriction enzyme recognition sequences in the 2A and 2C coding 
sequences, respectively, to confirm that no further mutations occurred in this region 
during the overlap PCR procedure, thus ensuring that the specific point mutation 
engineered into the cDNA genome of TMEV was the only difference between the 
wild type and mutant TMEV genomes. See Appendix B for details of sequencing 
pnmers. 
Table 3.3.1. Construction of recombinant vectors encoding specific point mutations in the 
coding region of the 2C protein in the cDNA genome of TMEV 
Position of amino acid Amino acid substitution 
Construct substitution mutation in 2C 
mutation 
coding sequence (amino acid) 
pGDVII-WT None None 
pGDVII-mt4 4 Arginine -> Alanine 
pGDVII-mt8 8 Glutamate -> Alanine 
pGDVII-mtI4 14 Lysine -> Alanine 
pGDVII-mtI8 18 Tryptophan -> Alanine 
pGDVII-mt23 23 Isoleucine -> Alanine 
pGDVII-mt29 29 Tryptophan -> Alanine 
3.3.3 Production of infectious wild type and mutant TMEV RNA by in vitro 
transcription of viral cDNA 
As the RNA of all positive sense ssRNA vlruses including Picomaviruses is 
infectious, viral RNA transcribed in vitro from the cDNA genome can be transfected 
into host cell cultures to produce replicating virus. The cDNA of the wild type and 
mutant TMEV genomes encoded by the constructs described in Table 3.3 .1 provided 
the template required for this reaction. 
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The template plasmids were linearised by restriction digestion with Bam HI at 37°C 
for I hour 30 minutes before being purified using the Wizard SV Gel and PCR Clean-
up System (Promega) as per manufacturer' s instructions. Iflg of each linearised 
template molecule was transcribed in vitro using the T7 Transcription Kit (Fermentas) 
for 2 hours at 37°C, as per manufacturer's instructions. As a positive control in vitro 
transcription was performed on the control template provided in the T7 transcription 
kit. RNA samples were stored at - 80°C until further use. 
3.3.4 Examining the replication proficiency of wild type and mutant TME 
viruses in BHK-21 cells 
(i) Transfection ofBHK-21 cells with wild type and mutant TMEV RNA 
Transfection mixtures comprising 100 fll 150 mM NaCl, I flg wild type or mutant 
viral RNA and 3.3 fll ExGen reagent were made up in sterile eppendorf tubes and 
incubated for I hour at room temperature (RT), vortexing at 5-minute intervals. A 
negative control reaction comprising 100 fll 150 mM NaCI, I flg control RNA 
(Section3.3.3) and 3.3 fll ExGen reagent was made up in the same way. 
Medium was aspirated from a 100% confluent monolayer of BHK cells grown 
overnight in a 24-well plate as described in Section 2.3.5. 400 fll DMEM (5% FCS, 
1% PSF) was aliquoted into each well. The transfection mixtures were added drop 
wise to their respective wells and the 24-well plate was incubated at 37°C and 5% 
CO2. After 4 hours incubation the medium and transfection reagents were aspirated 
off the cells and 500 fll of DMEM (5% FCS, 1% PSF) was added to each well and 
incubation continued for a further 92 hours to allow viral replication. 
Cytopathic effect (CPE) can be described as the visible evidence of viral replication in 
the form of host cells that round up, detach from the growth surface and later lyse. 
The quantification of CPE is achieved through a visual estimation of the approximate 
percentage of cells in the monolayer that have detached from the growth surface. 
BHK-21 cells transfected with wild type and mutant TMEV RNA were observed for 
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CPE over a l20-hour period. The % CPE after 12, 24, 48, 72, 96 and 120 hours was 
noted. 
Transfection of BHK-21 cells with RNA of the different mutant TME viruses was 
performed in separate 24-well plates to prevent possible cross-contamination of the 
different viruses. In all such plates one well of 100% confluent BHK cells was 
transfected with the negative control transfection mixture. Transfection of cells with 
the wild type and mutant TMEV RNAs occurred in the same experiment so the 
replication proficiency of the wild type and different mutant TME viruses could be 
directly compared. 
It was necessary to confirm that the appearance of CPE, or the lack thereof, on 
transfected cells was due to virus replication or the inability of the mutant TME 
viruses to replicate, respectively. To this end, growth medium was aspirated off cells 
120 hours post-transfection irrespective of whether CPE had been observed or not. 
This growth medium was aliquoted onto fresh BHK-21 cells grown to a 100% 
confluent monolayer overnight. Once again, three wells of 100% confluent BHK cells 
acted as negative controls in each 24-well plate. The appearance of CPE in this 
experiment was taken to indicate that replication had taken place. 
BHK-21 cells were transfected with wild type and mutant TMEV RNAs, in triplicate, 
on three separate occasions and on all three occasions the pattern of CPE development 
was similar for each virus. 
(ii) Preparation of wild type and mutant virus stocks 
Growth medium aspirated from cells displaying 90-100% CPE as a result of infection 
with wild type or mutant TME viruses was aliquoted onto BHK-21 cells grown to 
100% confluency in 25 cm3 flasks as detailed in Section 2.3.4. Cells were incubated at 
37°C, shaking at 50 rpm for 2 hours to allow virus adsorption. Cells were washed 
with serum-free DMEM and incubated 37°C and 5% CO2 with 7 ml DMEM (5% 
FCS, 1 % PSF) until 100% CPE was observed. At this point growth medium was 
aspirated from the flasks and centrifuged at I 000 rpm for 2 minutes to pellet cell 
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debris. Supernatants were stored in 1 ml aliquots at - 80°C and will be referred to as 
virus stocks from this point forward. From this point forward mutant viruses will be 
referred to according to the point mutation created in the 2C coding sequence, e.g. 
TMEV mutant 4 has a point mutation at amino acid 4 on the 2C protein. 
(iii) Confirmation that the appearance of CP E in BHK-21 cells was due to viral 
replication 
It was necessary to show that the CPE observed in cells transfected with wild type and 
mutant TMEV RNA was a result of viral replication and not a side effect of RNA 
transfection. To this end, the presence of nascent viral RNA in cells transfected with 
viral RNA produced in vitro was detected as described below. 
BHK-2l cells were grown to 100% confluency in the wells of a 6-well plate (Sarstedt) 
as detailed in Section 2.3.4, except 5.00 x 105 trypsinised cells were seeded into each 
well of the 6-well plate, as opposed to a 24-well plate, prior to overnight incubation at 
37°C and 5% CO2• Cells were transfected with RNA encoding wild type or mutant 
TME virus genomes as described above except that all ingredients of the transfection 
mixtures were in 7x the quantity to compensate for the larger number of cells. Two 
hours post transfection, mixtures were aspirated and cells were washed with 1 x PBS 
(PH 7.4) to remove remaining untransfected viral RNA. Cells were incubated with 
7ml DMEM (5% FCS, 1 % PSF) at 37°C and 5% CO2 until the initial stages of CPE 
were observed. Specifically, the initiation of visible CPE was observed as the 
appearance of many rounded cells and the formation of small zones of clearance. At 
this point all medium was aspirated and cells were covered with 500 III ice-cold 
Buffer RLN (50 mM Tris-HCl pH 8.0, 140 mM NaCl, 1.5 mM MgCh, 0.5% NP40, 
100 V lml RNase inhibitor, 1 mM DTT). Cells were scraped from wells, aliquoted into 
ice-cold 1.5 ml eppendorftubes and incubated on ice for 5 minutes to lyse cells. Total 
cytoplasmic RNA was isolated using the Qiagen RNeasy® Mini Kit (Qiagen) as per 
manufacturer's instructions. 
77 
The total cytoplasmic RNA was used as a template for the RT-PCR amplification of 
the coding region of the TMEV 2BC protein. Successful RT-PCR amplification of 
this coding region indicates the presence of nascent viral RNA in infected cells. 
RT-PCR was performed using the Qiagen OneStep RT-PCR Kit (Qiagen) as per 
manufacturer's instructions using l)lg of each isolated total cytoplasmic RNA sample 
as template RNA and the 2BF and 2CR primers (see Appendix C). It was found that 
of the two protocols described by the QIAGEN® OneStep RT-PCR Kit handbook, the 
one entailing the use of Q-solution gave a remarkably higher yield of PCR product. 
RT-PCR products were subjected to chain-termination-based sequencing (performed 
by Inqaba Biotechnical Industries (Pty) Ltd) using the 2Bfseq primer (see Appendix 
B). 
(iv) Confirmation that the absence of CPE in BHK-21 cells transfected with 
mutant TMEV RNA was not due to failed transfection 
It was necessary to prove that absence of CPE in BHK-21 cells transfected with 
mutant TMEV RN As was in fact due to an inability of the mutant viruses to replicate 
and not due to failed transfection of the RNA. To this end, BHK-21 cells were grown 
to 100% confluency in the wells of a 24-well plate as described in Section 2.3 and 
transfected with the mutant TMEV RNAs shown to not cause CPE, as described 
above. 
Four hours post transfection growth medium and transfection mixtures were aspirated 
of cells and total cytoplasmic RNA was isolated as described above. RT-PCR was 
performed on isolated RNA, also as described above. Successful amplification of a 
PCR product the size of the coding region of the TMEV 2BC protein would indicate 
the presence of viral RNA in the cells, thus indicating that transfection was successful. 
It is possible that successful PCR amplification of a fragment the size of the 2BC 
protein coding sequence is the result of residual untransfected RNA on the surface of 
the cells, however this is unlikely as the cells were washed twice with I x PBS (PH 
7.4) prior to the RNA isolation procedure. 
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3.3.5 Titration of replicating wild type and mutant TME virus stocks by 
plaque assay 
The concentration of virus particles in the virus stocks of the replicating wild type and 
mutant TME viruses was determined as plaque forming units (p.f.u.)/ ml of virus 
stock by plaque assay as described below. BHK-21 cells were grown to a 100% 
confluent monolayer in the wells of a 6-well plate in DMEM (5% FCS, 1 % PSF) at 
37°C and 5% C02. 
Eight ten-fold dilutions of wild type and mutant virus stocks were made in serum-free 
DMEM. Following compete aspiration of growth medium off cells, 1.5ml of virus 
stock dilutions between 1 x 10.3 - 1 x 10-8 were a1iquoted into each well and virus 
adsorption occurred at 37°C, shaking at 50 rpm for I hour 30 minutes. Diluted virus 
stocks were aspirated, cells were washed with serum-free DMEM and overlayed with 
3 ml overlay solution (50% DMEM, 1.25% Methocel (Fluka), 60 mM NaCI in sterile 
water). Plaque assays were incubated at 37°C, 5% CO2 until plaques (zones of 
clearance) were clearly visible in the cell monolayer. At this point cells were washed 
with I x PBS (PH 7.4) and fixed with 4% paraformaldehyde in I x PBS at room 
temperature for 10 minutes. Fixed cells were washed with 1 x PBS and stained with 
Coomassie staining solution (45% methanol, 45% water, 10% glacial acetic acid, 
0.002% wtlvol Coomassie Brilliant Blue [Saarchem]) for 5 minutes at room 
temperature. The number of plaques was counted and the titre of each virus stock was 
calculated in terms of p.f.u./ ml of original virus stock, taking the dilution factor into 
account. 
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3.3.6 Estimating virus yield for wild type and replicating mutant TME viruses 
The rate at which the replicating mutant 4, 14 and 23 TME viruses were able to cause 
CPE in a BHK-21 cell monolayer appeared inhibited compared with that of the wild 
type TMEV. It was thus necessary to quantify the inhibitory effect of these specific 
point mutations on the replication proficiency of TMEV. 
BHK-21 cells were grown to a 100% confluent monolayer in the wells of a 24-well 
plate in DMEM (5% FCS, 1% PSF) at 37°C and 5% CO2. Following the aspiration of 
all growth medium, cells were infected with wild type or mutant 4, 14 or 23 TMEV 
stock at a multiplicity of infection (m.oj.) of 3. Multiplicity of infection is defined as 
the number of virus particles present per cell in a particular sample. Viral adsorption 
occurred at 37°C, shaking at 50 rpm for I hour 30 minutes after which the virus was 
aspirated off cells and replaced with 500 fll DMEM (5% FCS, 1% PSF). Infection of 
BHK-21 cells with the wild type and the different mutant TME viruses was carried 
out in separate 24-well plates to prevent cross-contamination of the viruses. In all 24-
well plates three wells of 100% confluent BHK-21 cells remained uninfected as 
negative controls. Following infection, cells were incubated at 37°C and 5% CO2. 
The growth medium covering the cells was removed at specific time points, i.e. at I, 
7, 13, 20, 24, 27 and 30 hours post infection (h.pj.). Growth medium covering one 
well ofBHK-21 cells infected with each of the wild type and replicating mutant TME 
viruses was aliquoted into a sterile eppendorf tube, centrifuged at I 000 rpm for 2 
minutes to remove cell debris and stored at - 80°C for further analysis. The virus 
samples collected at the various time points post infection were titrated by plaque 
assay as described in Section 3.3.5. The ability of the various specific point mutations 
to inhibit the replication proficiency of TMEV was expressed as viable virus particles 
produced (p.f.u.l ml) against h.pj. 
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3.3.7 Investigating the host range of TMEV in mammalian cell culture 
BHK-21 cells have been previously established as a host system for TMEV 
replication in cell culture (Kong el ai, 1994, van Pesch et ai, 2001). A brief study was 
conducted to determine the ability of the wild type TMEV virus used throughout this 
research to replicate in other mammalian cell types in use in the tissue culture facility 
at Rhodes University, namely NIH-3T3 cells, Cos-7 cells and HeLa cells. 
Different cell lines were grown to 100% con fluency in the wells of a 24-well plate in 
DMEM (5% FCS, 1 % PSF) at 37°C and 5% C02 as shown in Figure 3.3.3. Growth 
medium was aspirated off the cells in alternate wells and replaced with wild type 
TMEV stock at a multiplicity of infection (m.o.i.) of 1. 
Infected Negative Infected Negative Infected Negative 
with control with control with control 
TMEV TMEV TMEV 
0 e 0 0 BHK-21 cells 
0 0 0 Cos-7 cells 
(I 0 0 0 NIH-3T3 cells 
e 0 0 0 HeLa cells 
Figure 3.3.3 Schematic diagram of study conducted to investigate the host range of wild type TMEV in 
cell culture. Different mammalian cell cultures were infected with wild type TMEV at an m.o.i. of I 
and observed for the development of ePE for 96 hours. 
Cells in wells not infected with TMEV acted as negative controls in the experiment. 
Virus adsorption occurred at 37°C, shaking at 50 rpm for 1 hour 30 minutes. Virus 
stocks were aspirated off the cells and replaced with DMEM (5% FCS, 1 % PSF). 
Incubation proceeded at 37°C and 5% C02 and cells were observed for the 
development ofCPE over 120 hours. 
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In order to show that any CPE observed in cells other than BHK-21 cells was due to 
TMEV replication, growth medium was aspirated from cells showing CPE and used 
to infect fresh cells of both the cell type in question and BHK-21 cells. This second 
infection step was performed using cells gown to 100% confluency in the wells of a 
24-well plate. The time taken for 100% CPE to be observed was recorded. 
3.3.8 Construction of recombinant vectors for the expression of mutant 
TMEV 2C coding regions in mammalian cells 
Subsequent to the quantification of the effect of amino acid substitution mutations in 
the N-terminal domain of the 2C protein on the replication proficiency ofTMEV, the 
effect of these same point mutations on the subcellular localisation of the TMEV 2C 
protein was investigated. This involved the transient expression of the mutant 2C 
protein in host cells followed by immunolocalisation studies. In order to transiently 
express the mutant TMEV 2C proteins in host cells the coding regions for these 
proteins were subcloned into the mammalian expression vector pcDNA3.1N5-His 
TOPO®. 
The construction of recombinant vectors encoding the mutant 2C proteins was 
performed in exactly the same manner as described for the wild type 2C protein in 
Section 2.3.1. The eDNA template molecules used to PCR-amplify the coding regions 
for these proteins and the names of the recombinant vectors are recorded in Table 
3.3.2. (See Appendix A for vector maps). 
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Table 3.3.2. Recombinant vectors constructed by inserting cDNA regions encoding 
mutant TMEV 2C proteins into the pcDNA3.1NS-His TOPO® mammalian 
expression vector 
Name Fwd Rvs Insert Amino acid position Amino acid 
primer primer Size (bp) on 2C protein substitution mutation 
pLMT2C4 2C4F 2CR 978 4 Arginine -> Alanine 
pLMT2C8 2C8F 2CR 978 8 Glutamate -> Alanine 
pLMT2CI4 2CF 2CR 978 14 Lysine -+ Alanine 
pLMT2CI8 2CF 2CR 978 18 Tryptophan -> Alanine 
pLMT2C23 2CF 2CR 978 23 Isoleucine -+ Alanine 
pLMT2C29 2CF 2CR 978 29 Tryptophan -> Alanine 
The presence of the correct insert in the recombinant vectors shown in Table 3.3.2 
was confirmed by restriction analysis and later by chain-termination-based sequencing 
(see Section 2.3.1) 
3.3.9 Transient expression and indirect immunofluorescent localisation of 
mutant TMEV 2C proteins in BHK-21 cells 
To achieve transient expression of the mutant TMEV 2C proteins, BHK-2l cells were 
transfected with the recombinant vectors shown in Table 3.3 .1 as described in Section 
2. 3.4. Transfected BHK-21 cells expressing mutant 2C proteins were subjected to 
indirect immunofluorescent staining as described in Section 2.3.5. 
Immunostained BHK-21 cells transiently expressing mutant TMEV 2C proteins were 
examined using either the Zeiss LSM 510 Meta confocal microscope at the Electron 
Microscopy Unit at the University of Kwazulu-Natal, Petermaritzburg as described in 
Section 2.3.6, or the Olympus BX-61 epifluorescence microscope in the Rhodes 
University Botany Department, Grahamstown. Cells that were imaged using the 
Olympus BX-61 epifluorescence microscope and AnalySIS B software were 
examined under the 60x oil immersion objective. Red fluorescence was emitted by the 
Texas Red® fluorophore (ExcitationlEmission: 596 nmI615 om) conjugated to the 
anti-mouse IgG and green fluorescence was emitted by the Alexa Fluor® fluorophore 
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(ExcitationlEmission: 495 nml519 nm) conjugated to the anti-rabbit IgG when cells 
were examined under the UMWIY2 (Excitation/Emission: 596 nm-615 nm) and 
UMWIB2 (Excitation/Emission: 390 nm-525 nm) filter cubes, respectively. 
3.4 RESULTS AND DISCUSSION 
3.4.1 Identification of conserved residues in picornavirus 2C proteins 
Multiple alignment analysis (Figure 3.4.1) was performed on the N-terminal amino 
acid sequences of several picornavirus 2C proteins to gain an indication of which 
amino acid residues are particularly highly conserved in this region of the protein. The 
purpose of this exercise was to determine the effect of mutating conserved amino acid 
residues in the 2C protein on the subcellular localisation of 2C and the replication 
proficiency ofTMEV. 
As the N-terminal domain of the picornavirus 2C protein is thought to be involved in 
the interaction of the protein with host membranes as well as negative-sense viral 
RNA during viral RNA replication (Paul et ai, 1994, Echeverri and Dasgupta, 1995, 
Echeverri et ai, 1998, Rodriguez and Carasco, 1995), it was expected that this region 
would be highly conserved throughout the Picornaviridae. Additionally it was 
expected that several amino acids within this region might be show a particularly high 
degrees of conservation, indicating a crucial role in either the tertiary structure of the 
2C protein or in the actual interactions formed between the 2C protein and host 
membranes or viral RNA. 
The multiple alignment analysis of picornavirus 2C proteins (Figure 3.4.1) revealed 
several amino acids with a degree of conservation of 50% or higher, with some 
showing up to 100% conservation. Six of these amino acids were selected (indicated 
by an asterisk in Figure 3.4.1) for substitution based on their high degree of 
conservation as well as their strong hydrophobicity/ hydrophilicity. Amino acids 4 
(arginine), 8 (glutamate) and 14 (Lysine) in the TMEV 2C sequence are all 
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hydrophilic ammo acids. Amino acids 18 (tryptophan), 23 (isoleucine) and 29 
(tryptophan) in the TMEV 2C sequence are relatively large hydrophobic amino acids. 
TMEV 
PV 
HRV 
FMDV 
GPLI AI GFTFA II AT;TIQ GDSWL F ACNAA L VS K S 
ANDGWF " F . ACNAA ~ L IA K S 
LKA " I ' IFAVL G LV L L 
SW K QI DHPQSK L 45 
EKIIPQA . KLEFVT K 49 
K LPQA KLEFCS K 50 
A S 3S 
Figure 3.4.1 Multiple sequence alignment of the N-tenninal amino acids of various picornavirus 2C 
prote ins using Blaslp internet-based software (NCBI, 2006). A multiple alignment was perfonned on 
the N-tenninal amino acids of the 2C proteins from the following picornaviruses: TMEV (strain 
GOVIl) 2C protein (Accession number: NP _740431.1); PV (Sabin I strain) 2C protein (Accession 
number: NP _740473 .1); HRV (strain B) 2C protein (Accession number: NP _740521.1); FMDV (strain 
01 K) 2C protein (Accession number: NP _740463.1). Red shading indicates 100% sequence homology, 
green shading indicates 50-75% sequence homology and blue shading indicates amino acids that do not 
display sequence homology but that have similar electrochemical properties. Asterisks indicate the 
amino acids 4,8, 14, 18,23 and 29 selected for mutagenesis in the TMEV (strain GOVI!) 2C protein. 
As mentioned in Section 1.3.4, the N-terminal amino acids of the 2C protein are 
thought to form a Class A amphipathic helix with a basic hydrophilic face that is 
exposed to the cytoplasm of host cells, and a hydrophobic face that is possibly 
inserted halfway into the phospholipid monolayer of membranes of the secretory 
pathway (Saier and McCaldon, 1988, Segrest et ai, 1994). With this in mind it is most 
likely that the hydrophobic amino acids in this domain of the 2C protein are important 
for anchorage of the protein to host membranes, and thus subcellular localisation, at 
the site of the viral replication complex while acidic and basic amino acids aligned 
along the cytoplasmic surface of the replication complex are possibly more likely to 
be involved in the binding of negative-sense viral RNA during RNA replication (Saier 
and McCaldon, 1988, Segrest el ai, 1994). Thus mutation of the large tryptophan and 
isoleucine residues would be likely to have a drastic effect on the secondary andlor 
tertiary structure of the 2C protein as well as the membrane binding abilities of the 
protein, while mutation of the acidic glutamate and basic arginine and lysine amino 
acid residues is more likely to interfere with the interaction of this protein with viral 
RNA. 
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3.4.2 Creation of amino acid substitution mutations in the eDNA of TMEV 
Overlap PCR was used to engineer amino acid substitution mutations into the N-
terminal domain of the cDNA coding sequence of the TMEV 2C protein substituting 
amino acid residues 4, 8, 14, 18, 23 and 29 of the 2C protein for alanine. Alanine was 
chosen to substitute these amino acid residues based on its small size and neutral 
charge. The constructs encoding the wild type and mutated TMEV genomes (Table 
3.3.1.) were subjected to chain-termination-based sequencing to verify the presence of 
the engineered mutations. As expected the point mutations engineered into the mutant 
TMEV 2C coding sequences were all present. No further mutations were detected 
although it must be noted that only a small region (approximately 1700) of each of the 
pGDVIl- constructs was sequenced due to the large size of the TMEV genome coding 
sequence and time constraints. It is possible that additional mutations existed outside 
of these regions. 
Of the mutant TME Viruses, mutants 8, 18 and 29 were unable to induce CPE 
indicating that the replication proficiency of these viruses was affected by the 
respective amino acid substitutions in the 2C coding sequence (see Section 3.4.3.). As 
the overlap PCR products were inserted into the TMEV cDNA between the Ace III 
restriction site at nucleotides 3929-3934 and the Eco N1 restriction site at nucleotides 
5538-5547 of the TMEV cDNA (Figure 3.3.2) it was necessary to sequence this 
region of the genome to ensure that no additional mutations had occurred during the 
overlap PCR process. 
Compared to the sequence of the GDVII strain ofTMEV (Pubmed accession number: 
2251141), a single Glu to Lys substitution mutation located at amino acid 69 on the 
2B sequence was present in pGDVII -8, 18 and 29 sequences suggesting that this 
mutation was also present in the original wild type coding sequence (See Appendix B 
for summary of sequencing reactions). Aside from the engineered mutations present 
in the coding sequences of TMEV mutants 8 and 29 no additional mutations were 
detected. In contrast, several mutations were detected in the coding sequence for 
TMEV mutant 18. Substitution mutations were detected at the coding sequences for 
amino acids 74, 75 and 76 in the 2A protein and amino acids 14 and 30 in the 2B 
protein (See Appendix B for details). Accordingly, the altered replication proficiency 
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of this ViruS cannot conclusively be attributed to the engineered amino acid 
substitution mutation. Due to limited time the pGDVII-18 construct was not re-
engineered, although this would be necessary to conclusively determine the effect of a 
point mutation at amino acid 18 of the 2C protein on TMEV replication. 
3.4.3 Determining replication proficiency of wild type and mutant TME 
viruses in BHK-21 cells 
(i) Transfection of BHK-21 cells with wild type and mutant TMEV RNA 
In order to determine the effect of substitution mutations at amino acid residues 4, 8, 
14, 18, 23 and 29 of the 2C protein on TMEV replication, BHK-21 cells were 
transfected with infectious RNA encoding wild type and mutant TME viruses. As 
described in 3.3.4, BHK-21 cells were transfected with infectious RNA encoding wild 
type and mutant TME viruses in the same experiment and this experiment was 
repeated in triplicate. In all experiments untransfected BHK-21 cells acted as negative 
controls. Cells were observed for the development of CPE over a 120-hour period. 
The results ofthese experiments are shown in Table 3.4.1 below. 
Table 3.4.1. The proportion of BHK-21 cells displaying CPE subsequent to transfection 
with RNA encoding wild type or mutant TMEV RNA 
Time (Hours) 
Transfected 
TMEVRNA Onset of 20% SO%CPE 80% 100% 
CPE CPE CPE CPE 
Wild type 6 8 10 12 IS 
Mutant 4 12 17 24 28 32 
Mutant 8 - - - - -
Mutant 14 85 - 109 117 120 
Mutant 18 - - - - -
Mutant 23 12 17 23 30 34 
Mutant 29 - - - - -
NoRNA - - - - -
CPE was not observed in the wells of BHK-21 cells transfected with transfection 
mixtures containing control RNA, indicating that the CPE observed in cells 
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transfected with RNA encoding TMEV wild type or mutants 4, 14 or 23 was not due 
to toxicity of any of the transfection components. 
Wild type TMEV appeared to replicate at a significantly faster rate than the mutant 4, 
14 and 23 TME viruses that were replicating. 100% CPE was observed in BHK-21 
cells transfected with wild type TMEV RNA after only IS hours while cells 
transfected with RNA encoding TMEV mutants 4 and 23 only showed 100% CPE 
after 32 and 34 hours, respectively (Table 3.4.1). These results suggest that point 
mutations at amino acids 4 and 23 in the TMEV 2C protein negatively effect but do 
not completely abolish viral replication. 
The onset of apparent CPE in cells transfected with RNA encoding TMEV mutant 14 
was only observed 85 hours post transfection. However after this point CPE advanced 
rapidly, with 100% CPE being observed at 120 hours post transfection. This result 
indicates that TMEV mutant 14 is able to replicate in BHK-21 cells, albeit at a 
severely attenuated rate . The rate at which CPE advanced between 85 and 120 hours 
suggests that this mutant virus may have evolved a mechanism to compensate for the 
engineered point mutation in some way and may be reverting to wild type TMEV. 
Very similar kinetics were observed in triplicate experiments where BHK-21 cells 
were transfected with TMEV mutant 14 RNA. 
When the growth medium covering cells transfected with the wild type and various 
mutant TMEV RNAs was aliquoted onto fresh preparations of 100% confluent 
monolayers ofBHK-21 cells, the appearance or absence of CPE occurred in the same 
trend as that recorded in Table 3.4.1 (Figure 3.4.2), confirming that CPE was a direct 
result of viral replication and not the transfection process. 
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Figure 3.4.2 The development of ePE over time in BHK-21 cells infected with wild type or TME 
viruses obtained from the growth medium covering BHK-21 cells previously transfected with wild type 
or mutant TMEV RNA. ePE was first observed in cells infected with wild type, mutant 4, mutant 14 
and mutant 23 TME viruses 5, 8, 84 and 8 hours post infection, respectively. 100% ePE was observed 
in cells infected with wild type, mutant 4, mutant 14 and mutant 23 TME viruses 18, 36, 120 and 36 
hours post infection, respectively_ 
However, when the cell lysate from the wells showing 100% CPE from TMEV 
mutant 14 was aliquoted onto a 100% confluent monolayer of BHK-21 cells and 
observed for a further l20-hour period, the development of CPE was repeatedly 
similar to that recorded in Table 3.4.1. This was unexpected as, if the rapid increase in 
CPE observed between 84 and 120 hours post transfection was due to a reversion of 
the mutant virus to wild type TMEV, the progression of CPE in BHK-21 cells 
infected with the virus in cell supernatant would be expected to progress at a more 
rapid rate than that recorded in Figure 3.4.2. 
Although uninfected control cells showed no CPE after 120 hours, close inspection 
revealed that cells were beginning to round up and after 144 hours approximately 25% 
of the cells had detached from the growth substrate but were not lysed. In all 
experiments where BHK-21 cells were either transfected with viral RNA or infected 
with wild type or mutant TME viruses, the appearance of CPE was distinguished from 
cell senescence as cells undergoing CPE were lysed and the cell debris accumulated in 
clumps. Cells undergoing senescence were rounded and detached from the growth 
substrate but were not lysed. 
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The lack of CPE observed in cells transfected with RNA encoding TMEV mutants 8 
and 29 (Table 3.4.1) indicates that mutation of amino acids 8 and 29 alters the activity 
of the 2C protein in such a profound manner as to totally disable viral replication. 
This same conclusion cannot be drawn from the lack of CPE observed in cells 
transfected with RNA encoding TMEV mutant 18 (Table 3.4.1) because, as described 
in Section 3.4.2, the TMEV mutant 18 eDNA template possessed several additional 
substitution mutations aside from the engineered mutation at amino acid 18 on the 2C 
protein. 
(ii) Confirmation that the appearance of CPE in BHK-21 cells was due to viral 
replication 
In order to establish a link between the appearance of CPE and viral replication it was 
necessary to show the production of nascent viral RNA in BHK-21 cells transfected 
with RNA encoding wild type, mutants 4, 14 or 23 TME viruses. To this end total 
cytoplasmic RNA was isolated from BHK-21 cells transfected with wild type or 
mutant TMEV RNA. RT-PCR was performed on the cytoplasmic RNA isolate using 
primers used to PCR-amplify the coding sequence for the 2BC protein as described in 
Section 2.3.2. The successful amplification of a PCR product the same size as the 2BC 
protein coding sequence (Figure 3.4.3) indicated the presence of nascent viral RNA in 
the transfected cells, thus suggesting a link between the appearance of CPE and viral 
replication. However, this link must be proven in future studies by showing the 
presence of viral replication in cells infected with TME viruses capable of inducing 
CPE in BHK-21 cells, as discussed below. 
Chain-termination-based sequencing of the RT-PCR products served to identify the 
presence of the amino acids substitution mutations in replicating mutant TME viruses 
and to detect the presence of any additional mutations that may have evolved in these 
viruses. Sequencing of the mutant 23 RT-PCR product confirmed the presence of the 
engineered mutation at amino acid 23 in the 2C protein coding sequence of progeny 
virions. No additional mutations were detected in the region sequenced suggesting 
that the mutant 23 TME virus did not develop further mutations in the 2C protein to 
compensate for the effect of the engineered mutations on the functioning of the 2C or 
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2BC proteins. It must be noted that sequencing the RT-PCR products only served to 
detect compensating mutations in the 2BC coding sequences of these mutant viruses. 
It is possible that other mutations had developed in other regions of the viral genome 
but due to the large size of the TMEV genome and time constraints this possibility 
was not explored. 
Sequencing of the mutant 4 and 14 RT-PCR products was repeated twice and four 
times, respectively, and in all sequences both the arginine -> alanine substitution 
mutation at amino acid 4 and the lysine -> alanine substitution mutation at amino acid 
14 on the 2C protein coding sequences had reverted back to the wild type coding 
sequences. No further mutations were detected in either of the RT-PCR sequences. 
The reversion of the TMEV mutant 4 back to the wild type virus is not consistent with 
the replication kinetics shown in Table 3.4.1 and Figure 3.4.2 as the TMEV mutants 4 
and 23 appeared to be replicating at similar rates. If the TMEV mutant 4 was reverting 
back to the wild type virus we would expect to see a slow initiation of CPE in BHK-
21 cells transfected with RNA encoding TMEV mutant 4 while the mutant virus was 
mutating back to the wild type, followed by a rapid progression of CPE as the wild 
type virus replicated. 
Furthermore, the development of CPE in BHK-21 cells infected with cell lysate from 
BHK-21 cells transfected with TMEV mutant 4 RNA would be expected to have 
kinetics similar to those of the wild type virus. This was not the case (Figure 3.4.2), 
indicating that it is possible that only some nascent mutant 4 RNA molecules are 
reverting to the wild type sequence producing a mixed population of mutant 4 and 
wild type TME viruses in infected BHK-21 cells and that the mutated 2C protein is 
acting as a dominant negative mutation on the wild type protein. A dominant negative 
mutation is defined by the University of Washington and Children's Health System as 
"a mutation whose gene product adversely affects the normal, wild-type gene product 
within the same cell" (Internet 3). Further studies will investigate whether there is a 
mixed population of mutant 4 and wild type TME viruses present in cell infected with 
mutant 4 TMEV and whether the substitution of amino acid 4 on the 2C protein is 
able to act as a dominant negative mutation, thus attenuating viral replication. The 
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discovery of such a mutation could aid In the development of novel disease 
treatments. 
The reversIOn of the TMEV mutant 14 RT-PCR product back to the wild type 
sequence was not consistent with the replication kinetics reported in Figure 3.4.2 as, if 
the rapid development of CPE in cells transfected with RNA encoding TMEV mutant 
14 between 85 and 120 hours (Table 3.4.1) was reflective ofa reversion to wild type, 
the development of CPE in BHK-21 cells infected with the cell lysate from the cells 
transfected with RNA encoding TMEV mutant 14 would be expected to follow a 
similar trend to that observed with the wild type virus (Figure 3.4.2). 
As with TMEV mutant 4, these results indicate that a lysine ...... alanine substitution 
mutation at amino acid 14 on the 2C protein may act as a dominant negative mutation 
by inhibiting the functioning of any wild type 2C or 2BC proteins present. However, 
the rapid development of CPE between 85 and 120 hours post transfectionl infection 
(Table 3.4.1, Figure 3.4.2) is not in keeping with the consistently slower development 
of CPE observed in cells infected with TMEV mutant 4. As mentioned above, control 
cells showed no CPE at 120 hours, at 144 hours approximately 25% of the cells had 
senesced and detached from the growth substrate. Taken together, this observation 
and the replication kinetics of the TMEV mutant 14 (Table 3.4.1, Figure 3.4.2) 
suggest firstly that the substitution mutation at amino acid 14 on the 2C protein may 
act as a dominant negative mutation which inhibits the functioning of any wild type 
2C protein to a greater extent than a substitution mutation at amino acid 4. Secondly, 
the rapid increase in CPE between 85 and 120 hours post transfectionl infection is the 
result of the combined effects of depleted nutrients in the growth medium 
(contributing to cellular senescence) and replication of the mutant 14 TME virus. 
In order to investigate the ability of the substitution mutations at amino acids 4 and 14 
on the 2C protein to acts as dominant negative mutations, future studies will involve 
an investigation of the effect of the simultaneously infecting cells with both wild type 
and mutant viruses on the replication kinetics of the wild type TME virus. 
As mentioned above, it must be noted that although BHK-21 cells were washed with 
PBS following transfection with wild type or mutant TMEV RNA, the RNA 
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originally transfected into the cells may have been isolated along with the total 
cytoplasmic RNA and would have thus provided a template for the subsequent RT-
PCR reaction. Thus the production of a correctly sized RT-PCR product does not 
convincingly prove that RNA replication was occurring. However, the reversion of 
TMEV mutants 4 and 14 to wild type does conclusively demonstrate the incidence of 
viral RNA replication in cells infected with these viruses. An alternative method for 
detecting viral RNA replication involves labelling nascent viral RNA with 
Bromouridine triphosphate (BrUTP) and the immunofluorescent detection of the 
replicating viral RNA by staining with primary antibodies raised against BrUTP and 
fluorophore conjugated secondary antibodies. This procedure will be performed as 
part of future work. 
(iii) Confirmation that a lack of CPE in BHK-21 cells transfected with mutant 
RNA was not due 10 failed transfection 
To investigate whether the lack of CPE observed in BHK-21 cells transfected with 
TMEV mutants 8, 18 and 29 RNAs was in fact due to an inability of the mutant 
viruses to replicate and not due to failed transfection of the RNA, total cytoplasmic 
RNA was isolated from transfected cells and RT-PCR was performed on isolated 
RNA as described in Section 3.4.4, using primers used to PCR-amplify the coding 
sequence for the 2BC protein as described in Section 2.3.2. The successful 
amplification of a PCR product the same size as the 2BC protein coding sequence 
indicated the successful transfection of cells with viral RNA (Figure 3.4.3). However, 
this conclusion can only be reached through the assumption that all untransfected 
RNA was removed by extensively washing the transfected cells with 1 x PBS (PH 
7.4) prior to RNA isolation. 
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Figure 3.4.3 BHK-21 cells were transfected with in vitro transcribed RNA encoding the TMEV 
genome with substitution mutations at amino acids 4.8, 14, 18,23 or 29 on the 2C protein. RT-PCR 
was performed on the total RNA isolated from transfected cells. RT-PCR amplification of a PCR 
product the same molecular weight as the TMEV 2BC protein coding sequence were electrophoresed 
through a 1% agarose gel (containing 0.16 flg/ml ethidium bromide) in Ix TAE buffer at 100V before 
being imaged under UV illumination. Lane J- A. PSI PCR molecular weight ladder, Lane 2- wild type 
TMEV RT-PCR product, Lane 3- TMEV mutant 4 RT-PCR product, Lane 4- TMEV mutant 8 RT-
PCR product, Lane 5- TMEV mutant 14 RT-PCR product, Lane 6- TMEV mutant 18 RT-PCR 
product, Lane 7- TMEV mutant 23 RT-PCR product, Lane 8- TMEV mutant 29 RT-PCR product. 
3.4.4 Titration of replicating wild type and mutant TME virus stocks by 
plaque assay 
The concentration of virus particles in the virus stocks of the replicating wild type and 
mutants 4, 14 and 23 TME viruses was determined as plaque forming units (p.f.u.) / 
ml of virus stock by plaque assays. At the start of the plaque assay procedure, when 
virus adsorption occurs, the BHK-21 cell monolayer is already 100% confluent. It was 
found that this confluent monolayer only survived under the methocel overlay 
solution during a plaque assay for a maximum of 96 hours before the cells began to 
senesce and detach from the growth surface. As ePE is only observed in cells infected 
with TMEV mutant 14 after 96 hours it must be noted that it was impossible to obtain 
an accurate titre of this virus stock by plaque assay. As discussed in Section 3.4.3 (i), 
it was surprising that insufficient viable virus particles were present in the TMEV 
mutant 14 stock to be able to obtain a titre in three days before the cells senesced. It is 
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possible that although this mutant virus appears to be consistently reverting to the 
wild type, a large proportion of the nascent virus particles are defective. Virus stocks 
were titrated during three identical experiments and the average titre (Table 3.4.2) was 
calculated and used from this point forward. 
Table 3.4.2. Titration of replicating wild type and mutant TMEV stocks. The 
concentration of viable virus particles in wild type and mutant TMEV stocks was 
quantified by plaque assay whereby 100% confluent monolayers of BHK-21 cells 
in 6-well plates were infected with eight tenfold dilutions of each virus stock and 
observed for the formation of plaques. 
TMEV stock Titre (p.f.u.! ml) 
1 2 3 Average 
Wild type 6.97xIO" 7.04 x 106 6.99 x 10° 7.00 X 106 
Mutant 4 17.82 x 106 18. J3 x 106 18.18 18.10 x 106 
Mutant 23 7.15 x 10" 7.07 X 106 7.05 x 106 7.09 x 106 
3.4.5 Constructing replication curves for wild type and replicating mutant 
TME viruses 
Observation of the percentage CPE, as indicated by the proportion of BHK-2I cells 
detached from the substrate, caused by the wild type and mutants 4, 14 and 23 TME 
viruses over time was not an accurate quantification of the effect of these point 
mutations on the replication proficiency of TMEV. A more accurate measure was 
obtained through the infection of BHK-2I cells with wild type and mutant TMEV 
virus stocks at an m.o.i. of 3. Samples of the growth medium covering the infected 
cells was removed at specific time points over 30 hours and titrated for virus 
concentration by plaque assay. The virus yield was then plotted against time to 
produce "virus yield curves" (Figure 3.4.4.). 
Virus yield curves were successfully constructed for the wild type and mutants 4 and 
23 TME viruses (Figure 3.4.4.). The difference in virus yield at the different time 
points between the wild type and mutant 4 and 23 TME viruses was significant. 
Consequently this experiment was only performed once as small differences in the 
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Once again no CPE was observed in cells infected with mutant 14 during the 30-hour 
time period and no viable virions were detected in the time point samples taken from 
these infected cells (Figure 3.4.4.). However 100% CPE was observed in the same 
cells 120 hours post infection showing that virus replication was occurring. Further 
studies over a 120-hour time period would be needed to examine this mutant TME 
virus' replication kinetics and to characterise the reversion of the point mutation at 
amino acid 14 on the 2C protein to the wild type. 
3.4.6 Investigating the host range ofTMEV in mammalian cell culture 
The ability of wild type TMEV GDVII to replicate in mammalian cell lines available 
at Rhodes University other than BHK-21 cells was investigated. NIH-3T3 cells (Kind 
gift of Professor G Blatch, Rhodes University, South Africa), Cos-7 cells (Kind gift of 
Professor R Hay, St Andrews University, UK) and HeLa cells (Kind gift of Dr M 
Ryan, St Andrews University, UK) were infected with wild type TMEV at an m.oj. of 
1 and observed for CPE over a 120 hour period. BHK -12 cells were infected in the 
same manner to act as a positive control. No CPE was observed in the "infected" or 
the negative control Cos-7 cells and HeLa cells. CPE was observed in the infected 
NIH-3T3 cells after 20 h.pj. and 100% CPE occurred at 56 h.pj. 100% CPE was 
observed in BHK-21 cells after 24 h.pj, as indicated by all the cells detaching from 
the growth substrate. No CPE was observed in the uninfected negative control NIH-
3T3 cells and BHK-21 cells. 
The growth medium covering NIH-3T3 cells and BHK-21 cells was removed after 
100% CPE was observed and ali quoted onto fresh 100% confluent NIH-3T3 cells and 
BHK-21 cells. The development of CPE in these cells proceeded at similar rates to 
those of the first round of infections with 100% CPE being observed at 50 h.p.i. in the 
NIH-3T3 cells and 20 h.pj. in the BHK-21 cells. These results indicate that TMEV 
GDVII can replicate in both BHK-2l and NIH-3T3 cell lines and that the same virus 
isolate can be replicated on first one cell line then the other. However the replication 
of the virus on NIH-3T3 cells appears inhibited compared to that on BHK-21 cells. 
Further studies are necessary to determine the exact kinetics of this difference in 
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replication rate and to determine whether a lower virus titre is produced in NIH-3T3 
cells. 
The ability of a virus to infect a cell type (cell tropism) is determined by many factors 
including the presence of specific receptor molecules on the cell surface and specific 
metabolic characteristics of the cell type. The factors determining the cell tropism and 
specifically the cell surface receptor bound by TMEV prior to viral entry into the host 
cell, are not understood but are thought to involve a 34-kDa glycoprotein (Kilpatrick 
and Lipton, 1991) as well as sialic acid (Zhou el ai, 1997). The extent and the nature 
of glycosylations might vary according to the cell type as demonstrated by Jnaoui el 
ai, 2002 in their study where they adapted the ODVII strain of TMEV to infect CHO-
K1 cells from BHK-21 cells. Such variations may be the cause of the attenuated 
ability ofTMEV, initially raised in a BHK-2l cell line, to infect NIH-3T3 cells. Both 
BHK-21 and NIH-3T3 cells are rodent cell lines. BHK-21 cells are a fibroblastic cell 
line derived from hamster kidney tissue explants while NIH-3T3 cells are a mouse 
fibroblastic cell line. Thus the ability of TMEV to replicate in NIH-3T3 cells is not 
surprising given that mice are the natural host of the virus. Likewise, the inability of 
TMEV to replicate in HeLa or Cos-7 cells was expected as these cell lines are derived 
from a human cervical adenocarcinoma and African green monkey kidney tissue 
explants, respectively. 
Further studies could explore the possibility that with repetitive rounds of replication 
on NIH-3T3 cells, TMEV ODVII may "adapt" to using this cell line as a host and in 
doing so viral replication kinetics may become comparable with those observed in 
BHK-21 cells. 
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3.4.7 Construction of recombinant vectors for the expression of mutant 
TMEV 2C coding regions in mammalian cells 
(i) Restriction analysis of recombinant vectors 
The coding regions for the mutant TMEV 2C proteins were subcloned into the 
mammalian expression vector pcDNA3.IN5-His TOPO® as described in Section 
3.3.8. Subsequent to purification from transformed E. coli JMI09 cells, recombinant 
vectors underwent restriction analysis with Bam HI and Xba I to confirm the 
presence of the correct insert. Figure 3.4.5 below is a digital image of agarose gel 
electrophoresis of the digested constructs. 
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Figure 3.4.5. Construction of recombinant vectors for the expression of mutant TMEV 2C coding 
regions in mammalian cells. Coding sequences for the mutant TMEV 2C proteins were PCR amplified 
from the cDNA of the viral genome and inserted into the multiple cloning site of the mammalian 
expression vector pcDNA3.1!V5-His TOPO®. The presence of the correct coding sequence inserts in 
the recombinant vectors was confirmed via restriction analysis with Bam H I and Xba 1. Digested 
vectors were electrophoresed through a 1% agarose gel (containing 0.16 fig/ml ethidium bromide) in 
Ix TAE buffer at 100V before being imaged under UV illumination. Lane \- ).. Pst DNA molecular 
weight ladder, Lane 2- pCOT2C containing an insert of the wild type 2C coding sequence, Lane 3-
pLMT2C4 containing an insert of the 2C mutant 4 coding sequence, Lane 4- pLMT2C8 containing an 
insert of the 2C mutant 8 coding sequence, Lane 5- pLMT2CI4 containing an insert of the 2C mutant 
14 coding sequence, Lane 6- pLMT2C 18 containing an insert of the 2C mutant 18 coding sequence, 
Lane 7- pLMT2C23 containing an insert of the 2C mutant 23 coding sequence, Lane 8- pLMT2C29 
containing an insert of the 2C mutant 29 coding sequence. All inserts are 978 bp in size while the 
pcDNA3.1!V5-His TOPO® vector is 5523 bp in size. 
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(ii) Chain-termination-based sequencing of recombinant vectors 
Chain-termination-based sequencmg was performed on the recombinant vectors 
shown in Figure 3.4.4 using the T7 primer (Invitrogen) to ensure the presence of the 
engineered mutation in the mutant 2C coding sequences. All the mutant 2C coding 
sequences contained the desired substitution mutation and no other mutations were 
detected. It must be noted however, that sequencing of these recombinant vectors with 
the T7 primer only resulted in the sequencing of at most the first 700 nucleotides of 
the mutant 2C coding sequences. Thus further sequencing with the BGH reverse 
primer is necessary before the presence of other mutations can be ruled out 
completely. 
3.4.8 Transient expression and indirect immunofluorescent localisation of 
mutant TMEV 2C proteins in BHK-21 cells 
With the aim of characterising the subcellular distribution of TMEV 2C proteins with 
point mutations at amino acids 4, 8, 14, 18, 23 and 29 and thus to determine the effect 
of these mutations on 2C localisation in host cells, BHK-21 cells were transfected 
with recombinant mammalian expression vectors encoding these proteins. Following 
an expression window of 19 hours, cells were fixed and immunostained with primary 
antibodies recognising the V5 epitope on the C-terminus of the expressed viral 
proteins as well as primary antibodies raised against specific marker proteins of the 
ER or Golgi apparatus. Subsequent to secondary staining with fluorophore-conjugated 
secondary antibodies, cells were mounted on microscope slides and examined by 
either laser-scanning confocal microscopy or epifluorescence microscopy. 
The TMEV 2C mutants 14, 18 and 23-V5 fusion proteins were all successfully 
expressed in BHK-21 cells at varying transfection efficiencies and cells were 
examined using the Zeiss LSM 510 Meta confocal microscope. Successful expression 
ofTMEV mutant 2C-V5 fusion proteins in transfected and immunostained BHK-21 
cells was indicated by the observation of red fluorescence when samples were excited 
with the 543nm laser line. Staining of organelle marker proteins was identified by 
green fluorescence when samples were excited with the 543nm laser line. 
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The TMEV 2C mutants 4, 8 and l8-VS fusion proteins were also successfully 
expressed in BHK-2l cells and cells were examined using the Olympus BX-6l 
epifluorescence microscope. Expression of TMEV protein-VS fusions was indicated 
by red fluorescence under the UMWIY2 cube due to the excitation of the Texas Red® 
fluorophore while green fluorescence resulting from the excitation of the Alexa 
Fluor® 488 fluorophore indicated the distribution of either the ERp60 ER marker 
protein or the ~-COP Golgi apparatus marker protein. 
A brief summary of the transfection efficiency of the constructs encoding the mutant 
2C proteins as well as the subcellular localisation of the various 2C mutant proteins is 
given in Table 3.4.3. 
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Table 3.4.3 Summary of the effect of amino acid substitution mutations in the TMEV 2C 
coding region on the replication proficiency of TMEV and the subcellular localisation of 
the 2C protein 
Position of Transfection Subcellular localisation of mutant 2C Replication 
amino acid efficiency of protein proficiency 
substitution on mutant 2C protein of mutant 
2C protein (%) virus 
o Faint reticular stain partially overlapping with Rapid 
ERp60 stain development of 
oAt high levels of expression protein was CPE in BHK· 
2C wild type 1-5 concentrated in concentrated structures in the 21 cells with 
perinuclear region that overlap with J3-COP high virus yield 
0 Faint perinuclear localisation 
o Majority of the protein is distributed in a 
reticular stain, partially overlapping with 
ERp60 
4 1-5 oAt high levels of expression protein was Retarded 
concentrated in concentrated structures in the development of 
perinuclear region that overlap with J3-COP CPE in BHK-
• Distinct perinuclear localisation 2 1 cells with an 
o Majority of the protein shows a cytoplasmic inhibited rate 
** 14 0.05 - 0.10 distribution 
of virus yield 
o Faint perinuclear localisation 
o Small punctate structures that partially 
overlap with the stain of the ER marker 
** 23 1-5 protein ERp60 
o Completely separate from J3-COP stain 
• No perinuclear stain 
o Majority of the protein is distributed in a 
reticular stain, partially overlapping with 
ERp60 
8 1-5 oAt high levels of expression protein was 
concentrated in concentrated structures in the 
perinuclear region that overlap with J3-COP 
o Distinct perinuclear localisation Does not cause 
o Majority of the protein shows a cytoplasmic CPE in BHK-
** 18 1-5 distribution 
21 cells 
• Faint perinuclear localisation 
o Majority of the protein is distributed in a 
reticular stain, partially overlapping with 
ERp60 
29 1-5 o At high levels of expression protein was 
concentrated in concentrated structures in the 
perinuclear region that overlap with J3-COP 
o Distinct perinuclear localisation 
** Note: The highlighted mutant 2C proteins in Table 3.4.3 displayed subcellular 
localisation patterns distinctly different to that of the wild type 2C protein. 
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(i) Transient expression of mutant 4, 8 and 29 TMEV 2C proteins in BHK-21 cells 
The TMEV 2C mutants 4,8 and 29-V5 fusion proteins were successfully expressed in 
BHK-21 cells at approximately equivalent transfection efficiencies to that of the wild 
type 2C protein. As with the wild type 2C protein, the majority of the mutants 4, 8 and 
29 2C proteins localised to a reticular stain that that partially overlapped with the 
ERp60 stain (Frames C, F, I and L, Figure 3.4.6). At higher levels of expression large 
structures in the perinuclear region that partially overlapped with the p-COP stain 
were also present (Frames C, F, I and L, Figure 3.4.7), however these structures were 
smaller and less numerous than those observed in cells expressing the TMEV 2C wild 
type protein. As with the 2C wild type protein, an approximately equal number of 
cells expressing the mutant 4, 8 and 29 2C proteins showed the two different protein 
distributions. 
Despite the many similarities, there was a distinct difference between the subcellular 
localisation of the wild type 2C protein and that of the mutant 4, 8 and 29 2C proteins 
in that cells expressing the 2C wild type protein showed a faint perinuclear stain while 
those expressing any of the mutant 4, 8 and 29 2C proteins showed a concentrated 
perinuclear stain. This was particularly evident in BHK-21 cells expressing the mutant 
29 2C protein. The subcellular localisation of the mutant 29 2C protein was also 
slightly different from that of the mutant 4 and 8 2C proteins as a slightly higher 
proportion of cells expressing the protein (60% as opposed to 50%) showed larger 
punctate structures in the perinuclear region, partially overlapping with the Golgi 
marker protein p-COP. 
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2C mutant 4 
2C mutant 8 
2C mutant 29 
2C wild type 
Figure 3.4.6. Subcellular localisation ofTMEV mutant 4, g and 29 2C-V5 fusion proteins in BHK-2I 
cells. BHK-21 cells were transfected with pLMT2C mutant constructs and expressed the encoded 2C 
mutant proteins. Cells were imaged using an Olympus BX6I epifluorescence microscope and 
AnalySIS B software. Cells are immunostained with primary antibodies raised against the V5 tag and 
the ERp60 ER marker protein, as well as fluorophore-conjugate secondary antibodies. Red 
fluorescence indicates the position of the mutant or wild type 2C-V5 fusion protein (Frames A, D, G 
and J), green fluorescence indicates the ERp60 stain (Frames B, E, Hand K) and yellow signal in the 
merged images (Frames C, F, I and L) indicates an overlap of red and green signals. The wild type 
and mutant 4, g and 29 2C proteins are localising to a reticular stain that partially overlaps with ERp60 
as well as showing distinct perinuclear localisation with some larger punctate structures adjacent to the 
nucleus. 
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2C mutant 4 
2C mutant 8 
2C mutant 29 
2C wild type 
Figure 3.4.7. Subcellular localisation ofTMEV mutant 4, 8 and 29 2C-V5 fusion proteins in BHK-2l 
cells. BHK-21 cells were transfected with pLMT2C mutant constructs and expressed the encoded 2C 
mutant proteins. Cells were imaged using an Olympus BX61 epifluorescence microscope and 
AnalySIS B software. Cells are immunostained with primary antibodies raised against the V5 tag and 
the p-COP Golgi marker protein, as well as fluorophore-conjugate secondary antibodies. Red 
fluorescence indicates the position of the mutant or wild type 2C-V5 fusion protein (Frames A, 0, G 
and J), green fluorescence indicates the p·COp stain (Frames B, E, Hand K) and yellow signal in the 
merged images (Frames C, F, I and L) indicates an overlap of red and green signals, The wild type 
and mutant 4, 8 and 29 2C proteins are local ising to a reticular stain as well as showing distinct 
perinuclear localisation with some larger punctate structures adjacent to the nucleus that partially 
overlap with P-COP, 
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The similarities between the localisation of the wild type and mutant 4, 8 and 29 2C 
proteins in BHK-21 cells suggests that amino acid substitution mutations at amino 
acid residues 4, 8 and 29 on the 2C protein do not grossly alter the localisation of this 
protein in host cells. Interestingly, of these three mutations only the mutant 4 TME 
virus is able to replicate in BHK-21 cells, while the mutant 8 and 29 TME viruses are 
unable to cause CPE in this cell line (Figure 3.4.4). In order to confirm the effects of 
these mutations on the localisation of the 2C protein the different proteins, future 
studies will include the examination of BHK-21 cells transiently expressing the 
different proteins using the same laser-scanning confocal microscope, unlike this 
study which had to resort to the use of two different microscopy techniques due to 
equipment constraints. 
Taken together, these results suggest that substitution mutations of amino acids 4, 8 
and 29 on the 2C protein do alter the replication proficiency of TMEV but that this 
effect is not a result of an altered ability of the 2C protein to localise to host cell 
membranes. However, in order to confirm that the subcellular localisation 
characteristics of the 2C protein is not altered by these mutations future studies will 
include membrane fractionation studies whereby BHK-21 cells, transiently expressing 
the wild type or mutant 4, 8 and 29 2C proteins, will be subjected to a membrane 
fractionation procedure followed by detection of the proteins in the different fractions 
by SDS-PAGE and Western analysis. 
(ii) Transient expression o/mutant 14, 18 and 23 TMEV 2C proteins in BHK-21 cells 
The TMEV 2C mutants 18 and 23-V5 fusion proteins were successfully expressed in 
BHK-21 cells at approximately equivalent transfection efficiencies (1-5 %) to that of 
the wild type 2C protein. In contrast, the TMEV 2C mutant 14-V5 fusion protein was 
only expressed at extremely low transfection efficiencies with approximately 0.05-
0.10 % of the total cells present expressing the protein. These three mutant proteins all 
displayed subcellular localisation patterns that were distinctly different to that of the 
wild type TMEV 2C protein (Table 3.4.3). 
The mutant 18 2C protein showed an even cytoplasmic distribution with a very faint 
perinuclear stain in all cells expressing this protein (frame D, Figures 3.4.8 and 3.4.9). 
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2C mutant 14 
2C mutant 18 
2C mutant 23 
2C wild type 
Figure 3.4.8. Subcellular localisation ofTMEV mutant 14, 18 and 23 2C-V5 fusion proteins in BHK-21 cells. BHK-
21 cells transfected with pLMT2C mutant constructs or pCOT2C and expressing either a TMEV mutant 2C-V5 
fusion protein or the wild type 2C-V5 fusion protein, respectively, and imaged using a Zeiss LSM 510 Meta 
confocal microscope and LSM 510 software. Cells are immunostained with primary antibodies raised against the V5 
tag and the ERp60 ER marker protein, as well as fluorophore-conjugate secondary antibodies. Red fluorescence 
indicates the position of the mutant or wild type 2C-V5 fusion protein (Frames A, D, G and J), green fluorescence 
indicates the ERp60 stain (Frames B, E, Hand K) and yellow signal in the merged images (Frames C, F, I and L) 
indicates an overlap of red and green signals. The mutant 14 and 18 2C proteins displayed and even cytoplasmic 
localisation with a very faint perinuclear stain. The mutant 23 2C protein localised to small distinct punctate 
structures that partially overlapped with the ERp60 stain. The localisation patterns of these mutant 2C protein were 
different from that of the wild type 2C protein that localised to a reticular stain as well as showing distinct 
perinuclear localisation with some larger punctate structures adjacent to the nucleus. 
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The substitution mutation at amino acid residue 18 converted a tryptophan residue to 
an alanine residue. Tryptophan is a large negatively charged amino acid compared to 
the neutral, small alanine and thus it is possible that such a gross change in the 
properties of the amino acid sequence would alter the tertiary structure of the 2C 
protein, thus affecting its ability to localise to host membranes. 
Like the mutant 18 2C protein, the mutant 14 2C protein showed an even cytoplasmic 
distribution with a very faint perinuclear stain in all cells expressing this protein 
(frame A, Figures 3.4.8 and 3.4.9). The replication proficiency of TMEV was 
inhibited by this same mutation (Figure 3.4.3) although mutant 14 TMEV was seen to 
revert back to the wild type virus after a significant time period following infection. 
Taken together, these results suggest that a substitution mutation at amino acid residue 
14 on the 2C protein affects the ability of this protein to associate with host 
membranes in a manner that severely inhibits viral RNA replication. Once again, the 
ability of this mutation to affect the membrane association characteristics of the 
TMEV 2C protein will be investigated through membrane fractionation studies. 
The 2C mutant 23 protein localises to small punctate structures that partially overlap 
with the stain of the ER marker protein ERp60 (frame G, Figure 3.4.8) but are 
completely separate from the stain of the peripheral Golgi marker protein ~-COP 
(frame G, Figure 3.4.9). Additionally, in approximately 50% of cells expressing the 
2C mutant 23 protein the ERp60 stain was extremely faint while the same stain in the 
remaining 50% of expressing cells was more punctate than reticular unlike cells not 
expressing the protein. The localisation of the 2C mutant 23 protein differed from that 
of the wild type 2C protein which was seen to localise to a faint reticular structures as 
well as to large structures adjacent to the nucleus, partially overlapping both the 
ERp60 and ~ -COP stains. Taken together these observations suggest that the 2C 
mutant 23 protein may be associating with and modifying the ER membranes in some 
way but is not associated with the membranes of the peripheral Golgi apparatus. In 
view of the fact that TMEV mutant 23 is able to replicate at an inhibited rate, the 
significance of the altered localisation of the 2C mutant 23 protein suggests that 
another virus protein is able to compensate for any altered functioning of the 2C 
protein. 
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2C mutant 14 
2C mutant 18 
2C mutant 23 
2C wild type 
Figure 3.4.9. Subcellular localisation ofTMEV mutant 14, 18 and 23 2C-V5 fusion proteins in BHK-
21 cells. BHK-21 cells transfected with pLMT2C mutant constructs or pCOT2C and expressing either 
a TMEV mutant 2C-V5 fusion protein or the wild type 2C-V5 fusion protein, respectively, and imaged 
using a Zeiss LSM 510 Meta confocal microscope and LSM 510 software. Cells are immunostained 
with primary antibodies raised against the V5 tag and the p-COP Golgi marker protein, as well as 
fluorophore-conjugate secondary antibodies. Red fluorescence indicates the position of the mutant or 
wild type 2C-V5 fusion protein (Frames A, D, G and J), green fluorescence indicates the p-COP stain 
(Frames B, E, Hand K) and yellow signal in the merged images (Frames C, F, I and L) indicates an 
overlap of red and green signals. The mutant 14 and 18 2C proteins displayed and even cytoplasmic 
localisation with a very faint perinuclear stain. The mutant 23 2C protein localised to small distinct 
punctate structures that were completely separate from the I3-COP stain. The localisation patterns of 
these mutant 2C protein were different from that of the wild type 2C protein that localised to a reticular 
stain as well as showing distinct perinuclear localisation with some larger punctate structures adjacent 
to the nucleus. 
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The biological significance of the altered localisation of the 2C mutant proteins with 
respect to the role of the 2C protein in viral replication is not clear. In order to link the 
ability of point mutations in the N-terminal domain of the 2C protein to attenuate, and 
in some cases completely abolish, TMEV replication a loss of function in either the 
2C or 2BC proteins must be demonstrated. To this end future studies would firstly 
involve the localisation of transiently expressed 2BC mutant proteins followed by the 
characterisation of the membrane binding abilities of both the mutant 2C and 2BC 
proteins compared with those of the wild type 2C and 2BC proteins. Further 
investigations could compare the ability of the mutant and wild type TMEV 2C 
proteins to bind negative sense viral RNA and to exhibit ATPase/GTPase activity. 
3.5 CONCLUSIONS 
Point mutations were successfully created at highly conserved amino acid residues in 
the N-terminal domain of the 2C protein. The following conclusions were reached 
regarding the effect ofthese mutations on the ability ofTMEV to replicate in BHK-21 
cells and on the subcellular localisation of the 2C protein: 
I. Amino acids 4, 8, 14, 18, 23 and 29 at the N-terminal domain of the TMEV 2C 
protein are highly conserved throughout the picornavirus family. Amino acid 
substitution mutations were successfully created at these amino acid residues in 
the cDNA genome of TMEV, inserted into the pBlueScript® II Phagemid 
Vector. 
2. Amino acid substitution mutations at amino acids 4, 14 and 23 attenuate but do 
not completely abolish TMEV replication. The point mutation at amino acid 23 
is retained in the replicating mutant TME virus. In contrast repeated chain-
termination based sequencing revealed that the point mutations at amino acids 4 
and 14 both revert to the wild type sequence in a portion of the viable virus 
particles present. 
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3. The replication kinetics of TMEV mutant 23 differ to that of wild type TMEV. 
The rate of TMEV mutant 23 nascent virions produced over time and the 
uppermost concentration of virions produced when 100% of the infected BHK-
21 cells had succumbed to CPE were both drastically lower than that of the wild 
type virus. 
4. The retarded replication kinetics of TMEV mutant 4 closely resembled those of 
TMEV mutant 23. In view of the reversion of the engineered mutation to the 
wild type sequence this suggests that a mixed population of wild type and 
mutant virions are present and that the TMEV mutant 4 replication may 
dominate that of the wild type virus. 
5. The replication kinetics of TMEV mutant 14 indicate that although a portion of 
the virus particles present in BHK-21 cells infected with this virus may have 
reverted to wild type TMEV, the substitution mutation at amino acid 14 on the 
2C protein as a dominant negative mutation to any wild type 2C or 2BC proteins 
present to a greater extent than the mutation at amino acid 4. 
6. Point mutations at amino acids 8, 29 and possibly amino acid 18 of the 2C 
protein completely abolish the ability of TMEV to replicate in BHK-21 cells 
indicating that these mutations dramatically alter the ability of the 2C or 2BC 
proteins to interact with negative sense viral RNA and host cell membranes 
possibly preventing the assembly of the viral replication complex and viral RNA 
replication. 
7. In addition to BHK-21 cells, TMEV strain GOVII is able to infect NIH-3T3 
cells in tissue culture but is unable to infect HeLa or Cos-7 cells. The 
development ofTMEV-induced CPE in NIH-3T3 cells is retarded compared to 
that in BHK-21 cells but it is unknown whether repeated rounds of infection of 
the virus in NIH-3T3 cells would enable the virus to "adapt", adjusting the 
replication kinetics ofthe virus in this cell line. 
8. The localisation of transiently expressed mutant 4, 8 and 29 TMEV 2C proteins 
in BHK-21 cells was similar to that of the wild type 2C protein. This suggested 
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that the altered ability of the mutant 4, 8 and 29 TME viruses to induce CPE in 
BHK-21 cells was not a symptom of an altered localisation of the 2C protein in 
host cells. Further studies would investigate whether the altered ability of the 
mutant 4,8 and 29 TME viruses to cause CPE in BHK-21 cells was linked to an 
altered membrane-association ability, a reduced ATP/GTPase activity or altered 
ability of these proteins to bind the negative strand of viral RNA during viral 
replication. 
9. Transiently expressed mutant 14 and 18 TMEV 2C proteins showed an even 
cytoplasmic distribution with a faint perinuclear stain. The contrast of this 
localisation pattern with that of the wild type 2C protein suggests that these 
proteins have an altered ability to localise in host cells and that this may be the 
cause for the altered ability of mutant 14 and 18 TME viruses to induce CPE in 
BHK-21 cells 
10. Transiently expressed TMEV mutant 23 protein localised to small punctate 
structures that partially overlap with the stain of the ER marker protein ERp60 
but are completely separate from the stain of the peripheral Golgi marker protein 
~-COP. As previously mentioned, the wild type 2C protein localises to a faint 
reticular stain and! or large structures adjacent to the nucleus and partially 
overlaps with both the ERp60 and ~-COP stains. These contrasting localisations 
suggest that the mutant 23 2C protein localises to regions of the secretory 
pathway in a dissimilar manner to that of the wild type 2C protein. 
II. Further studies would investigate the effect of the specific point mutations 
engineered into the 2C protein in this study on the membrane association 
characteristics of both the mutant 2Cand 2BC proteins. This would be followed 
by an investigation of the effect of the point mutations on the ability of the 2C 
protein to bind negative sense viral RNA and to exhibit ATPase/GTPase 
activity. 
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4 General discussion and future studies 
4.1 GENERAL DISCUSSION AND FUTURE WORK 
Primarily, this study sought to increase the general understanding of the interactions 
formed between picornavirus non-structural proteins and host cell components with 
the broader aim of expanding knowledge to allow the development of novel strategies 
for the control of picornavirus infections. 
The localisation of the TMEV non-structural 2B, 2C, 2BC and 3A proteins in BHK-
21 cells was compared to that of the corresponding FMDV and PV proteins. Despite 
the highly conserved genome organisation of the Picornaviridae, notable differences 
in the localisation of the FMDV and PV non-structural proteins in host cells have 
been reported (Doedens and Kirkegaard, 1995; Moffat et ai, 2005 ; Aldabe and 
Carasco, 1995; Bienz et ai, 1987; Bienz et ai, 1990; Bienz et ai, 1992; Cho et ai, 
1994; Schlegel et ai, 1996; Rust et ai, 2001 ; Doedens et ai, 1997, Neznanov et ai, 
2001). 
The distribution of transiently expressed TMEV 2B protein in a reticular stain in 
BHK-2l cells resembled that of the FMDV 2B protein (Moffat et ai, 2005). However, 
there was some apparent colocalisation with the Golgi marker protein ~-COP, 
suggesting that the localisation of the TMEV 2B protein may also imitate that of the 
PV 2B protein which localises exclusively to the Golgi (Doedens and Kirkegaard, 
1995). Similarly, the localisation of the TMEV 2C protein most closely mimicked that 
of the FMDV 2C protein and not that of the PV 2C protein, as discussed in Section 
2.4.2. 
The TMEV 2BC protein appeared to locate exclusively to the Golgi. This distribution 
was distinct from that of both the PV and FMDV 2BC proteins which have been 
shown to associate with the membranes of the ER (Moffat et ai, 2005; Rust et ai, 
2001). The TMEV 3A protein localised to the ER as well as the peripheral Golgi. The 
former observation, together with the distorted swelling of ER cisternae, resembled 
the localisation of both the PV and FMDV 3A proteins to an extent (Moffat et ai, 205; 
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Doedens et ai, 1997; Neznanov et ai, 2001). Thus the comparison of the distributions 
of the transiently expressed 2B, 2C, 2BC and 3A proteins in host cells with the 
FMDV and PV proteins served only to demonstrate the diverse manner in which 
corresponding picornavirus proteins interact with host cell components while 
highlighting the involvement of secretory pathway membranes in picornavirus 
replication. 
Future studies will involve an investigation of the membrane association 
characteristics of these TMEV proteins in order to gain a more complete 
understanding of their interaction with host membranes. This will involve the 
transient expression ofthe TMEV proteins in BHK-21 cells, followed by a differential 
fractionation procedure and coimmunoprecipitation of the TMEV proteins and the 
various organelle marker proteins from membrane fractions pertaining to specific 
organelles. 
Following the description of the localisation of the non-structural TMEV proteins, the 
effect of these proteins on the ultrastructure of the same host cells will be investigated 
to determine which, if any, of the 2B, 2C, 2BC or 3A proteins are able to induce the 
disassembly of the Golgi complex and! or the formation of vesicles. This will be 
performed through the examination of BHK-21 cells transiently expressing viral 
proteins by transmission electron microscopy. Following this, protein transport assays 
will be conducted to identify whether these proteins are able to disrupt protein 
trafficking through the exocytic pathway. 
A more complete understanding of the roles played by the various picornavirus non-
structural proteins in the assembly of the virus replication complex on the surface of 
modified host membranes is dependent on the identification of the mechanism 
through which these proteins interact with the host membranes in question. Interaction 
with host membranes must either occur directly or be mediated through the interaction 
of viral proteins with host membrane proteins. Picornavirus proteins may also form 
additional viral protein-host protein interactions during other stages of the virus 
replication cycle. Identification and understanding of these interactions would greatly 
enhance the general understanding of picornavirus replication as well as possibly 
providing targets for therapeutic drugs. Future studies will endeavour to identify and 
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describe interactions between TMEV non-structural proteins and host proteins 
through the coirnrnunoprecipitation of viral and host proteins using protein pull-down 
assays. 
The detection of the TMEV 2B, 2C, 2BC and 3A proteins by Western analysis during 
membrane fractionation procedures or protein pull-down assays as well as the 
localisation of these proteins in transiently expressing host cells by electron 
microscopy is reliant on the availability of antibodies against these proteins. To this 
end, this study sought to express and purify a hydrophilic, antigenic region of the 2C 
protein in fusion with an N-terminal GST-tag. This was successfully achieved and 
future studies will involve the large-scale expression and purification of the GST-
2C 178 fusion peptide and the production of antibodies against this peptide, which will 
recognise both the TMEV 2C and 2BC proteins. The expression, purification and 
raising of antibodies against the 2B and 3A proteins may also be performed in future. 
Various amino acid substitution mutations in the highly conserved N-terminal domain 
of the TMEV 2C protein affected the localisation of this protein in BHK-l cells as 
well as the overall replication proficiency of the TME virus to different extents. The 
mutation of amino acids 14, 18 and 23 caused the mutant 2C proteins to localise in a 
manner distinct from that of the wild type 2C protein, while the localisation of the 2C 
protein was less dramatically altered by the mutation of amino acids 4, 8 and 29. In 
contrast, mutation of amino acids 8, 18 and 29 on the 2C protein completely inhibited 
the ability of TMEV to induce CPE in BHK-21 cells, while TME viruses with amino 
acid substitution mutations at amino acids 4, 14 and 23 showed an inhibited ability to 
induce CPE in BHK-21 cells. 
In order to discern whether the altered ability of the mutant TME viruses to cause 
CPE in BHK-21 cells is a direct consequence of an altered membrane association 
ability of the mutant 2C proteins, the association of these mutant proteins with host 
cell membranes will be investigated by the comparative coirnrnunoprecipitation of the 
mutant and wild type 2C proteins with various organelle marker proteins from 
membrane fractions pertaining to specific organelles. 
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4.2 CONCLUSION 
In conclusion, this study has described the localisation of the TMEV 2B, 2C, 2BC and 
3A proteins in BHK-21 cells and the effect of introducing amino acid substitution 
mutations at highly conserved residues in the N-terminal domain of the 2C protein on 
the localisation of this protein as well as the overall replication proficiency ofTMEV. 
Additionally the research reported here has prepared an extensive platform from 
which future research activities will be able to greatly increase our understanding of 
the varied interactions formed between host cell components and the proteins of 
different picomaviruses. 
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Appendix A Vector Maps 
A.I Commercial vectors 
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Figure A.I The pcDNA3.1N5-His© TOPO® mammalian expression vector (Invitrogen) 
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Figure A_2 The pBlueScript® II Phagemid Vector (Slratagene) 
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A.2 Recombinant vectors with pcDNA3.IN5-His© TOPO® as the parent vector 
The insert shown in the recombinant vector below represents the coding sequence for 
anyone of the TMEV proteins shown in Table A.!, 
Table A.I Recombinant vectors and corresponding inserts represented by Figure 
A.4 
Recombinant 
vector 
pLMT2B 
pCOT2C 
pLMT2C4 
pLMT2C8 
pLMT2CI4 
pLMT2CI8 
pLMT2C23 
pLMT2C29 
pLMT2BC 
pLMT3A 
pLMT2C60 
pLMT2BC60 
TMEV protein Insert size Recombinant vector size 
coding sequence (bp) 
2B 380 
2C 978 
2C mutant 4 978 
2C mutant 8 978 
2C mutant 14 978 
2C mutant 18 978 
2C mutant 23 978 
2C mutant 29 978 
2BC 1 358 
3A 264 
2C60 180 
2BC60 560 
AmpR 
pcDNA3.1/V5-HiS-TOPO 
Neo R 
CMV P 
T7 P 
.fum HI (9Zl) 
Insert 
-.<:.. xoo I ('9>51 
V5·6xHis 
(bp) 
5903 
6 SOl 
6 SOl 
6 SOl 
6501 
6501 
6 SOl 
6501 
6881 
5787 
5703 
6083 
Figure A.4 A representative of the recombinant vectors created through the insertion of the wild type 
2B, 2C, 2BC and 3A, truncated 2C and 2BC and mutant 2C TMEV coding sequences into the 
mammalian expression vector pcDNA3.IN5-His© TOPO®. The insert in this recombinant vector 
represents anyone of these coding sequences. 
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A.3 Recombinant vector constructed by inserting the coding sequence of the 
TMEV genome into the pBlueScript® II Phagemid Vector 
Table A.2 Recombinant vectors and corresponding inserts represented by Figure 
A.4 
Recombinant vector 
pGDVII-WT 
pGDVII-mt4 
pGDVII-mt8 
pGDVlI-mt14 
pGDVII-mtI8 
pGDVII-mt23 
pGDVII-mt29 
TMEV genomic sequence 
Wild type 
Substitution mutation at amino acid 4 on 2C P!otein 
Substitution mutation at amino acid 8 on 2C protein 
Substitution mutation at amino acid 14 on 2C protein 
Substitution mutation at amino acid 18 on 2C protein 
Substitution mutation at amino acid 23 on 2C protein 
Substitution mutation at amino acid 29 on 2C protein 
AmpR 
4 F 
Xho 1(669) 
Sal I (6751 
Feo RV(698) 
17P 
TJP 
Not 1(8828) 
Xoo 1(8821) 
&1m HI (880<)) pGOVIl-WT or 
mt vector 
11050 bp 
PstI(7408) 
lMEV genome 
Figure A.S A representative of the recombinant vectors named pGDVlI·WT or pGDVII·mt, created 
through the insertion of the wild type or mutant TMEV genomic sequences into the pBlueScript® II 
Phagemid Vector. 
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A.2 pLMG2T2C178 recombinant vector 
G lutathi one S-transferase 
BamH1 
Ptac 
pLMG2T2C178 
5178 bp 
2C178 coding sequence 
Eco R1 
Figure A.6 The pLMG2T2C 178 recombinant vector created through the insertion of the 2C 178 peptide 
into the bacterial expression vector pGEX-2T. 
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AppendixB Sequence data 
B.l Coding regions for the wild type and truncated TMEV P2 and 3A proteins 
subcIoned into the pcDNA3.lfV5-His TOPO mammalian expression vector 
The constructs resulting from the subcloning of the TMEV 2B, 2C, 2BC and 3A 
coding regions into the mammalian expression vector pcDNA3.1fV5-His TOPO® 
were sequenced using T7 forward and BGH reverse sequencing primers (Invitrogen). 
Recombinant TMEV Protein Sequencing Protein Undesirable mutations 
vector Encoded Primers in frame 
Single substitution (Glu to Lys) 
pLMT2B 2B T7 &BHG Yes present at amino acid 69. Present 
in pGD7 templates 
pCOT2C 2C T7&BHG Yes None 
Single substitution (Glu to Lys) 
pLMT2BC 2BC T7 &BHG Yes present at amino acid 69. Present 
in pGD7 templates 
pLMT3A 3A T7 Yes None 
pLMT2C60 Truncated 2C T7 Yes None 
pLMTIBC60 Truncated 2BC T7 Yes None 
B.2 Coding regions for mutant TMEV 2C proteins subcIoned into the 
pcDNA3.lfV5-His TOPO mammalian expression vector 
The constructs resulting from the subcloning of the mutant TMEV 2C coding regions 
into the mammalian expression vector pcDNA3.1fV5-His TOPO® were sequenced 
using T7 forward and BGH reverse sequencing primers (Invitrogen). 
Recombinant Position of Sequencing Protein Undesirable mutations 
vector amino acid Primers in frame 
substitution 
pLMTIC4 4 T7 Yes None 
pLMTIC8 8 T7 Yes None 
pCOT2C14 14 T7 Yes None 
pCOT2C18 18 T7 Yes None 
pLMT2C23 23 T7 Yes None 
pLMT2C429 29 T7 Yes None 
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B.3 Recombinant pLMG2T2C4 vector 
Recombinant Coding Sequencing Peptide in 
vector region Primers frame 
pLMG2T2C4 2C178 pGEX3' Yes 
peptide sequencing primer 
The sequence of the pGEX 3' sequencing primer is as follows: 
5'-CCGGGAGCTGCA TGTGTCAGAGG-3' 
Undesirable 
mutations 
None 
B.4 Wild type and mutant TMEV genome sequences inserted into the 
pBlueScript® II Phagemid Vector 
Recombinant vector Sequencing Desired mutation 
primer present 
pGDVII-mt4 2Bf Yes 
pGDVII-mt8 2Bf Yes 
pGDVII-mtl4 2Bf Yes 
pGDVII-mtI8 2Bf Yes 
pGDVII-mt23 2Bf Yes 
pGDVII-mt29 2Bf Yes 
The sequence of the 2Bf sequencing primer is as follows: 
5'-CCTGTGCAGTCGGTTTTTCAGCC -3' 
B.5 Replicating TMEV mutants 4 and 23 RT-PCR products 
Undesirable 
mutations 
None 
None 
None 
None 
None 
None 
RT-PCR product Sequencing Desired mutation 
Primers present 
TMEV mt 4 RT-PCR 2Bf No 
TMEV mt 14 RT-PCR 2Bf No 
TMEV mt 23 RT-PCR 2Bf Yes 
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B.6 Non-replicating TMEV mutants 8, 18 and 29 sequenced between the Ace III 
and Eco NI sites overlayed with the sequences in point 5 above 
Recombinant Sequenced Sequencing Desired Undesirable mutations 
vector Primers mutation 
present 
AccIII fwd • Substitution mutation at amino 
pGDVII-mt8 Yes AccIII rev Yes acid 69 in the 2B protein. Present 
in all pGD-7sequences. 
• 3 substitution mutations at amino 
acids 74, 75, 76 III the 2A 
protein. 
pGDVII-mt18 Yes AccIII fwd Yes • 2 substitution mutations at amino 
AccIlI rev acids 14&30in the 2B protein. 
• Substitution mutation at amino 
acid 69 in the 2B protein. Present 
in all pGD-7 sequences. 
AccIII fwd • Substitution mutation at amino 
pGDVII-mt29 Yes AccIII rev Yes acid 69 in the 2B protein. Present 
in all pGD-7sequences. 
The sequence of the AccIII forward sequencing primer is as follows: 
5'-CCCGCTTCTCTCTACCGC -3' 
The sequence of the AccIII reverse sequencing primer is as follows: 
5'-CCTGTCTGGTGGGGACTGGGC -3' 
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Appendix C Primers for PCR amplification 
Table C.I Primers used for PCR amplification of TMEV protein coding sequences 
PCR Forward primer Reverse primer 
product (5' - 3') (5' - 3') 
2B 2BF: 2BR:CTGAGGTTGCATGACATTGG 
TTTGGATCCACCATGCCTGTGCAGTCGTTT 
TTCAG 
2C 2CF: 2CR: 
TTTGGATCCACCATGGGGCCTCTACGCGAG GGGCCCTCTAGACTCTGGGCAACCAAGCTGT 
G TC 
2BC 2BF 2CR 
3A 3AF: 3AR: 
TTTGGATCCACCATGTCCCCACCAGACTGG GGGCCCTCTAGACTCTGTTCGCCCTCAGAGA 
CAAC GC 
2C60 2CF 2C60R: 
CCCGGGTCTAGACTAGGGAATTCCATAAGC 
2BC60 2BCF 2C60R: 
CCCGGGTCTAGACTAGGGAATTCCATAAGC 
2Cl78 ASqeF: ASqeR: 
CCCGGATCCACTAGCTGGTTCAAGCAGG CCCAAGCTTTCAGCTAGAGGTGAAAGGGGT 
Table C.2 Primers used for the overlap PCR amplification of mutant TMEV genome 
codinl! sequences 
Overlap PCR Round I (reaction 1) Round 1 (reaction 2) Round 2 
product 
TMEV GDVII TME28CF R4AF TME28CF 
mutant 4 R4AR TME28CR TME28CR 
TMEVGDVII TME28CF E8AF TME28CF 
mutant 8 E8AR TME28CR TME28CR 
TMEV GDVII TME28CF K14AF TME28CF 
mutant 14 K14AR TME28CR TME28CR 
TMEV GDVII TME28CF W18AF TME28CF 
mutant 18 W18AR TME28CR TME28CR 
TMEVGDVII TME28CF I23AF TME28CF 
mutant 23 I23AR TME28CR TME28CR 
TMEV GDVII TME28CF W29AF TME28CF 
mutant 29 W29AR TME28CR TME28CR 
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Table C.2 Sequences of primers used for overlap PCR reactions 
Primer name Sequence (5' - 3') 
TME28CF GTG CTC ACC TIC CGG A TI CCA GGC TIC GGT CTG 
TME28CR CCA TIT TCA CAA CCT GTI GAA GGT TGT AGA C 
R4AF GCC TCT AGC CGA GGC CAA TG 
R4AR CAT TGG CCT CGG CTA GAG GC 
E8AF CGA GGC CAA TGC CGG TIT T AC 
E8AR GGT AAA ACC GGC ATI GGC C 
K14AF ACC TTI GCC GCC AA T A TI GAA TGG 
K14AR CCA TIC AAT ATI GGC GGC AAA GG 
W18AF GAA TAT TGA AGC CGC CAC GAA AAC C 
W18AR GGT TTT CGT GGC GGC TIC AA T A TI C 
123AF ACG AAA ACC GCC CAG TCC ATI G 
123AR CAA TGG ACT GGG CGG TIT TCG T 
W29AF CCA TTG TCA ATG CCC TT A CT A GC 
W29AR GCT AGT AAG GGC A TI GAC AA T GG 
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